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Abstract
Preliminary studies have been undertaken on the enzyme, glutamate 
mutase. Stereochemically pure (2S,3S)-3-ethylaspartic acid has been 
synthesized. The turnover of this substrate analogue by glutamate mutase 
has been investigated. Possible reaction products have been synthesized.
(2S,3S)-[1 ',1 ',2',2',2'-^H]-3-Ethylaspartic acid has been prepared and a 
novel synthesis of [1-^H]-ethanol has been investigated with the aim of 
preparing (2S,3S)-[1 '-^H]-3-ethylaspartic acid.
In order to investigate the mechanism of elimination of ammonia from 
(2S ,3R )"3 -m eth ylasp artic  acid, by the enzym e 3-m ethy laspartase , 
stereospecific routes to (2S,3R)-3-methylaspartlc acid and [3-^H]-(2S,3R)-3- 
methylaspartic acid have been explored. The compounds were obtained in 
high enantiomeric excess and with >97 % incorporation of deuterium into 
the latter. It has been demonstrated that 3-methylaspartase catalyses the 
direct elimination of ammonia from these substrates, presumably by a syn- 
elimination mechanism. The kinetic parameters, and K^, have been 
determ ined  for both com pounds at 1 and 50 mM potassium  Ion 
concentrations. A deuterium isotope effect on (^ M ) of 7.15 ± 2.74 was 
measured for the reaction at 1 mM potassium ion concentration. A large 
^(V ) of 6 .79  ±  0 .92  was also observed at 50 mM potassium  ion 
concentration, in contrast to results with the natural isomer which show the 
effect is completely suppressed at this potassium ion concentration. Values 
for ^(V/K) were also obtained at 1 and 50 mM potassium ion concentrations. 
They were 3.39 ± 1.6 and 4.10 ±  1.3, respectively. The isotope effect on 
V/K was measured at 1 mM potassium ion concentration. A value of 1.0028 
±  0.0040 was observed for (2S,3R)-3-methylaspartic acid, and, a value of 
1.0033 ±  0.0043 observed for [3-^H]-(2S,3R)-3-methylaspartic acid.
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Vppax maximum rate of substrate turnover at saturation
List of Amino Acids
Amino acid Three letter code Single letter
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamic acid Glu E
Glutamine Gin Q
Glycine Gly G
Histidine His H
Isoleucine lie I
Leucine Leu L
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
T ryptophan Trp W
Tyrosine Tyr Y
Valine Val V
CHAPTER ONE
INTRODUCTION
GLUTAMIC ACID
FERMENTATION
1.1.1 The Methyiaspartic Acid-Eathway.
Glutamic acid (1) is used as the main energy source in certain obligate 
anaerobesi. A number of catabolic routes for glutamic acid exist. In the soil 
anaerobe Clostridium tetanomorphum, and several other Clostridial 
species, the route utilized is the ‘methylaspartic acid pathway’ (Scheme 1.1). 
This glutamic acid degradation pathway was first elucidated by H. A. Barker 
and co-workers^ studying Ciostridium tetanomorphum. This species of 
bacteria {Ciostridium tetanomorphum strain HI (ATGC 15920)) has been 
the enzyme source for most of the studies performed on the pathway.
There is also some evidence that this fermentation route operates in the 
photosynthetic, purple nonsulphur bacteria, Rhodospirilium rubrum and 
Rhodopseudomonas spheroides  ^ (see section 1.1.5, p. 7.). However it is 
thought not to be the major catabolic pathway^. A similar pathway may also 
be used in an anabolic sense by the bacterium Acetobacter suboxydans^>^ 
(see section 1.1.6 , p. 10.), although it is not the primary route of glutamic acid 
assimulation^.
1.1.2 Elucidation of the Methvlaspartic Acid Pathway
The first step in the methylaspartic acid pathway (Scheme 1.1) is the carbon 
skeleton  rearrangem en t of (2 S )-g lu tam ic  acid ( 1 ) to (2 S ,3 S )-3 -  
methylaspartic acid (2). The reaction is catalysed by glutamate mutase, a 
coenzyme 8^2 -dependent enzyme®. The next step involves deamination of
(2S,3S)-3-methylaspartic acid, by the enzyme, 3-methylaspartase®, to give 
mesaconic acid (3) ((E)-2-methylbutenedoic acid). Ammonia is lost by an 
anti- elimination. Hydration of the double bond of mesaconic acid, in an 
anti- Markovnikov fashion, by mesaconasei®, gives (S)-citramalic acid (4). 
Citramalate lyase^  ^ then cleaves the molecule into pyruvic acid and acetic 
acid. The pyruvic acid is oxidatively decarboxylated to give acetyl-CoA. 
Two acetyl-CoA units form butyryl-CoA and, hence, butyric acid. Adenosine 
triphosphate (ATP) is generated from cleavage of the thioesters.
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Scheme 1.1 The Methylaspartic Acid Pathway
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A number of routes for glutamic acid degradation were postulated in the 
years following the initial observation, in 1937, that glutamic acid was 
converted to acetic acid, butyric acid, carbon dioxide, ammonia and 
hydrogen"'. Quantitative analysis showed that only one mole of carbon 
dioxide was produced per mole of glutamic acid. This excluded any 
possible degradation pathway via a-ketoglutaric acid (5), succinic acid (6), 
fumaric acid (7), malic acid (8 ), oxaloacetic acid (9) and pyruvic acid 
(essentially the tricarboxylic acid cycle in an oxidative direction) (Scheme 
1.2), which would yield at least three moles of carbon dioxide per mole of 
glutamic acid. However other pathways, e.g. the 2-hydroxyglutaric acid 
pathway (see section 1.1.3, Scheme 1.3), would produce one mole of 
carbon dioxide per mole of glutamic acid.
With the advent of specifically labelled "'^C-glutamic acids, it became 
possible to ascertain the fate of the individual carbon atoms of glutamic acid 
during fermentation. Wachsman showed, in 1955, that the labels derived 
from C-1 and C-2 of glutamic acid were found in acetic acid. The label at C- 
4 of glutamic acid enriched C-1 and 0-3  of butyric acid and 0 -5  of glutamic 
acid was oxidized to carbon dioxide^ ^
Paper chromatographic analysis of the products from the reaction of 
glutamic acid with a cell-free extract of C. tetanomorphum revealed the 
accumulation of a UV-absorbing acidic constituent. This compound was 
identified as mesaconic acid^^ xhe structure was confirmed by showing 
that authentic mesaconic acid was a substrate for the extract. Thus, it was 
evident that the linear carbon chain of glutamic acid had been converted into 
a branched chain compound, mesaconic acid.
In further work, by Munch-Petersen and Barker, using [i^cj-glutamic acids, 
the fate of the carbon atoms in mesaconic acid was determined"'^. They 
discovered that C-1 and 0-2  of glutamic acid were transferred together from 
0-3  of glutamic acid to 0-4, using the numbering system of the glutamic acid 
carbon skeleton. Thus the bond between 0-2  and 0-3  of glutamic acid had 
cleaved and a new bond had formed between the original 0 -2  and 0 -4  of
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glutamic acid. The C-3 methylene group of glutamic acid had become the 
methyl group of mesaconic acid (see Schemes 1.1 and 1.14).
It was not obvious how glutamic acid was converted to mesaconic acid. In 
their investigations into the number and nature of the enzymes involved in 
the conversion, Munch-Petersen and Barker treated the crude cell-free 
extract from C. tetanomorphum with charcoaM^. This extract was found to 
be completely inactive when incubated with glutamic acid. However, in the 
presence of ammonium ions, the extract utilized mesaconic acid"'®. A new 
amino acid accum ulated. It was shown to be (2 S ,3 S )-L -f/7reo -3 - 
methylaspartic acid"'^. This intermediate was the direct amination product of 
mesaconic acid. Hence it appeared that (2S)-L-glutamic acid was converted 
to the branched chain amino acid, (2S,3S)-3-methylaspartic acid, in one 
step. This reaction was dependent upon a novel cofactor which was 
Inactivated by charcoal.
1.1.3 The 2-Hydroxyglutaric Acid Pathway
Whilst the methylaspartic acid pathway is important in certain anaerobes, 
other routes of glutamic acid degradation are also available"'®. One such 
route is the 2-hydroxyglutaric acid pathway (Scheme 1.3) elucidated by 
Westlake in 1966^®. In this pathway, (S)-glutamic acid (1) is converted, via 
2-ketoglutaric acid (5), to (2R)-hydroxyglutaric acid (10),20 and eventually to 
acetic acid and butyric acid. Thus the linear carbon chain of glutamic acid 
remains intact in the butyric acid product. This was confirmed by the 
labelling pattern of butyric acid produced by the fermentation of ^^C-labelled 
glutamic acid in cell suspensions of Peptococcus aerogenes
The decarboxylation of glutaconyl-CoA (11) liberates 30 kJ moM free 
energy^f. The organism uses this energy source to drive a sodium pump 
and thus establish an electrochemical sodium gradient which allows the 
transport of metabolites in and out of the cell.
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Scheme 1.3 The 2-Hydroxyglutaric Acid Pathway
1.1.4 The Occurrence of the Two Pathways
Buckel and Barker^^ surveyed several species of bacteria, examining the 
butyric acid labelling patterns obtained when [4-i^C]-glutamic acid was 
fermented. This gave an indication of how extensively each pathway 
occurred.
Butyric acid from the fermentation of [4-i"^C]~glutamic acid via the 
methylaspartic acid pathway had labels at C-1 and C-3, as it was derived 
from the condensation of two identical acetyl groups, mainly derived from C- 
3 and C-4 of glutamic acid. In contrast the butyric acid, from the 2- 
hydroxyglutaric  acid pathw ay, was labelled  at only C -4 , as no 
rearrangement of the carbon chain had occurred. Material from the 
methylaspartic acid pathway also contained twice the radioactivity of the 
butyric acid formed via the 2-hydroxyglutaric acid route. Assays for 3- 
methylaspartase and 2-ketoglutarate reductase, key enzymes from each 
pathway, were also performed^^.
The results showed that the 2-hydroxyglutaric acid pathway was used by a 
wide variety of bacteria e.g. Peptococcus aerogenes, Acidaminococcus 
fermentans, Fusobacterium nucleatum, Fusobacterium fusiformis and 
Clostridium microsporum. This latter microorganism may be wrongly 
classified as a Clostridium and may in fact be a Fusobacterium 22. Thus, 
the 2-hydroxyglutaric acid pathway is used by representatives of several 
genera, whereas, the methylaspartic acid pathway seemed to be restricted 
mainly to Clostridia.
1.1.5 Glutamic Acid Metabolism in Photosvnthetic Bacteria
In the photosynthetic bacteria , R hodospirilium  rubrum  and  
Rhodopseudomonas spheroides, 3-methylaspartic acid, mesaconic acid 
and citramalic acid were detected as intermediates^-^. However the 
methylaspartic acid pathway accounted for only 10 to 20 % of glutamic acid
7
metabolism^. The major proportion of glutamic acid (80 %) was converted to
2-ketoglutaric acid (5) and hence to 2-hydroxyglutaric acid (12) and succinic 
acid (13) (Scheme 1.4).
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Scheme 1.4 The Conversion of Glutamic Acid to Succinic Acid
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1,1,6 Glutamic Acid Biosynthesis in Acetobacter suboxydans
The obligate aerobe Acetobacter suboxydans appears to lack a functional 
tricarboxylic acid cycle^^. However it does biosynthesize glutamic acid^" ,^ 
presumably by another route. Cheldelin et al. reported that two pathways 
operated. One involved the condensation of glyoxylic acid and oxaloacetic 
acid (9), and the other was essentially the reverse of the methylaspartic acid 
pathway25. Administration of ^^C-labelled pyruvic acid and acetic acid to 
either growing cells or a cell free extract gave labelled glutamic acid and 3- 
methylaspartic acid. Citramalic acid and mesaconic acid were also 
demonstrated to be intermediates on the pathway. All intermediates were 
isolated and characterised.
However, the 3-methylaspartic acid isolated did not co-crystallize with 
synthetic (2R/S,3S)-3-methylaspartic acid, which was mainly in the threo- 
form. Also, the slow conversion rate of the isolated 3-methylaspartic acid to 
mesaconic acid on incubation with 3-methylaspartase from Clostridium  
tetanomorphum indicated that the l-erythro -isomer of 3-methylaspartic acid 
was utilized in this pathway^^. Kato isolated Coenzym e from 
Acetobacter suboxydans ^6. It may be present as the cofactor for glutamate 
mutase.
How ever, more recent workers failed to find any evidence for the 
methylaspartic acid pathway in Acetobacter suboxydans and showed that a 
third pathway was entirely responsible for glutamic acid biosynthesis^. They 
showed the bacteria lacked only the succinate dehydrogenase enzyme of 
the tricarboxylic acid cycle. Thus, cells grown on an a c e t a t e - 1  
containing media showed 100 % incorporation of radioactivity at C-5 of 
glutamic acid. This labelling pattern would be expected from a partial 
tricarboxylic acid cycle, namely the aconitase-isocitrate dehydrogenase 
pathway (Scheme 1.5). In this route acetyl-CoA and oxaloacetic acid (9 ) 
combine to give citric acid (14) which is converted to isocitric acid (15), then 
to 2-ketoglutaric acid (5) and finally glutamic acid (1).
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COENZYME Bi2-DEPENDENT
ENZYMES
1.2.1 Coenzvme B^o Catalysed Reactions
The cofactor, coenzyme B 2^ (Figure 1.2), is required for the catalysis of a 
wide range of rearrangement reactions. These reactions all involve a vicinal 
interchange between a hydrogen atom and a group X (Scheme 1.6).
a— C a— C
H X X H
Scheme 1.6 Generalized Coenzyme 8^2 - Dependent 
Vicinai interchange Rearrangement
The X group can vary from acyl or alkyl groups, which give carbon skeieton 
rearrangements, to alcohol or amine groups, as In the dehydratase and 
aminomutase catalysed rearrangements. The enzymes which catalyse such 
rearrangem ents  are m ethylm alonyl-C oA  m utase (EC 5 .4 .9 9 .2 )^ ^ , 
m ethyleneglutarate mutase (EC 5 .4 .99.4)28, glutamate mutase (EC
5.4.99.1)29, isobutyryl-CoA mutase^O, did dehydrase (EC 4.2.1.28)81, 
glycerol dehydrase (EC 4.3.1.30)82, ethanolamine ammonia lyase (EC 
4 .3 .1 .7 )88, p.lysine mutase (EC 5.4.3.3)8^^'85 D-a-lysine mutase (EC 
5.4.3 .4)88, D-ornithine mutase (EC 5.4.3.5)87,38, L-leucine-2,3-aminomutase 
(EC 5.4.3.7)89 and ribonucleotide reductase (EC 1.17.4.2)40 (Scheme 1.7). 
Many of these enzymes contain two subunits; one which binds the 
coenzyme and another which has suiphydryl groups.
The four enzymes which catalyse carbon skeleton rearrangement reactions 
are particularly intriguing. Amongst these glutamate mutase is unique in that 
it catalyses a rearrangement in which the migrating group (X) is centred on 
an sp8 carbon. The other coenzyme 8^2 catalysed carbon skeleton 
rearrangements all occur with migration from an sp^ carbon.
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1.2.2 Coenzyme
The B-|2 molecule is the most complex non-polymeric compound found in 
nature^l. Its history began in 1926 when Minot and Murphy reported the 
effectiveness of whole liver treatment on pernicious anaemia^^, a disease 
which is now controlled by vitamin B.|2 injections. In 1934 they were 
awarded the Nobel Prize for Medicine and Physiology ‘for their discoveries 
concerning liver therapy against anaemias’. The active factor in liver was 
isolated in a crystalline form simultaneously by Folkes"^  ^ and Smith^^ in 
1947. Its structure was determined in 1956 by Dorothy Hodgkin^®. At the 
time it was the largest structure yet elucidated by X-ray crystallography. Two 
years later Barker isolated the biologically active form of the vitamin, known 
as coenzyme 812'^ ®’^ .^ Its structure was also confirmed by Hodgkin"*®.
The molecule consists of a corrin ring with a cobalt ion at its centre. The 
corrin ring is a tetrapyrrole macrocycle and as such it is related to the 
porphyrin ring. However the corrin ring differs in several ways from the 
porphyrin system (Figure 1.1). In the corrin ring there is less unsaturation 
and the A and D pyrrole rings are iinked directly. The substitution of ring D is 
reversed relative to rings A to C"*®.
The four pyrrole nitrogen atoms are ligated to the cobalt at the centre. The 
two remaining positions above and below the plane of the ring are filled by 
further ligands whose nature determines the biological role of the corrin 
system. In mammalian systems the fifth ligand of coenzyme 6^2 is always a 
5,6-dimethylbenzimidazole group, although some bacteria contain other 
benzimidazoles or adenine analogues as the heterocyclic base®®. The 
base is bonded through its N-3 lone pair. The sixth position in the 
octahedral arrangement is occupied by an adenosyl moiety, via C-5’, in the 
case of the coenzyme (Figure 1.2), a cyano group in the vitamin and a 
methyl group in the case of methylcobalamin. These sixth ligands are all 
attached by carbon-cobalt (G-Go) bonds. The 8^2 molecules are the only 
organometallic compounds known in nature®*. The coenzyme form is easily 
inactivated by light, which catalyses cleavage of the G-Go bond®^.
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Hydroxycobalamin then forms in solution.
Corrin Porphyrin
Figure 1.1 The Corrin and Porphyrin Rings
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Figure 1.2 Coenzyme B12
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1.2.3 General Mechanism of Rearrangement
All the coenzyme B-|2-dependent enzymes are thought to employ similar 
mechanisms for catalysis®'', although, due to the diversity of rearrangements 
catalysed (Scheme 1.7), finer details must obviously vary. A general 
mechanism®® is shown in Scheme 1.8 and summarized below.
The reaction is initiated by an enzyme-induced hemolytic dissociation of the 
C-Co bond of the coenzyme to generate a cob(ll)alamin species and a 5'- 
deoxyadenosyl radical (Ado-CHg") C®)- Next a hydrogen atom is 
abstracted from the substrate, by the 5'-deoxyadenosyl radical, to generate a 
substrate radical and 5'-deoxyadenosine (Ado-CHg) (17). Rearrangement 
of the substrate radical then occurs, either directly or through further 
intermediate steps, to give a radical product (18). Finally the product radical 
abstracts a hydrogen atom, from 5'-deoxyadenosine, to give the product 
and regenerate the 5 ’-deoxyadenosyl radical (19) which recombines with 
the cob(ll)alamin species to regenerate the coenzyme (20).
It is envisaged that the corrin ring becomes distorted when bound to the 
enzyme. The ring is pushed up, thus, increasing the steric repulsion 
between the ring and the 5'-deoxyadenosyl group and hence weakening the 
C-Co bond®4. The initial homolysis of the C-Co bond may be brought about 
by additional strain caused by the substrate binding®®.
Cobalt (II) is paramagnetic, thus the cob(ll)alamin (B^2r) species generated 
by hemolytic cleavage of the C-Co bond of the coenzyme should give an 
electron paramagnetic resonance (ERR) signal. Such signals have been 
detected, by ERR techniques, in the diol dehydrase®®»®®, ethanolamine 
ammonia lyase®^ ®® and ribonucleotide reductase®® systems, and recently 
in the methylmalonyl-CoA mutase®® and glutamate mutase®"* systems. 
These results lend credence to the proposed mechanism.
There is also spectroscopic evidence, from Babior®® and Abeles®®, for a 
carbon-centred free radical intermediate in the ethanolamine ammonia
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lyase®® and diol dehydrase®® catalysed rearrangements. The use of 
substrate analogues, which reacted more slowly than the natural substrates, 
allowed such species to be identified.
Rearrangement of the substrate radical, S' could occur directly to give the 
product radical, or carbonium ion, carbanion or organocobalt intermediates 
could be invoked®" .^
Frey and Abeles®^ demonstrated that if in the diol dehydrase catalysed 
reaction the migrating hydrogen was labelled, its label became scrambled 
with the two 5 ’ methylene hydrogens. Thus, all three hydrogens had 
becom e equ iva len t, as would occur in the m ethyl group of 5 ’- 
deoxyadenosine. Babior obtained a similar result in experiments with the 
ethanolamine ammonia lyase system®®. Abeles and Babior have also 
demonstrated the reversible formation of 5'-deoxyadenosine in these two 
enzyme systems®®-®^.
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Scheme 1.8 General Mechanism for Coenzyme 8,2 Rearrangements
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1.2.4 Methyimalonyl-CoA Mutase
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(2R)-methylmalonyl-CoA succinyl-CoA
(21) (22)
Scheme 1.9 Methylmalonyl-CoA Mutase Catalysed Rearrangement
The enzyme methylmalonyl-CoA mutase (EC 5 .4 .99 .2 ) catalyses the 
Interconversion of (2R)-methylmalonyl-CoA (21) and succinyl-CoA (22)®® 
(Scheme 1.9). It is the only Big-dependent mutase found in mammalian 
tissue®”* and is involved in propionic acid metabolism®®. Here propionic 
acid, the degradation product of isoleucine and fatty acids, is activated as 
propionyl-CoA, carboxylated to (2S )-m ethylm alonyl-C oA  and then  
epimerized to (2R)-methylmalonyl-CoA. The coenzyme Big-dependent 
reaction, then, gives succinyl-CoA^®.
In bacteria, e.g. Propionibacterium shermanii, the metabolic flow is in the 
opposite direction, i.e. succinic acid is degraded to propanoic acid^T Again 
the pathway also requires an epimerase.
Wood's spectrophotometric assay for methylmalonyl-CoA mutase activity 
coupled together several enzyme reactions (Scheme 1.10)^^ other 
enzymes were present in excess, with respect to the mutase. The assay 
involved epimerization of the (2R)-methylmalonyl-CoA, produced by the 
reaction of the methylmalonyl-CoA mutase with succinic acid, to the (2S)- 
enantiomer, by methylmalonyl-CoA epimerase. This was then converted, by 
oxaloacetate transcarboxylase, in the presence of pyruvic acid, to propionyl- 
CoA and oxaloacetic acid. The oxaloacetic acid was then converted to (2S)- 
malic acid by malate dehydrogenase, a NAD+-dependent enzyme. The
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consumption of NADH, determined at 340 nm, gave a m easure of 
methylmalonyl-CoA mutase activity.
Succinyl-CoA mutase {2R)-methylmalonyl-GoA
epimerase(2R)-methylmalonyl-CoA  '..  (2S)-methylmalonyl-CoA
{2S)-methylmalonyl-CoA transcarboxylase 
+ pyruvic acid
oxaloacetic acid 
+ NADH + H+
malate
dehydrogenase
propionyl-GoA 
+ oxalacetic acid
(2S)-malic acid 
+ NAD+
Scheme 1.10 Methylmalonyl-GoA Mutase Assay
The m olecular weight of methylmalonyl-GoA from sheep liver was 
determined, by Ochoa, to be 165 000 Da^®. Retey showed the bacterial 
enzyme, isolated from Propionibacterium shermanii, had a molecular weight 
of 124 000 Da, with two subunits of approximately 65 000 Da^^. The 
enzyme from both sources contained two moles of coenzyme per mole of 
enzyme^®'^®. In both sources of enzyme, the coenzyme was protected from 
inactivation by light, when bound to the enzyme^®. The coenzyme also gave 
some protection to the mammalian enzyme from inactivation by thiol specific 
inhibitors such as N-ethylmaleimide and iodoacetate^®. The bacterial 
enzyme did not appear to contain essential suiphydryl groups^®.
The pH optimum for the mammalian enzyme^® was 7.0 and for the bacterial 
enzyme^® 7.4. The equilibrium constant for the conversion of succinyl-GoA 
to methylmalonyl-GoA was measured by Wood^®, at 23.1. The for 
succinyl-GoA was 34.5 pM and for methylmalonyl-GoA, 80 pM.
Eggerer and Swick used labelling experiments to establish that the GoA
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thio ester group (COS-CoA) was the migrating group^^-^®. Wood^^ and 
Phares et al. confirmed that migration was intramolecular. The steric 
course of the migration at C-2 was elucidated using deuterium labelling^^, 
and that at C-3, using the substrate analogue, ethylmalonyl-CoA (23)®^ (see 
also below). These experiments showed migration occurred with retention 
of configuration at both centres.
When monodeuteriated (2R)-[2-^H]-methylmalonyl-CoA was used as the 
substrate, the succinyi-CoA produced contained up to 40 % unlabelled and 
dideuteriated material®'*. Retey®® suggested that a proportion of the product 
radical underwent a 1-2 hydrogen shift, before reabstracting a hydrogen 
from 5 ’-deoxyadenosine. This would result in the product molecule being 
orientated in such a way that the reformed 5'-deoxyadenosyl radical could 
abstract a deuterium, to give the product radical again. The product radical 
could then reabstract a hydrogen, from the 5 ’-deoxyadenosine, to give 
unlabelled product. A monodeuteriated product radical could abstract the 
deuterium atom from the 5 ’-deoxyadenosine and so become dideuteriated.
The use of ethylmalonyl-CoA (23) to probe the methylmalonyl-CoA mutase 
system has helped to further elucidate the mechanism. Retey first showed 
that ethylmalonyl-CoA was a substrate for the enzyme in 1973®®. The major 
product was (2R)-m ethylsuccinyl-C oA  (24) (Schem e 1 .11 ). Using 
ethylm alonyl-CoA  stereospecifically labelled with deuterium  at the  
methylene of the ethyl group, further details of the rearrangement were 
elucidated®^ (Scheme 1.12). Retey found the pro -R hydrogen was removed 
preferentially from the methylene of the ethyl group (25). However, there 
was also significant removal of the pro -S hydrogen (26) when the pro -R 
hydrogen was replaced by deuterium. This showed that hydrogen 
abstraction was a slower step than interconversion between the two 
conformations of the ethyl group. Rearrangement then gave the product 
radical to which a hydrogen was returned predominantly by Re-attack (27). 
Retey showed the reaction was not stereochemically clean, with some 
interconversion between the two possible conformations of the substrate 
radical, resulting in a mixture of final products.
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Scheme 1.11 The Rearrangement of the Substrate Analogue,
Ethylmalonyl-CoA
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1.2.5 Glutamate Mutase
^*^2 glutamate NH2 ÇO2H
H . , „ i  .  mutase  ^ ' ^ C H ,
HOgC^ "COgH HOgC H
L-glutamic acid (2S,3S)-3-methyl-
j aspartic acid
(2)
Scheme 1.13 Glutamate Mutase Catalysed Rearrangement
The enzym e g lu tam ate m utase catalyses the carbon skeleton  
rearrangement of L-glutamic acid (1) to (2S,3S)-3-methylaspartic acid (2) 
(Scheme 1.13)^. It is the first enzyme on the glutamic acid degradation 
pathway used by clostridia and some other species of bacteria (see section
1.1)^^. The enzyme from Clostridium tetanomorphum has been most 
extensively studied®^.
Barker used two assays for glutamate mutase activity. A spectrophotometric 
assay detected the build up of mesaconic acid, when L-glutamic acid was 
incubated with glutamate mutase and 3-methylaspartase (the latter being in 
excess)®. The alternative anaerobic assay was based on the conversion of
3-methylaspartic acid to glutamic acid®. Aliquots were removed and 
assayed with 3-methylaspartase to measure how much 3-methylaspartic 
acid remained unconverted.
The enzyme consists of two components, designated Component S (a 
calcium phosphate supernatant fraction) and Component E (a gel &luate 
fraction)®®. The purification of each component was accomplished by 
Barker, who achieved 20 - 25 % yields of Component S after 350-fold 
enrichm ent®^ and an 18 % yield of Com ponent E a fter 180-fo ld  
enrichment®®. Barker estimated the molecular weight of Component S to be 
17 000 Da and that of Component E to be 128 000 Da.
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The enzyme from Clostridium cochlearium  was recently purified by 
Buckel®®. He showed the molecular weight of Component S from this 
enzyme was 16 000 Da and that Component E was a homodimer of 
molecular weight 100 000 Da. Marsh®®, also confirmed, in 1992, that 
glutamate mutase from Clostridium tetanomorphum  consisted of a 
m onom eric Com ponent S of m olecular weight 15 000  Da and a . - %
homodimeric Component E with subunits of 50 000 Da. Marsh cloned and 
sequenced the genes for Components S®® and E®^  from the Ciostridium 
tetanomorphum source. The N-terminal sequences for Component S from 
Clostridium cochlearium  are almost identical to those from the C . 
tetanomorphum source®®-®®-® .^
Barker reported that the purified Component E appeared faint pink in 
colour®®. This was probably due to small amounts of bound corrinoid 
vitamins, rather than coenzyme, as the addition of coenzyme (and 
Component S) was required for activity. Barker found Component E was 
relatively stable if cationic buffers, eg. Tris were avoided. He noted that 
inactivation by such buffers was prevented by addition of substrate. This 
was evidence for the substrate binding to the E component.
B arker showed that Com ponent S required incubation with  
m ercaptoethanol, which reduces disulphide bonds, to produce the  
component in its monomeric, active form. He also found it easier to purify 
the protein in the reduced form, as it was chrom atographica lly  
homogeneous. If allowed to oxidize, about 20 % of the S component took 
on the dimeric form. However, the component was more stable to storage in 
an oxidized state®
The amino acid composition, determined by Barker, for Component S® ,^ 
correlates well with the sequence obtained by Marsh®®. The S Component 
contains 4 to 5 cysteine residues per molecule. Barker suggested, from the 
results of experiments with mercuribenzoate, iodoacetate and arsenite, that 
one cysteine was deeply buried, whereas two were always available to react 
with thiol specific reagents and two could form disulphide bonds®^.
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Iodoacetate and mercuribenzoate both inhibited the activity of reduced 
Component S. However dimeric Component S was not inactivated by 
iodoacetate and upon reduction with mercaptoethanol exhibited activity. 
This demonstrated that a sulphydryl group which formed a disulphide bond 
in the oxidised dimer was partially responsible for enzyme activity. Arsenite 
also inhibited enzyme activity. Arsenite inactivation is evidence for vicinal 
dithiol groups.
Barker could not detect a stable complex between the mutase components 
by gel filtration techniques®^. However he reasoned that the two 
components had appreciable affinity for each other as activity could be 
detected at very low protein concentrations.
The binding of the coenzyme to Component E was facilitated by Component 
S. Experiments showed that Component E alone bound one coenzyme 
molecule but with excess Component S it bound two molecules of 
coenzyme®^. Component S alone did not bind coenzyme. Increasing the 
Component S : Component E ratio increased activity, until a maximum rate 
was reached. Further increases in the ratio of components had no effect on 
activity. However the for the coenzyme continued to decrease. This 
indicated that the catalytic function of Component S was separate from its 
function of enhancing coenzyme binding. The ratio of Component E to 
Component S at half maximal enzyme activity was 1.6. The rate determined 
for various ratios of components gave a saturation curve with respect to 
either component®^.
The equilibrium for the reaction favours the conversion of 3-methylaspartic 
acid to glutamic acid; the opposite direction to that of the physiological 
reaction. Barker measured Kgq at 30 °C and pH 8.2 as 10.7®. The enzyme 
showed most activity at pH 8.5 but was active between pH 6,0 and 9.8®. The 
pH of 8.2 was chosen for most experiments to avoid interference from 
mercaptoethanol in UV spectra. The enzyme showed maximal activity at 38 
°C, and half maximal activity at 27 °C®. This was quite different to the 
temperature for maximal activity of methylaspartase, which was 55 °C®.
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The only substrates found for glutamate mutase were the physiological 
substrates, L-glutamic acid and 3-methylaspartic acid®. The for glutamic 
acid was 1.5 mM and for 3-methylaspartic acid was 0.5 mM®®. Barker tested 
D-glutamic acid, 3-ethy las partie acid, a-, p- and y-methyl-DL-glutamic acid, 
L-giutamine, the y-methyl ester of L-glutamic acid and DL-a-aminoadipic 
acid for activity but no turnover was detected®. Buckel has shown that 
(2S ,4S )-4 -flu o ro g lu tam ic  acid, (2R ,3R S )-3 -flu o ro g lu tam ic  acid, 2- 
methyleneglutaric acid, (S)-3-methylitaconic acid and itaconic acid are 
competitive inhibitors for glutamate mutase®®. He also recently obtained 
evidence for a paramagnetic species as an intermediate in the reaction with 
substrate , and also in the presence of the inhib itors, (2 S ,4 S )-4 -  
fluoroglutamic acid and 2-methyleneglutarlc acid®i. This may be the low- 
spin Co" species, B^2r  which would be generated after homolytic cleavage 
of the coenzyme C-Co bond.
A series of coenzyme analogues have been examined by various groups. 
The following changes were made to the heterocyclic base at the sixth 
ligand position of the coenzyme whilst still conferring activity to the enzyme; 
5-hydroxybenzim idazole®®, 2,6-diam inopurine, adenine, 5 (6 )-n itro - 
b e n z im id a zo le , 5 {6 )-a m in o b e n z im id azo le , 5 (6 )-tr iflu o ro m e th y l-  
benzimidazole, benzimidazole®^, purine, 2-chloropurine, 2-thiopurine, 6- 
methylmercaptopurine and 5,6 dimethylbenzimidazole®®. Those analogues 
found to be inactive included corrinoid vitamins, methyl, carboxymethyl and 
5-deoxyuridyl cobalamins and cobinamide coenzyme®®. As the corrinoid 
vitamins, without a deoxyadenosyl group, and the cobinamide coenzyme, 
without a nucleotide, were inactive, these experiments suggested that a 
deoxyadenosyl moiety and a heterocyclic base were required for activity, but 
that the enzyme was tolerant of fairly major alterations in the heterocyclic 
base.
S tereochem ical studies revealed the glutam ate m utase catalysed  
rearrangement occurred via cleavage of the bond between C-2 and 0 -3  in 
the glutamic acid molecule, followed by transfer of the carboxyaminomethyl 
fragment thus formed, from 0-3 to 0-4 , with inversion of configuration at 0 -
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496,97 This was accompanied by removal of a hydrogen from C-4 and 
addition of a hydrogen to C-3, thus forming a methyl group at this carbon 
(Scheme 1.14). No exchange of hydrogens with the solvent occurred®®. 
More recently Hartrampf and Buckel fermented (2S,3R)- and (2S,3S)-[3-^H,
3-®H] glutamic acids with growing cells of Clostridium tetanomorphum and 
determined the chirality of the butyric acid produced®®. They showed that 
racemizatlon occurred at C-3, the methyl group of 3-methylaspartic acid.
HOgC^ HHgN,.Coenz. Bi2
CO2H
HoC
.CO2H
CO2H
Scheme 1.14 Schematic Diagram of Rearrangement 
Catalysed by Glutamate Mutase
LZ3. IVI.ethyleneglutarate....M.u,tase
2-methyleneglutarate
mutase
HO2C ‘CO2H
HO2C
CO2H
2-methyleneglutaric acid
(28)
(3R)-3-methylitaconic acid
(29)
Scheme 1.15 2-Methyleneglutarate Mutase Catalysed Rearrangement
2 -M e th y le n e g lu ta ra te  m utase catalyses the rearran g em en t of 2- 
methyleneglutaric acid (28) to (3R)-3-methylitaconic acid (29) (Scheme 
1.15)1®®. This reaction is a step in the fermentation of nicotinic acid to
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%ammonia, propionic acid, acetic acid and carbon dioxidei®\
Buckel purified the enzyme from Clostridium barkeri i®2 He discovered it 
was a homotetramer, with a subunit molecular weight of 70 000 Da. The 
enzyme seemed to form a complex, stabilized by hydrophobic interactions, 
with 3-methylitaconate isomerase, the next enzyme on the pathway. The 
coenzyme remained active if the enzyme was purified in the dark^®®, but 
was inactivated by exposure to light. Protection from inactivation of the 
coenzyme by light was given by the natural substrates. No evidence for any 
conformational strain was observed in the coenzyme whilst bound to the 
enzyme.
In order to assay for activity, Buckel coupled the mutase reaction to that of 3- 
methylitaconate isomerase, which converts the (R)-3-methylitaconic acid, 
produced by the mutase, to 2,3-dimethylmalic acidi®®. The UV absorbance 
due to the latter compound was measurable at 240 nm. The equilibrium 
constant for the conversion of (R )-3 -m e th y litaco n ic  acid to 2- 
methyleneglutaric acid was 0.26 ±  0.04, at Ï  = 0.1 M and 25 °C1®®. The 
apparent value for the coenzyme was 50 pM and for 2-methyleneglutaric 
acid 4 mlV|i®®.
Buckel showed the rearrangement occurred with migration of the acrylic acid 
moiety from C-3 to 0-4^®^. The stereochemistry of the reaction was 
investigated at 0 -4  (0-3 in (R)-3-methylitaconic acid), using (3R)-methyl-[3- 
®H]-itaconic acid. Inversion of configuration was observed at this 
positioni®"^. Inversion of configuration also occurred in the glutamate 
mutase reaction but retention of configuration was observed in the 
methylmalonyl-OoA mutase reaction.
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1.2.7 Diol Dehydrase 
OH
OH
diol
dehydrase H
+ HgO
O
(2R)-1,2-propanediol (30) ^propionaldéhyde
(2S)-1,2-propanediol (31)
Scheme 1.16 Diol Dehydrase Catalysed Rearrangement
Diol dehydrase catalyses the irreversible conversion of both enantiomers of 
1,2-propanediol (30,31) to propionaldéhyde (32) (Scheme 1.16)1®®. Abeles 
showed the enzyme also converted glycerol to p-hydroxypropionaldehyde®i 
and 1,2-ethanediol to acetaldehydei®®. Toraya demonstrated that glycerol 
also caused irreversible inactivation of the enzymei®®. The enzyme plays a 
role in glycerol fermentation in microorganismsi®®. Several methods of 
measuring diol dehydrase activity have been devised. Abeles coupled the 
rearrangement to a NAD+-dependent alcohol dehydrogenase reaction and 
measured the decrease in absorbance due to NADH with timei®^. Other 
methods converted the aldehyde product of the diol dehydrase reaction to 
the 2,4-dinitrophenyIhydrazone derivative®l or azine derivative 1®®, which 
could be quantified
The molecular weight of diol dehydrase was determined, by Toraya, to be 
230 000 ±  10 000 Dal®®, j ^q enzyme had two components; Component F 
had a molecular weight of 26 000 Da and Component S, 200 000 Dai®®. 
Component S consisted of at least four different polypeptide chains. The 
enzyme appeared to bind one mole of coenzyme per mole of enzymeii®. 
Both components were required for activity and coenzyme bindingin n^. 
Reassociation of the components was promoted by the substratei®®. The 
enzyme was irreversibly inactivated by exposure to oxygen®®, although 
protection was afforded by the substrateii®, suggesting the substrate bound 
close to the coenzyme.
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The use of thiol-specific alkylating agents showed that Component S 
contained thiol group(s)iii-H®  Modification of the thiol group(s) prevented 
coenzyme bindingH t
Lee and Abeles showed diol dehydrase required a monovalent cation for 
activity®i. Potassium, rubidium, ammonium and méthylammonium cations 
were most active. Activity was thus related to ionic radius^®. The 
monovalent cation was involved in binding the coenzyme to the enzyme.
Diol dehydrase has a wide substrate specificity, accepting both enantiomers 
of 1,2-propanediol and an number of other glycols, including 3-fluoro-H® 
and 3-chloro-1,2-propanediolsHA Abeles showed that the pro -R hydrogen 
migrated stereospecifically in the reaction with (2R)-1,2-propanediol (30), 
and the p r o - S  hydrogen with (2S)-1,2-propanediol (31 )1 18,119. No 
incorporation of solvent protons occurredi^®. Retey showed the hydroxyl 
group migrated stereospecifically, to form a gem-dio|i^i, from which water 
was then eliminated, again s te re o s p e c if ic a lly iT h e  deuterium isotope 
effect for the overall reaction was found to be 10 - 1211®>H®, indicating that 
cleavage of the substrate C-H bond was rate-limiting. The tritium isotope 
effect for transfer of hydrogen from the substrate to the coenzyme was 20. 
Abeles measured isotope effects of 125 for tritium and 28 for deuterium, for 
the transfer of hydrogen from the coenzyme to the product^ 1 ®.
Abeles and Fukui investigated the effect on enzyme activity of modifying the 
coenzymei®^'i®®. Structure / activity correlations led to the following 
conclusions: firstly, very few changes could be made to the adenosyl group 
without loss of activityi®®, secondly, the benzimidazoyl ligand was not 
involved in catalysisi®^ and also that the coenzyme propionamide side 
chains interact with the enzyme to facilitate C-Co bond cleavage and 
stabilize radical intermediatesi®®
In 1970 , S ch rau zer proposed that the diol dehydrase cata lysed  
rearrangement occurred by a 1,2-hydride shifti^®. He accounted for the 
transfer of label between substrate and coenzyme by invoking an exchange
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between labelled propionaldéhyde and the coenzyme after the hydride shift. 
However, Abeles’ measurements of the specific activities of the coenzyme, 
substrate and product, during the course of the reaction with 1,2-[1-®H]- 
propanediol as substrate gave specific activity values for the coenzyme 
which were much larger than those for the substrate or product^®^. This was 
inconsistent with an equilibration process. Schrauzer also proposed that the 
enzyme abstracted a hydrogen from C-4’ of the coenzyme^^®. Once again 
Abeles and co-workers showed that no labelling occurred at this centre 
during the course of the reaction Schrauzer’s proposals show, perhaps, 
the folly of studying model systems in isolation from the enzyme reaction.
1.2.8 Ethanolamine Ammonia-Lyase
ethanolamine 
,OH ammonia lyase
HoN + NH3 
H
ethanolamine acetaldehyde
(33)
Scheme 1.17 Ethanolamine Ammonia-Lyase Catalysed Rearrangement
Ethanolamine ammonia-lyase catalyses the deamination of vicinal amino 
alcohols to carbonyl compounds and ammonia. The natural substrate for 
the enzyme is ethanolamine (33), which is converted to acetaldehyde and 
ammoniai®® (Scheme 1.17). The enzyme was first obtained by Kaplan and 
S tadtm an from an uncharacterized  Clostridium  spec ies  in large  
quantities'*®®. It was a large protein of molecular weight, 520 000 Da"*®®. 
The enzyme had subunits of 36 000 Da and 51 000 Da arranged in two 
stacked rings with five or six subunits in each ring'*®'*. Between one and 
three moles of coenzyme were tightly bound to each mole of enzyme'*®®. 
Experiments by Babior showed the enzyme had two active sites. Enzyme 
activity was destroyed by thiol-specific reagents^®®.
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Kaplan and Stadtman showed a monovalent cation was required for 
activityi®®. Potassium was most suitable but ammonium and rubidium also 
supported activity. Sodium and lithium were competitive inhibitors.
Babior showed, using [1-®H]-ethanolamine that the hydrogen was removed 
from C-1 stereospecifically®®. However racemization occurred when it was 
replaced at C-21®®.
The enzyme accepts a number of other substrates as well as ethanolamine. 
These include (S)-2-aminopropanol (34)1®^, (R)-2-aminopropanol (35)1®® 
and 1 -amino-2-propano|i®®. Babior measured the K,  ^values for the above 
substrates. The K ^ for ethano lam ine was 22 pM i® ^ , for (S )-2 -  
aminopropanol, 15.5 pMi®® and for (R)-2-aminopropanol, 63.6 pMi®®.
(S )-2 -A m i nopropanol was deam inated  at 1 - 2 % of the rate of 
ethanolamine 1®®. The coenzyme was irreversibly destroyed in an abortive 
side reaction that occurred once every 300 - 400 catalytic cycles®®*i®®. 
Retey and Babior showed the pro -S hydrogen was abstracted from C-11®®. 
This hydrogen was transferred to C-2, where inversion occurred as the 
amino group left. Ammonia was eliminated from the gem  -amino alcohol 
thus formed, to give propionaldéhyde. Unlike the rearrangem ent of 
ethanolamine the reaction was, to a small extent, reversiblei®^.
(R)-2-Aminopropanol reacts at 12 % of the rate of the (S)-enantiomeri®^. 
Retey and Babior found that, with this substrate, the pro -S hydrogen was 
again removed from C-11®®. Hence the hydrogen threo - with respect to the 
amino group was abstracted in the (R)-enantiomer but that erythro - to the 
amino group in the (S)-substrate. The hydrogen was replaced with retention 
of configuration at C-2, in contrast to the inversion seen with the (S)- 
enantiomer. The enzyme also catalysed the conversion of the (R)- 
enantiomer to the (S)-enantiomeri®®.
Babior found the turnover of 1-amino-2-propanol was very slow and that 
catalytic activity of the enzyme was lost after only a few turnoversi®®. The
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reaction products were acetone and ammonia. Again a hydrogen was 
abstracted from the carbon bonded to the alcohol (C-2). In this case 
abstraction occurred from a secondary centre.
Babior demonstrated, using [1-®H]-ethanolamine, that the hydrogen 
m igrated via the 5' position of 5 ’-deoxyadenosinei^® . He also  
dem onstrated the reversible formation of 5 ’-deoxyadenosine as an 
intermediate in the reaction®^-141. e p r  studies showed signals attributable 
to cob(ll)alamin, the product of homolytic cleavage of the Co-C bond, and a 
substrate radical®^*®®. With 2-aminopropanol as substrate the radical was 
identified, using labelled substrates, as the 2-aminopropanol-1-yl radical®®. 
The cob(ll)alamin and substrate radicals signals appeared at the same rate, 
approximately twice that of the overall catalytic reaction.
Using both deuterium and tritium labelled ethanolamine and [5 ’-®H]- 
coenzyme B.|2, Babior measured the tritium isotope effect for each of the two 
hydrogen transfer steps, the overall deuterium isotope effect and the 
deuterium isotope effect for the second hydrogen transfer s t e p " * 142. The 
overall deuterium isotope effect on was 7.4. This was in close 
agreement with the value for the second hydrogen transfer step. Thus 
indicating the second hydrogen transfer step was rate limiting. There was 
an exceedingly large tritium isotope effect on the second hydrogen transfer 
step, of 160, which was not predicted from the deuterium isotope effect and 
has not been explained.
The isotope effects observed for (S)-2-aminopropanol (34) were similar to 
those for ethanolaminei®®*®®. However the values for the (R)-enantiomer 
(35) were very different. They showed the first hydrogen transfer step was 
rate limiting with (R)-2-aminopropanol as substrate. Based on these isotope 
effects and the stereochemical results discussed above, Babior suggested a 
common intermediate for the two reactions, namely the product radical 
corresponding to the (S)-configuration (36) (Scheme 1.18)143. This 
required inversion of configuration at C-2 of the (R)-enantiom er after 
migration of the amino group.
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1.2.9 The Aminomutases
lysine 2,3- 
amlno- 
mutase—— I
NH NH
HOpCNH NH2
L-lysine
(37)
NH,
HOgC
p-lysine
mutase NHg  ........—  HOgC
(38)
NH2 NH2
(3S)-L-p-lysine
(44)
(3S,5S)-diamlnohexanoic
acid
(45)
NHa-lysine
mutase  ^ HO2CNH
HOoC
NH
NH2
D-lysine
(46)
NH
NH
D-ornithine
D-ornithine
mutase
(48)
2,5-diaminohexanoic
acid
(47)
HO2C NH2
Hi,„^
HgN'
(2R,4R)-f/?reo-2,4- 
diaminopentanoic acid 
(49)
HO2C
L-leucine-2,3-
aminomutase HOpC
L-leucine 3-amino-4-methyl-
(50) pentanoic acid
(51)
Scheme 1.19 Aminomutase Catalysed Rearrangements
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This group of enzymes Includes four coenzyme B^2“dependent enzymes 
and the related lysine 2,3-aminomutase (Scheme 1.19). A survey of the 
aminomutases highlights how different systems have evolved to solve the 
same catalytic problem.
1.2.9.1 Lysine 2.3-Aminomutase
Lysine 2,3-aminomutase catalyses the rearrangement of L-a-lysine (37) to 
L-p-lysine (38)^44 The enzyme is not coenzyme B i2-dependent but 
requires S-adenosyl-methionine (39) (Figure 1.3)^45 termed by Barker the 
‘poor man's adenosylcobalamin'^ 46 cofactor for a reaction very similar to 
that catalysed by coenzyme B^g-dependent enzymes.
HpN
^  COgH
Figure 1.3 S-Adenosylmethionine
Lysine 2,3-aminomutase also requires pyridoxal phophate (PLP) (see 
Scheme 1.20), cobalt and iron sulphur centres for a c t i v i t y ^ 4 7  The related 
coenzym e B ^g-dependent enzym es, p-lysine m u t a s e ^ 4 S  a -ly s in e  
a m i n o m u t a s e ^ 4 9  D -ornithine am inom utase”*^® and L -leucine 2 ,3 -
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aminomutase®® (Scheme 1.19) are also PLP-dependent.
In Clostridia, lysine 2,3-aminomutase catalyses the first step in the 
degradation  of lysine to am m onia and acetyl-CoA'*® '*. In other 
microorganisms the enzyme is responsible for the p-lysine derived acyl 
subunit found in some antibiotics'*®®.
Recent work on this system, by Frey, using lysine 2,3-aminomutase isolated |
from Clostridium SB4'*®® showed the enzyme was a hexamer of molecular 
weight 285 000 D a ' * ® 4 .  The enzyme contained 12 to 13 iron and sulphur 
atoms, greater than three cobalt atoms and 5.5 moles of PLP, per hexamer.
Frey found the enzyme was activated by the reaction of S-adenosyl- 
methionine with the reduced metal (Fe-S) centre, leading to the formation of 
a reactive adenosyl-metal c o f a c t o r ' * ® 4 .  The role of the cobalt is not known.
The adenosyl-metal cofactor then underwent reversible homolytic cleavage 
to give the 5 ’-deoxyadenosyl radical. The rearrangement mechanism was 
then very similar to that of a coenzyme B^g'd^P^^dent rearrangement 
(Scheme 1.8). However, during the reaction, the lysine molecule was bound 
to PLP (Scheme 1.20)^®®. PLP facilitated the 1,2-imino shift, by stabilizing 
the radical intermediates. Thus the rearrangement occurred as follows; a 
hydrogen was abstracted from the substrate (3 9 ), P LP -m ediated  
rearrangement of the substrate radical occurred (40), to give an aziridine 
intermediate (41), a 1,2-imino shift produced the product radical (42) which 
reabstracted a hydrogen (43), to give the PLP-bound product.
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Scheme 1.20 Mechanism for the Reaction Catalysed by
Lysine 2,3-Aminomutase
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Labelling experiments showed the 3-pro- R hydrogen of lysine was 
transferred to the 2-pro- R position in (3-iysine. This was accompanied by 
concomitant migration of the amino group from C-2 to C-3 I®®. There was no 
exchange of hydrogens with the soivent^^^. PLP probably plays a similar 
role in the coenzyme B^2"dependent aminomutase reactions, facilitating 
transfer of the amino group.
Frey performed EPR studies on lysine 2,3-aminomutase which indicated the 
presence of an organic radical interm ediately^. Deuteriation of the 
substrate led to changes in the signal. This indicated the lysine carbon 
skeleton was the host for the radical centre. Changes in the hyperfine 
splitting patterns in the EPR spectra of [2-^H]-iysine and [2-i^C]-iysine  
allowed further identification of the radical species. It appeared to be a n - 
radical with the unpaired spin localized primarily in a p orbital on C-2 of 13- 
lysine.
L-p“Lyslne, Miilass,/ D:a-Lysine Mutase
The clostridial enzyme L-p-lysine mutase catalyses the second step in the 
fermentation pathway of lysine to ammonia, acetic acid and butyric acid, the 
conversion of L-p-lysine (44) to (2S,5S)-erythro -3,5-diaminohexanoic acid 
(45) (Scheme 1.19)1®^. The protein complex responsible for L-p-iysine 
mutase activity also catalyses a D-a-lysine mutase reactioniso which 
converts D-a-lysine (46) to 2,5-diaminohexanoic acid (47) (Scheme 1.19)^^. 
The complex has a molecular weight of 250 000 D ai49.i50 stadtman 
showed the complex from Clostridium sticklandii consisted of an E^  and E2 
protein. E^  bound the cobalamin coenzyme and E2 contained sulphydryl 
groups. Both catalytic activities required coenzyme B^2» PLP, ATP, divalent 
and monovalent cations and a mercaptany4,i48
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1.2.9.3 D-Ornithine Mutase
D-Ornithine mutase, also found in Clostridia, catalyses the first step in the 
fermentation of ornithine to acetic acid, carbon dioxide, aianine and 
ammonia^^-yy. it catalyses the conversion of D-ornithine (48) to (2R,4R)- 
threo -2,4-diaminopentanoic acid (49) (Scheme 1.19). Baker showed the 
enzyme had a molecular weight of 200 000 Da with subunits of 90 000 Da 
and 12 800 Daiyo. D-ornithine mutase is also dependent on PLP and 
coenzyme B^2' but has no requirement for ATP or cations.
1.2.9.4 L"Leucin.e.,2>3r,Ami.o.flm.LLtase.
L-Leucine 2,3-aminomutase is widely distributed in bacteria, mammals, 
plants and yeast^^-iy^ iy^. it was first discovered in Clostr idium  
sporogenes where it catalyses the first step in the fermentation of L-leucine 
to isobutyric acid, the conversion of L-leucine (50) to p-leucine (51) (Scheme 
1.19)^^. The enzyme is also coenzyme 6^2 PLP-dependent.
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1.2.10 Model Reactions
Modelling coenzyme B^g-dependent reactions may provide an insight into 
the mechanisms of the enzyme catalysed reactions. Manipulation of the 
reaction conditions, to favour either free radical or cobalt-m ediated  
mechanisms, gives a body of information which can be used to lend 
credence to the general reaction scheme postulated above (pp. 1 9 - 2 0 ,  
Scheme 1.8).
1.2.10.1 Models for 2-Methvieneqlutarate mutase
The enzyme catalysed rearrangement of 2-methyleneglutaric acid (28) to 
methyiitaconic acid (29) could occur by an entirely free radical mechanism 
(Scheme 1.21) in which a hydrogen is abstracted from 2-methyleneglutaric 
acid (28) to give the substrate radical (52), which rearranges to the cyclic 
intermediate (53), and then to the product radical (54). Reabstraction of the 
hydrogen gives the product (29). Scheme 1.22 shows an alternative cobait- 
mediated mechanism.
The free radical pathway (Scheme 1.21) has some chemical precedent, 
namely, rearrangem ent of the but-3-enyl radical (55), via a cyclo- 
propylcarbinyi radical (56), to give the pent-1-enyi radical (57) (Scheme 
1.23)iyy. Golding similarly showed that the 3-ethoxycarbonyl but-1-enyl 
radical (58) rearranged to the 4-ethoxycarbonyl but-1-enyl radical (59) by a 
free radical mechanism. Again a cyclic intermediate (60) can be envisaged 
(Scheme 1.24). A tin radical was used to initiate the reaction. The 
corresponding cobaloxime compounds did not rearrangei®i. However, 
Dowd showed, in a similar system, that the cobalt adduct of b is -  
(tetrahydropyranyl) methylitaconate (61) did rearrange, at room temperature, 
to give a mixture of 2-methylenegiutaric acid (28), the rearrangement 
product, methyiitaconic acid (29) and butadiene 2,3-dicarboxylic acid (62) 
(Scheme 1.25)1
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Scheme 1.21 Radical Mechanism for the Conversion of
2-Methyleneglutaric Acid to Methyiitaconic Acid
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Scheme 1.22 Cobalt Mediated Mechanism for Conversion of 
2-Methyleneglutaric Acid to Methyiitaconic Acid
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Scheme 1.23 Chemical Precedent for a Free Radical Mechanism for the 
2-Methyleneglutarate Mutase Catalysed Rearrangent
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Scheme 1.24 Free Radical Model for the 2-Methyleneglutarate
Mutase Catalysed Rearrangement
COgH
COgTHP
COgTHP HgO, rt
COpH
Co
COgH
(61)
COgH
(29)
COgH
(62)
Scheme 1.25 Cobalt Mediated Model of the 2-Methyleneglutarate
Mutase Catalysed Rearrangement
■1..2J.(L£ Models fQi,M.e.th.y,lmal.Q.nyl-CoA Mutase
S im ilarly various model reactions have been designed to mimic the 
m ethylm alonyl-CoA mutase catalysed rearrangem ent. A variety of 
mechanisms have been shown to operate in these models. Dowd showed 
that the cobalt adduct of dimethyl m ethylm alonate (63) underwent 
rearrangement, in water, in the dark, at room temperature and physiological 
pH, to give succinic acid (13) in 3 % yield. Methylmalonic acid (64) and 
malonic acid (65) were also formed'*®^ (Scheme 1.26). Halpern also 
showed that cobalt adduct of diethyl 2 ,2-dimethylmalonyl thio ester (66) 
rearranged to give some diethyl methylsuccinyl thio ester (67) and some 
un rearranged material (68). However the bromo-analogue (69) also gave 
the rearrangement product (67)^®'^ (Scheme 1.27). Hence both cobalt- 
mediated and free radical mechanisms were shown to operate with this 
substrate. Lowe and Ingraham showed that yet another mechanism was
49
possible with their rearrangement of 1 -carbethoxy-2-oxocyclopentyl- 
m ethyl(pyridinato)bis{dim ethylglyoxim ato)cobalt(IM ) (70) to ethyl 3- 
oxocyclohexanecarboxylate (71) (Scheme 1.28)^®®. Such a ring expansion 
must occur via the carbanionic intermediates (72) and (73). Some ethyl 2- 
0 X 0 - 1 -methylcyclopentanecarboxylate (74) was also formed.
Retey devised a cobaloxime in which the substrate was covalently attached 
to side chains on the corrin ring"*®®. The substrate radical formed by 
homolysis of the C-Co bond was therefore trapped close to the cobalt. Thus, 
the chemistry of the reaction was influenced by the cobalt. A transition state 
was postulated in which the cobalt interacted with the migrating CoA thio 
ester and with the carbon centres between which the CoA thio ester 
migrated. Retey's bridged cobaloxime system gave up to 95 % yield of the 
rearrangement product.
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Scheme 1.26 Cobalt Mediated Rearrangement 
of Dimethyl Methylmalonic Acid
EtS
(67)COpEt
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Scheme 1.27 Free Radical and Cobalt Mediated Rearrangements
of Diethyl 2,2-Dimethylmalonyl Thio Ester
.COpEt
Co:
(70) (72) (73)
I)
COgEt COpEt
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i) HS(CH2)4SH
Scheme 1.28 Ionic Rearrangement Mechanism Mimicking the
Methyl malonyl-CoA Mutase 
Catalysed Rearrangement
1.2.10.3 Models for. G iutamat,e.-Mutaae.
Dowd showed diethyl 3-brom om ethyl-3-m ethyl-2-oxosuccinate (75) 
rearranged in the presence of a vitamin 3^2 nucleophile to give diethyl 4- 
methyl-2-ketoglutaric acid (76) in 71 % yield (Scheme 1.29)1^7 This 
reaction serves as a partial model for the rearrangement of 3-methylaspartic 
acid to glutamic acid. However in contrast, the Schiffs base of diethyl 3- 
bromomethyl-3-methyl-2-oxosuccinate (75), namely, diethyl 3,3-dimethyl-2- 
benzylimino succinate (77), would not rearrange in the presence of vitamin 
B i2s> but did rearrange with tri-n -butyltin hydride, to give diethyl 4-methyl-2- 
benzylimino glutarate (78) (Scheme 1.30).
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Scheme 1.29 Cobalt Mediated Rearrangement of
Methylaspartic Acid Mimic
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Scheme 1.30 Free radical Rearrangement of 
Methylaspartic Acid Mimic
In an a lte rn a tive  approach, M urakam i developed a hydrophobic  
microenvironment to use as a mimic for the apoenzyme‘’®®>'*®®>^ 70 -pj-,jg 
consisted of single-walled bilayer vesicles formed by aggregates of synthetic 
peptide lipids. Chemical modification of the cobalamin molecule made it 
hydrophobic and hence the coenzyme inserted into the apolar domain of the 
membrane (Figure 1.4). Diethyl 3-methylaspartic acid was successfully 
induced to rearrange to give diethyl glutamic acid, in this environment. 
Vanadium trichloride and atmospheric oxygen were used to generate the 
substrate radical, which then reacted with the hydrophobic cobalamin to give 
a C-Co bond. The C-Co bond was cleaved by photolysis. The membrane
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served to keep the substrate radical and coenzyme in close proximity, 
allowing the cobalt ion to promote rearrangement.
N+ N+
+ +
polar head region
hydrogen belt domain 
amino acid residues
nonpolar domain 
hydrocarbon double chains
(CH3)3N-^(CH2)5C0NHCH(CH3)C0N
Peptide lipid - N^C5Ala2Cn+i
(CH2)nCH3
(CH2)nCH3
Figure 1.4 Peptide Lipid Single-Walled Bilayer Vesicle 
with Hydrophobic Vitamin B^ g 
- an Artifical B^ g Holoenzyme
1.2.11 Conclusion
The experimental evidence available form both enzyme and model studies 
supports the hypothesis that catalysis involves homolytic cleavage of the 
coenzyme C-Co bond, to initiate the reaction. The high energy radical 
formed must be bound, by the enzyme, in such a way that it abstracts a 
hydrogen only from the substrate and does not undergo any radical 
quenching processes. The enzyme then induces the rearrangement which 
is possibly mediated by the coenzyme cobalt ion.
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THE AMMONIA-LYASES
1.3.1 Ammonia - lyases
Ammonia-lyases are defined as enzymes which catalyse carbon to nitrogen 
(C -N) bond cleavage, to give ammonia and a double bo nd^^\ This 
constitutes a large group of enzymes which use a variety of coenzymes to 
bring about catalysis. For example, glucosaminate ammonia-lyase (EC 
4 .3 .1 .9 )1 7 ^ , serine sulphate am m onia-lyase (EC 4 .3 .1 .10)^73 and  
carbam oyl-serine am m onia-lyase (EC 4.3.1.1)^^"^ require pyridoxal 
phosphate (PLP). Ethanolamine ammonia-lyase (EC 4.3.1.7)175 requires 
coenzyme 8 2^» while ornithine cyc/o-deaminase (EC 4.3.1.12)176 requires 
nicotinam ide (NAD+). The remaining am m onia-lyases: formimino- 
tetrahydrofolate cycio- deaminase (EC 4.3.1.4)177^ 3-alanyl-CoA ammonia- 
lyase (EC 4.3 .1 .6)178, porphobilinogen deam inase (EC 4 .3 .1 .8 )179 , 
dihydroxyphenylalanine ammonia-lyase (EC 4.3.1.11)1^^, methylaspartase 
(EC 4 .3 .1 .2 )8, aspartase (EC 4 .3 .1.1)1^1, histidase (histidine ammonia- 
lyase) (EC 4 .3 . 1 .3)1^2 and phenylalanine ammonia-lyase (EC 4.3.1.5)1®^ 
have no specific organic cofactors. The latter four enzymes have been 
studied in some detail and can be considered together. They all catalyse 
the elimination of ammonia from amino acids to give trans- carbon to carbon 
double bonds. 3-Methylaspartase catalyses the elimination of ammonia 
from (2S,3S)-3-m ethylaspartic  acid (2 ) to give mesaconic acid (3). 
Aspartase catalyses the elimination of ammonia from aspartic acid (79) to 
give fumarie acid (7). Histidase catalyses the elimination of ammonia from 
(2S)-histidine (80) to give urocanic acid (81) and phenylalanine ammonia- 
lyase catalyses the elimination of ammonia from phenylalanine (82) to give 
frans-cinnamic acid (83) (Scheme 1.31)
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Scheme 1.31 Ammonia-lyase Catalysed Reactions
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1.3.2 Elimination Mechanisms
Considerable effort has been spent on elucidation of the mechanism of 
elimination of ammonia in these enzyme systems. Stereochemical studies 
have shown that ammonia is eliminated in an anf/-fashion. However, these 
observations in isolation do not give insight into the mechanism of the 
elimination process. Carbonium ion (Scheme 1.32), carbanion (Scheme 
1.33) and concerted (Scheme 1.34) mechanisms are all feasible, in 
principle. Kinetic studies have thus been used to differentiate between 
these mechanistic possibilities (see pp. 61, 67, 75 and 78).
In the carbonium ion mechanism (Scheme 1.32), ammonia is eliminated first 
(84). This leaves a carbonium ion at C-2 which is quenched by elimination 
of a hydrogen from C-3 (85). The double bond is thus formed (86) (Scheme |
1.32). This mechanism would be disfavoured as it places a positive charge 
a- to a carboxyl group. This simplifies the problem to differentiation between 
carbanionic and concerted mechanisms. In the carbanion mechanism a 
hydrogen is removed from C-3 first (87). This carbanion is stabilized by the 
adjacent carboxyl group. Ammonia is then eliminated (88), to give the 
product (86) (Scheme 1.33). In the concerted mechanism a hydrogen Is 
eliminated from 0-3  and ammonia is eliminated from C-2 simultaneously 
(89), to give the product molecules (86) (Scheme 1.34).
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Scheme 1.32 Carbonium Ion Mechanism for the Elimination
of Ammonia from an Aspartic Acid
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Scheme 1.33 Carbanion Mechanism for the Elimination 
of Ammonia from an Aspartic Acid
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Scheme 1.34 Concerted Mechanism for the Elimination 
of Ammonia from an Aspartic Acid
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1.3.3 Aspartase
Aspartase occurs widely in bacteria^^^'^G4 plants'*®^ and mammals^®®, 
where it catalyses the reversible conversion of (2S)-aspartic acid (79) to 
fumaric acid (7) and ammonia (Scheme 1.31). The enzyme from E. cofi W  
has been most thoroughly investigated'*®^. Tokushige showed that 
aspartase from this source had a molecular weight of 193 000 Da and 
consisted of four identical subunits, each of 48 500 ±  500 Da, arranged in D2 
symmetry. He also detemined the primary sequence'*®®.
No alternative substrates to aspartic acid and fumaric acid have been found 
for aspartase, but the ammonia can be replaced by hydroxylamine to give N- 
hydroxyaspartic acid'*®®. Viola et al. showed aspartase was an allosteric 
enzyme, I.e. it was activated by aspartic acid binding at a site remote from 
the active site^®®. Some substrate analogues were found for the allosteric 
site.
The enzyme displayed cooperative kinetics at alkaline pH, indicated by a 
sigmoidal relationship between the substrate concentration and the rate. At 
pH 6.0, however, it exhibited Michaelis-Menten kinetics'*®'*. Depue and 
Moat showed aspartase was activated by divalent cations (Ca®+, Mg^+, 
Mn®+, Co^+, Zn^+, Cd^+) above pH 8.0, and that above pH 9.0 there was an 
absolute requirement for a divalent cation. However below pH 8.0 the 
enzyme was completely active in the absence of divalent cations'*®^. 
Potassium also caused activation at high substrate concentrations (>20 
mM), but inhibited at lower concentrations'*®^. In the absence of added 
metal ions, the pH optimum, for the deamination reaction, dropped from 8.7 
to 7.7. The for aspartic acid was 1 mM^®^.
The use of reagents to specifically modify certain amino acids showed there 
were two cysteine residues, and one or possibly two histidine residues, that 
were essential for enzyme activity'*®®>^ ®4. The presence of aspartic acid and 
magnesium ions afforded protection to cysteine residues 140 and 430 from 
modification by N-(7-d imethylamino-4-methyl-3-coumarinyl) maleimide
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(DACM), a fluorescence reagent, specific for thiols'*®®. Similarly the 
presence of aspartic acid, fumaric acid or chloride ions (an inhibitor) 
prevented inactivation of the histidine residue(s) by diethyl pyrocarbonate, a 
histidine specific modifying agent. Cysteine modification increased the 
for aspartic acid, whereas modification of the histidine residue(s) caused 
inactivation. Tokushige therefore concluded that the histidine residue(s) was 
situated at the active site, where it acted as a general base, while the 
cysteines were required for binding, either at the active site or the remote 
aspartic acid binding site.
Nuiry's kinetic studies, using the enzyme isolated from Hafnia a/ve/, showed 
a negligible primary isotope effect of 1.04 on and 1.02 on V/K for the 
deamination of (2S,3R)-[3-^H]-aspartic acid. A significant '*®N primary 
isotope effect of 1.0239 ± 0.0014 was also observed on V/K^®®. These 
results indicated a two-step mechanism was occurring, in which C-N bond 
cleavage was, at least, partially rate limiting.
Porter and Bright showed 3-nitroalanine (90) bound very strongly to 
aspartase, especially in its ionized form (K^/Kj = 220 above pH 9.0)^®^. 
They suggested that 3-nitroalanine was mimicking the stable aci - 
carboxylate intermediate (91) (Figure 1.5) of a carbanion mechanism  
(Scheme 1.33). Young showed that the 3-pro -R hydrogen of aspartic acid 
was abstracted as a proton from C-3, by one of the cysteine residues, prior to 
the rate limiting C-N bond cleavage'*®®. The evidence therefore pointed to 
an E1 gb mechanism for aspartase. However, the complicated cation effects 
and allosterism have still to be fully explained.
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Figure 1.5 ionized 3-Nitroalanine Mimicking the Intermediate
of a Carbanionic Mechanism
1.3.4 Histidase
Histidase catalyses the elimination of ammonia from (2S)-hlstidine (80) to 
give urocanic acid (81) (Scheme 1.31). H istidase is found in both 
mammals'*®® and microbes^®®. In bacteria, it is the first enzyme in histidine 
catabolism ^®^ Most studies have used the enzym e isolated from 
Pseudom onas fluorescens, which Rechler showed was a tetram er of 
molecular weight 222 000 Da^®^. Peterkofsky measured the for histidine 
as 9 mM below pH 8.5 and 24 mM above pH 9.0. For urocanic acid the 
was 7 mM at pH 9.0^®®.
Abeles showed histidase was inhibited by sodium borohydride, but that 
protection was afforded by the presence of substrate^®4. Reduction with 
sodium borotritide, followed by acid hydrolysis of the inactive enzyme, gave 
tritiated alanine. This was the only labelled residue^®®. Similarly, ‘*4c- 
labelled nitromethane inactivated the enzyme. It was demonstrated that, 
after acid hydrolysis, the labelled molecule had reacted either by p- 
displacement of an unknown group, or p-addition at a dehydroalanine 
residue®®®. Taken together these results provided compelling evidence for 
the existence of a dehydroalanine residue at the active site. It was thought 
that the dehydroalanine residue was probably attacked, in a M ichael 
fashion, by the amino group of the substrate (92) to give an enzyme bound 
intermediate (Scheme 1.35).
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Peterkofsky showed, by labelling experiments in tritiated water, that the 
abstraction of a proton from C-3 (93) was stereospecific (Scheme 1.35)®®®. 
This gave a carbanionic intermediate (94)®®^. C-N bond cleavage then 
produced the urocanic acid product (95). Elimination was facilitated by 
delocalization of charge through the dehydroalanine system . The  
dehydroalanine residue was finally regenerated by loss of ammonia, to give 
the active enzyme and product (96)
In the original work on the enzyme, in 1962, Peterkofsky showed, through 
the use of ^®N ammonia, that exchange of ammonia into the substrate did 
not occur®®®. Peterkofsky also showed that incubation of histidine and ^4Q_ 
urocanic acid gave labelled histidine. However, in the absence of histidine 
the back reaction did not occur. Free ammonia and urocanic acid did not 
give the amination product. Furata and co-workers incubated L-[5’-®H]- 
histidine with histidase to investigate the rate of hydrogen exchange at C- 
5*208 They showed the rate of increase in concentration of unlabelled 
urocanic acid did not depend on the rate of formation of urocanic acid. 
Unlabelled urocanic acid was still formed even after urocanic acid formation 
was complete. These results suggested the formation of an amino-enzyme 
complex, derived from histidine, as an intermediate in the reaction. The 
back reaction (amination of urocanic acid to give histidine) did not occur 
unless the enzyme had been incubated with histidine, to allow the amino- 
enzyme intermediate to form.
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1.3.5 Phenylalanine Am mo ni a-Lyase
Phenylalanine ammonia-lyase catalyses the elimination of ammonia from 
(2 S)-phenylalanine (82) to give frans-cinnamic acid (83) (Scheme 1.31). 
Phenylalanine ammonia-lyase is found in many plants and some lower 
organisms2®®>2io. In higher plants the enzyme diverts phenylalanine into 
secondary metabolism^oi. The elimination product, frans-cinnamic acid, is 
further metabolized into a variety of phenylpropanoid compounds such as 
lignins, coum arins, stilbenes and anthocyanins^^\ In contrast, in 
microorganisms the enzyme has a catabolic role. The phenylalanine 
am m onia-lyases from m aize, potatoes and the yeast-like  fungus  
Rhodotorula glutinis have been most extensively studied.
Havir and Hanson showed phenylalanine ammonia-lyase, from all three 
sources, was a tetramer of molecular weight 330 000 D a^i^.sia y^e  
enzyme from potatoes was specific for (2S)-phenylalanine, but that from 
maize and Rhodotorula glutinis turned over both (2S)-phenylalanine and 
(2S)-tyrosine2i 4. The potato enzyme turned over (2R)-phenylalanine but at 
1/5000 of the rate for (2S)-phenylalanine. (2 R)-Phenylalanine was also a 
competitive inhibitor^i^. The enzyme also accepted p -fluoro- and p -chloro- 
phenylalanine as s u b s tra te s ^ H a n s o n  and Havir also showed that it 
acted on the cyclohexadlenyl analogue, 3-(1,4-cyclohexadienyl)-L-alanine, 
to give trans -3-(1,4-cyclohexadienyl)acrylic acid^”*®. Amrhein synthesized a 
variety of inhibitors for phenylalanine ammonia-lyase, including (S )-2- 
aminooxy-3-phenylpropanoic acid (97) (K; = 1.4 nM)2i7, (R)-(1-amino-2- 
phenylethyl)phosphonic acid (98) (Kj = 1.5 |liM)219 and 2-aminoindan-2- 
phosphonic acid (99) (K| = 0.08 pM)2l9.
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Figure 1.6 Inhibitors of Phenylalanine Ammonia-lyase
Hanson and Havir showed the deamination reaction did not follow  
Michaelis-Menten kinetics^^^-^"*®. At the optimum pH (pH 8.7), the apparent 
Km increased, from 0.038 mM to 0.26 mM, and the apparent V^ax doubled, 
as the concentration of (2S)-phenylalanine was increased from 0.01 mM to
6.7 mM. Michaelis-Menten kinetics were restored by the presence of the 
competitive inhibitor (2R)-phenylalanine. The presence of the product, 
trans -cinnamic acid, also restored Michaelis-Menten kinetics and caused 
inhibition of the reaction. These observations suggested that phenylalanine 
ammonia-lyase was an allosteric enzyme. The enzyme was efficient at low 
substrate concentration but with increasing substrate concentration  
effic iency decreased. This system therefore controls the flow of 
phenylalanine and tyrosine metabolites into secondary metabolism.
Unlike the histidase catalysed reaction, the phenylalanine ammonia-lyase 
catalysed reaction was fully reversible; incubation of the enzyme with
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la b e lled  trans- c innam ic acid and am m onia gave lab e lled  (2 S )- 
phenylalanine. If unlabelled (2S)-phenylalanine and labelled trans- 
cinnamic acid were incubated together, labelled (2S)-phenylalanine was 
produced faster than expected for the back reaction. Havir and Hanson 
rationalized this result by invoking an amino-enzyme intermediate which 
allowed a partial back reaction (between labelled trans- cinnamic acid and 
the amino-enzyme intermediate to give (2S)-phenylalanine) to occur at such 
a rate.
Hanson and Havir found, as with histidase, that sodium borotritide, 
inactivated phenylalanine ammonia-lyase, giving, after acid hydrolysis of the 
inactive enzyme, [ 3 - ^ H ] - a l a n i n e 2 2 0 , 2 2 i  Similarly ‘‘ ^C-nitromethane^^^ 
caused inactivation of the enzyme, giving [4-"*4c]-aspartic acid (the usual 
product of acid hydrolysis of nitroaikyl aci- salts) after acid hydrolysis.
Zon and Laber showed that the m echanism  of e lim ination  was  
stereospecific^^^. The pro- 3S hydrogen was eliminated. Cleland studied 
the mechanism of phenylalanine ammonia-lyase using deuterium and 
isotope e ffec ts ^ (2S )-P h en y la la n in e  gave a ^(V/K) value of 1.15. The pH 
dependence of the isotope effects showed the active substrate was the 
monoanion. Extrapolated ‘'^(V/K) values for the unlabelled monoanion of 
(2S)-phenylalanine were 1.0021 and, for the deuterlated compound, 1.0010. 
This finding is in accord with a stepwise carbanion m echanism . 
Experiments of this type will be discussed in more detail in Chapter 3 (pp. 
1 5 8 - 159).
The enzyme from yeast has been crystallized^^"^, but as yet no crystal 
structure has been published.
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1.3,6 M,ethyJasp.artas.e.
Methylaspartase catalyses the reversible elimination of ammonia from
(2S,3S)-3-methylaspartic acid (2) to give mesaconic acid (3) (Scheme 1.31). 
It also catalyses a rapid exchange between the 3-H of the substrate and the 
solvent. Much of the early work carried out in the 1960’s has been recently 
reinvestigated by Gani et al. However, it is presented here to provide a 
context for the more recent work.
1.3.6.1 Enzyme Structure
The enzyme from Clostridium tetanomorphum has a molecular weight of 
100 000 Da, as determined by sedimentation equilibrium measurements^^^. 
Treatment with 6 M guanidine hydrochloride cleaved the enzyme into two 
subunits of 50 000 Da^^e Hsiang and Bright reported that p -chloro- 
mercuribenzoate in a molar excess of 8-fold cleaved the enzyme into four 
subunits of 25 000 Da, as measured by density gradient sedimentation 
techniques^^^. The enzyme was assigned an (ap)2 subunit structure based 
on W u’s electrophoretic evidence, suggesting that the four subunits were not 
h o m o g e n e o u s 2 2 8 .  However, in later work, Cohen showed the enzyme 
behaved as a homodimer of molecular weight 49 000 Da^^®. SDS-PAGE  
under a variety of conditions failed to show any evidence of splitting into 
smaller subunits. A tryptic digest of the enzyme performed in 1968 by Wu 
and Williams resulted in 55 peptides, corresponding to half the total number 
of arginine and lysine residues present in the enzyme. This was further 
evidence for the enzyme being a dimer of identical subunits^^o. Also Gani’s 
N-terminal sequence analysis published in 1992 unambiguously identified 
the first 26 amino acids, indicating the presence of only one N-terminal 
sequence^^\
Photooxidation studies, performed by Williams and Libano, in 1966, showed 
that the rate constant for enzyme activity loss was nearly identical to that for
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sulphydryl destruction, suggesting a sulphydryl group was required for 
activity^^^. The enzyme was also inactivated by the thiol alkylating agent, N- 
ethylmaleimide. Analysis of the protection from inactivation given by various 
substrates and substrate analogues implied that the sulphydryl group |
(cysteine residue) was in close proximity to C-3. W illiams and Libano 
suggested that this cysteine was the base responsible for the removal the 3- 
H of (2S,3S)-3-methylaspartic acid.
1.3.6.2 Early Kinetic Work
A number of properties of 3-methylaspartase were described in the first 
major paper on the enzyme by Barker in 1959®. The pH optimum for 3- 
methylaspartase was 9.7. The enzyme was most active at 55 °C, although it 
lacked stability at this temperature. The equilibrium constant, K^q, for the 
deamination reaction was determined as 0.3.
Barker showed a divalent and a monovalent cation were required for 
activity®. Magnesium was the most active divalent metal ion, although 
nickel, cobalt, zinc, iron, manganese and cadmium also served as 
cofactors®®®. Bright obtained the following order of activation: Mg®+ > 
Mn®+> Co®+> Ni®+ ®®4. Calcium and strontium were inhibitors. It was noted 
that activity was related to ionic radii. Those ions with radii of less than 1 Â 
were activators, whereas those with larger radii were inhibitors®®®. A variety 
of monovalent cations activated the enzyme. Potassium was most effective 
and others less so, activity decreased in the following order; K+ > NH4+ > 
Rb+> Li+ > Na+ > Cs+ ®. The K^ for potassium was 3 mM, under Barker’s 
conditions. At high concentrations potassium inhibited the reaction. The 
ammonium ion, being a deamination product as well as serving as a 
m onovalent cationic activator, caused the enzym e to behave auto- 
catalytically in the absence of potassium.
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1.3.6.3 Early Work on Binding Order
Bright and Silverman showed 3-methylaspartic acid bound as the free 
amino acid and not as an amino acid - magnesium complex®®®. Incubation 
of the enzyme, with 3-methylaspartic acid in the absence of magnesium, 
afforded the enzyme protection against inhibition by mercuribenzoate. Thus 
the substrate must bind to the enzyme either first or in a random order with 
the divalent cation®®®. Kinetic analysis showed that a random order, rapid 
equilibrium addition of the divalent cation and 3-methylaspartic acid to the 
enzyme was most likely.
Fields and Bright performed EPR measurements, using manganese as the 
divalent cation, which showed two metal ions were bound per enzyme 
molecule®®^. It was therefore suggested that the enzyme had two active 
sites. This correlated with the number of mesaconic acid binding sites found 
by gel filtration of 3-methylaspartase in buffer containing mesaconic acid®®®, 
Hsiang and Bright also showed the enzyme was inactivated by two 
equivalents of p -chloromercuribenzoate®®®. As the enzyme was insensitive 
to arsenite, the two essential thiol groups were not located at the same 
active site.
1.3.6.4 Evidence for a Carbanion Mechanism
In Bright's original studies, a primary deuterium isotope effect for the 
deamination of (2S,3S)-L-f/?reo-3-methylaspartic acid was not observed®®®. 
It was concluded, therefore, that C-H bond cleavage was not rate limiting. 
Furthermore, exchange of the 3-H of the substrate with solvent was 
observed to occur at a rate faster than that for the deamination reaction. This 
finding supported the notion that a carbanion was formed at C-3 and that 0 -  
N bond cleavage was rate limiting. Bright also showed that ^®N-ammonia 
was incorporated into 3-methylaspartic acid at a neglible rate compared with 
3-H exchange with the solvent®®®. This indicated that C-H and C-N bond 
cleavage were separate events and tended to exclude the possibility of a
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s-
concerted mechanism. The lack of ammonium ion exchange also ruled out 
the operation of a carbonium ion mechanism. J
Preparations of 3-methylaspartase have also been reported to turnover (2S,
3R)-L-eryfhro -methylaspartic acid®. Barker suggested that this activity was 
an inherent property of 3-methylaspartase as the ratio of L-erythro - to L- 
threo - activity remained constant throughout the purification of the enzyme.
He also noted that the rates of deamination of both compounds were 
dependent upon the potassium and magnesium ion concentrations and 
were inhibited by calcium ions. The fact that (2S,3R)-3-methylaspartic acid 
was a substrate for the enzyme also lent credence to a carbanion  
mechanism for 3-methylaspartase. The carbanion intermediate generated 
at C-3 would be identical for both substrates.
Thus, 3-methylaspartase was originally held as the archetypal example of 
an enzyme which operated by a carbanionic mechanism®®®.
1.3.6.5 Substrate Specificity
3-Methylaspartase tolerates a wide variety of substituents in place of the 
methyl group at C-3. L-Aspartic acid®, 3-ethyiaspartic acid®, 3 -n -  
propylaspartic acid, 3-iso- propylaspartic acid®^® and, more recently, 3- 
chloroaspartic acid®"^  ^ have been shown to be substrates. 3-Fluorofumaric 
acid and 3-bromofumaric acid (100) were also substrates®^®. Although 
(2R,3S)-3-fluoroaspartic acid was produced in low yields, a number of side 
products were also formed, resulting in a mixture of products. 3- I
Bromofumaric acid (100) was a good substrate for 3-methylaspartase. |
However the (2R,3S)-3-bromoaspartic acid (101) produced, being an a- 
bromo acid, was unstable under the incubation conditions and cyclized to 
form 2,3-aziridinedicarboxylic acid (102) (Scheme 1.36). Attack by an active 
site base or nucleophile (103) also occurred, causing alkylation (105), and 
hence inactivation, of the enzyme (Scheme 1.37). This would provide a 
means of identifying the active site base / nucleophile, as this residue would
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be covalently linked to a labelled 3-bromoaspartlc acid substrate.
COpH
3-Methylaspartase
(101)(100)
HOpC
(102)
Scheme 1.36 The Formation of 2,3-Aziridinedicarboxylic Acid
from Bromofumaric Acid
Enz Enz
COpH
HOpC
B or NuB or Nu
(103) (104)
Scheme 1.37 Labelling of the Active Site Base / Nucleophile
of 3-Methylaspartase
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Gani used the enzyme to synthesize stereochemioaily pure 3-halogeno- and 
3-alkyl aspartic acids from the correspondingly substituted fumarie acids. 
The C-3 deutehated isotopomers were also prepared, by incubation of the 
appropriate fu marie acid with the enzyme in deuterium oxide^^f. Deuterium 
was thus incorporated stereospecifically at C-3. The kinetic parameters for 
amination of the substituted fumaric acids (Table 1.1) and deamination of the 
3-substituted aspartic acids (Table 1.2) were determinecA^^.
Table 1.1 Kinetic Parameters for the Amination of Substituted Fumaric Acids
Substrate
(mM)
^max
(x10“® mol dm"^ min"i)
Fumaric acid 23 ± 2 .2 1702
Mesaconic acid 1.24 ± 0 .0 8 894
Ethylfumaric acid 1.05 ± 0 .2 583
Chlorofumaric acid 3.52 ±  0.71 382
Bromofumaric acid 2.64 ± 0 .5 3 425
n -Propylfumaric acid 2.1 ± 1 .3 4.2
/so-Propylfumaric acid 5.5 ± 3 .0 5.3
n -Butylfumaric acid <0.05
lodofumaric acid <0.05
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Table 3.2 Kinetic Parameters for the Deamination of 3-Substituted Aspartic 
Acids
Substrate
(mM)
^max
(x10‘® mol dm'3 min'f)
3-Methy!aspartic acid 2.37 ± 0.2 654
Aspartic acid 10 .5 1 0 .82 4.8
3-Ethylaspartic add 1 7 .0 8 1 1 .4 292
3-Chloroaspartic acid >50 382
The K^ values for the fumaric acids studied were very similar, with the 
exception of fumaric acid (see Table 1.1). The high K^ for fumaric acid 
indicated that it bound poorly. The magnitudes of for amination of the 
sm aller fumaric acids were all similar. The rate then dropped off 
dramatically with the iso -propyl- and n -propyl fumaric acids, while n -butyl- 
and lodofumaric acid did not react at all. It appeared that a point was 
reached when the alkyl /  halogène substituent was too large to fit in the 
methyl binding pocket of the enzyme active site.
There was more variation in for the deamination reaction (see Table 
1.2). 3-Ethylaspartic acid and 3-chloroaspartic acid were deaminated at 
about half the rate of the natural substrate, whereas aspartic acid was a 
much slower substrate. However in the amination direction the rates of 
reaction for fumaric acid and mesaconic acid are almost identical. This 
implied a step in the deamination reaction was more sensitive to the size of 
the substituent than any of the reverse reaction steps. This interesting result 
led to further investigations of the enzyme mechanism.
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1,3.6.6 Primary Qauterium Isotope-Effects
Primary deuterium isotope effects were measured for 3-methylaspartic acid, 
aspartic acid and 3-ethylaspartic acid (Table 1.3)^ '^ .^
Table 1.3 Kinetic Parameters for the Deamination of 3-Substituted Aspartic 
Acids and 3-Substituted-[3-^H]-Aspartic Acids
Substrate
(mM)
^max 
(xIO’® mol 
dm"3 m in'f)
D(V)
&
D(V/K)
3-Methylaspartic acid 2 .3 7 1 0 .2 654
3-[3-^H]-Methylaspartic acid 2.3510.25 385.2 1 .7 1 0 .3
Aspartic acid 10 .510.82 4.8
[3-2 H]-Aspartic acid 10 .510 .82 4.8 1.0
3-Ethylaspartic acid 1 7 .0811 .4 292
3-[3-2H]-Ethylaspartic acid 17 .6611 .6 250.6 1 .1 6 1 0 .2
A significant primary deuterium isotope effect was seen on the deamination 
of 3-methylaspartic acid (see Table 1.3). This was contrary to the work of 
Bright who did not observe an isotope effect for this reaction. The presence 
of a primary deuterium isotope effect implied that C-H bond cleavage was at 
least partially rate limiting and threw into question the carbanion mechanism 
proposed by Bright^^®. Cleavage of the C-H was, necessarily, kinetically 
more important than previously assumed.
The lack of a deuterium isotope effect, for the deamination of aspartic acid, 
and the reduced isotope effect seen with the 3-ethyl substrate, compared to 
the natural substrate, suggested that both (2S)-aspartic and (2S,3S)-3-
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ethylaspartic acid were deaminated by a mechanism greater in carbanion 
character than that of the natural substrate. This was rationalized by 
invoking a torsional distortion of the dihedral angle between the 2-C-N and 
3-C-H bond, in these two substrates, away from the 180° required for a 
concerted anti -elim ination and presumably attained for (2 S ,3 S )-3 -  
methylaspartic acid (105) (Figure 1.7). With aspartic acid the interaction 
between the 3-H and the methyl binding pocket (106) would be smaller than 
with the natural substrate. Conversely, there would be a strained interaction 
between this pocket and the ethyl group of 3-ethylaspartic acid (107). The 
unnatural substrates would be subject to poor orbital alignment in a 
carbanion intermediate. Hence C-H bond cleavage would become less rate 
limiting, as C-N bond cleavage became more difficult and, therefore, more 
rate limiting itself.
Ethylfumaric acid was noted to bind more tightly at the active site than the 
physiological substrate. Therefore product debinding may have become 
partially rate limiting with (2S,3S)-3-ethylaspartic acid as substrate, masking 
the chemical steps of the reaction. Hence the elimination of ammonia from 
3-ethylaspartic acid may still occur concertedly.
With (2S)-aspartic acid the values for both substrate and product were 
substantially higher than for the physiological compounds so substrate /  
product dissociation should not be rate limiting. It seems likely that (2S)- 
aspartic acid is deaminated by a carbanion mechanism. Exchange of the C- 
3 hydrogen with solvent occurred, for L-aspartic acid, at approximately one- 
tenth of the rate for 3-methylaspartic acid.
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Figure 1.7 Active Site Binding of (2S,3S)“3-Methy!aspartic Acid (105), 
(2S)-Aspartic Acid (106) & (2S,3S)-3-Ethyiaspartic Acid (107) 
in 3-Methyiaspartase
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Bright’s originai experiments attempted to measure a primary deuterium 
isotope effect for the deamination of 3-methyiaspartic acid at 50 mM 
potassium  ion concentration 's^  However, at this potassium  ion 
concentration the effect was m a s k e d ^ I t  was only at lower potassium ion 
concentrations that the isotope effect was observed with the effect being 
maximal at 1 mM potassium ion concentration. The lower level of deuterium 
incorporation in Bright’s substrate (87 % label compared with the >95 %  
deuterium incorporation Botting and Gani obtained) may also have helped 
mask the effect.
1.3.6.7 15.N Isotope Effects and Double isotope Fractionation
As a deuterium isotope effect had been observed, C-H bond cleavage was 
considered at least partially rate limiting. However this result provided no 
information as to whether a balanced stepwise carbanion mechanism or a 
concerted mechanism was occurring.
To d istinguish between these two m echanism s, a double isotope  
fractionation experiment was performed^^®. in this experiment the kinetic 
isotope effect on C-N bond cleavage was measured in the presence and 
absence of deuterium at C-3 of 3-methylaspartic acid, in a concerted 
mechanism isotopic substitution at C-3 should have no effect on, or 
increase, the isotope effect on C-N bond cleavage. A balanced stepwise 
carbanion mechanism would show a reduced kinetic isotope effect for C-N 
bond cleavage in the presence of deuterium at C-3. (See p. 158 - 159 for a 
more detailed explanation.) Values of 1,0246 ±  0.0013 and 1.0241 ± 0.0009  
were obtained for the i^N isotope effect in the presence of protium and 
deuterium at C-3 respectively. As these values were identical, within 
experimental error, they implied that the reaction followed a concerted 
pathway with a single transition state involving both 3-C-H and 2-C-N bond 
cleavage.
For (2S)-aspartic acid a double isotope fractionation experiment showed a
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smaller 1^N isotope effect in the presence of d e u t e r i u m ^ 4 7 ^  as one would 
expect for a balanced stepwise mechanism. However, as no deuterium 
isotope effect was observed with aspartic acid^^^, this result has yet to be 
fully explained.
1.3.6.8 Exchange Reactions
Further experiments showed that the exchange of the 3-H of (2S,3S)-3- 
methylaspartic acid with the solvent was consistent with a concerted 
mechanism245, (2S,3S)-3-M ethy!aspartic acid and (2S ,3S )-[3 -^H ]-3- 
methylaspartic acid were incubated in tritiated water. This allowed the rate 
of protium or deuterium wash-out from the substrates to be measured as 
tritium wash-in. The primary deuterium isotope effect on loc the 
exchange reaction (^(o)ex)) at pH 9.0 was measured as 1.6. The size of the 
isotope effect was not dependent on the ratio of the rates of exchange and 
deamination, which showed gross changes with pH. This suggested that 
exchange occurred after a slow step which followed C-H bond cleavage. It 
also indicated that exchange did not occur at the free carbanion level, as 
• (^Dex) was constant with pH.
A product trapping experiment was devised to ascertain why i^N-iabelled  
ammonia was not incorporated into the substrate in an exchange reaction. 
Incubation of 1^N-Iabelled ammonia and [3-^H3]-mesaconic acid with 
uniabeiied (2S,3S)-3-methyiaspartic acid showed rapid formation of [1^N, 
methyl -^Hg]-3-methyiaspartic acid. The singly labelled species were 
formed only slowly and could be accounted for by reaction with free 
uniabeiied substrates.
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1.3.6.9 Binding and Debinding Orders
Methylamine was found not to be an activator of 3-methyiaspartase and was 
a competitive inhibitor of 3-methylaspartic acid in the deamination reaction 
and of ammonia and mesaconic acid in the amination direction^^^. These 
two experiments showed that mesaconic acid and the ammonium ion were 
released at the same rate with random debinding. This hypothesis was also 
supported by the fact that mesaconic acid was a competitive inhibitor of
(2S,3S)-3-methylaspartic acid. The increase in rate of hydrogen exchange 
observed with increasing ammonium ion concentration^^® was rationalized 
as being caused by retardation of the release of the products from the 
enzyme.
Gani suggested there was a slow step after C-N bond cleavage but before 
the formation of the E.NH^^+.Mes complex, during which the ammonium ion 
was relocated within the active site. During this step, 3-H exchange also 
occurred. The substrates then either recombined to give 3-methyiaspartic 
acid or formed the enzyme-product complex and dissociated.
The evidence presented for the second binding site for ammonia was firstly 
that the rate of reaction was observed to depend upon [NH,^+]^ i.e. two 
molecules of ammonia were involved. Secondly, ammonia acted as a non­
linear uncompetitive product inhibitor for the deamination process, it was 
proposed that 3-methylaspartase reacted by the mechanism depicted in 
Scheme 1.38. In this mechanism uniabeiied 3-methylaspartate enters an 
active site fully saturated with i®N-ammonium ions (108), the ammonium ion 
from the first ammonium binding site is displaced. The 3-H and C-N bonds 
then break concertedly (109), leaving unlabelled ammonium bound at the 
first ammonium binding site (110). At this stage deuterium exchange can 
take place with the hydrogen removed from 0-3 by the enzyme base, but 
exchange of ammonium at the first ammonium binding site is blocked by the 
product molecule. Reamination of mesaconate (111) gives [3-^H]-3- 
methyiaspartate, retaining an uniabeiied amino group (112).
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Scheme 1.38 Two Ammonia Binding Site Mechanism for 3-Methylaspartase
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Sodium borohydride did not cause inactivation of S-methylaspartase^"^® as it 
did with the dehydroalanine residue containing enzymes, h i s t i d a s e ^ 0 4  g^d 
phenylalanine a m m o n i a - l y a s e ^ ^ O  However, phenylhydrazine caused 
irreversible inactivation of the enzyme, with some protection against 
inactivation being conferred by the substrate.
The tryptic peptide containing an active site residue selectively labelled with 
[1-i^C]-N-ethylmaleimide by Wu and Williams^^o^ for which the amino acid 
composition was known, could not be identified in the nucleotide base 
sequence of the enzyme obtained from the recent genetic work^^i, if it was 
assumed that the labelled residue was a cysteine. However, if the labelled 
residue was taken as a serine a match was obtained. In order to explain the 
reaction of serine with N-ethylmaleimide, a post-translational modification of 
the serine to a dehydroalanine residue (113) was invoked (Scheme 
1.39)248. The dehydroalanine residue could conceivably be attacked by the 
amino group of the substrate (114) to give a 2,3-diaminopropanoic acid 
residue (115) which could then react with N-ethylmaleimide, alkylating the 
enzyme (116) (Scheme 1.40).
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Reanalysis of Bright’s work at low pH showed that the substrate and 
magnesium ion bound in a random steady state manner and then the 
potassium ion bound245. At pH 6.5 and high potassium ion concentrations 
the binding order was compulsory, with the potassium ion binding after the 
substrate, potassium was also released before the first product. At pH 9.0 |
the magnesium ion could bind before the substrate, which bound in rapid 
equilibrium; potassium bound after the substrate. At low magnesium ion 
concentrations a binding order of: the substrate, then potassium and then 
magnesium was favoured. At low potassium ion concentrations, the 
substrate bound in the steady state. Cooperativity existed between the two 
active sites of the enzyme, which was In a new catalytic form with a high 
affinity for potassium.
HgN+
(113) (114)
Scheme 1.39 Proposed Reaction of Putative Dehydroalanine Residue
in the 3-Methylaspartase Active Site 
with 3-Methylaspartic Acid
(115) (116)
Scheme 1.40 Proposed Mechanism of Inactivation of
3-Methylaspartase by N-Ethylmaleimide
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CHAPTER TWO
GLUTAMATE MUTASE
RESULTS AND DISCUSSSION
%4
i:
Z I  Introduction
The enzym e g lu tam ate  m utase catalyses the carbon skeleton  
rearrangem ent of L-glutamic acid to (2S ,3S)-3-m ethylaspartic  acid.
Although a number of coenzyme 2-dependent enzymes have recently 
been studied in some detail (see pp. 12 - 44), Barker’s original studies i
remain the major literature source for glutamate mutase. The rearrangement 
has however been studied in terms of model reactions (see pp. 52 - 54).
Our approach to studying glutamate mutase involved, initially, purification of 
the enzyme to allow construction of a gene probe, followed by eventual 
cloning and over-expression of the enzyme in E. colL It was envisaged that
(2S,3S)-3-ethylaspartic acid, which could be accessed in a stereochemically 
pure form using 3-methylaspartase, may act as a substrate analogue for 
glutamate mutase. This molecule and its labelled variants could be used as 
mechanistic probes for the enzyme.
ZZ  PetegtLon of Glutamate Mutase Activity
Clostridium tetanomorphum cell paste, obtained on a service basis from the 
Department of Biology at the University of East Anglia, was the intended 
source for glutamate mutase. The bacteria were grown up on Barker’s 
media^ (Table 2.1) using growing conditions which were a modification of 
Barker’s original method249.229 Barker obtained both glutamate mutase 
and 3-methylaspartase from bacteria grown under these conditions. The 
cell paste provided, after very little purification (see p. 167 -168), an extract 
rich in 3-methylaspartase. There was no significant removal of material from 
the substrate or product pools by contaminating activities. The activity of 
such enzymes on the methylaspartic acid pathway was suppressed under 3- 
methylaspartase assay conditions, as their cofactors were not present. 
Glutamate mutase requires coenzyme B^2 for activity^^o and, similarly, 
mesaconase requires Fe2+ for activity'si.
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Table 2.1 Media for Growing Up Clostridium tetanomorphum
Component Concentration (g/l)
Sodium glutamate 10.62
Yeast extract 3.1
M gS04.7H 20 0.25
FeS04.7H 20 0.11
MnCl2. 2H2O 0.002
Na2Mo04 0.0025
CaClg. 2H2O 0.015
O0 CI2 0.005
K2HPO4 5.4
KH2PO4 1.5
Glucose 7.2
Ail the enzymes on the glutamic acid fermentation pathway should be 
strongly expressed in C. tetanomorphum grown with glutamic acid as the 
major carbon source. Any differences in activity levels are attributable to the 
enzyme’s physiological role in the cell. The first enzyme in the pathway is 
often the controlling enzyme, determining flux through the pathway. Any 
accumulation of intermediates is determined by the activity levels of the 
other enzymes in the pathway.
A crude extract was prepared, from C. tetanomorphum cell paste, based on 
the partial purification procedure for 3-methylaspartase (see p 167 - 168). 
Barker’s purification procedures for the individual components of glutamate 
mutase indicated that both components should co-extract with the 3- 
methylaspartase under these conditions®^»®®.
Barker used a spectrophotometric assay, to determine glutamate mutase 
activity, measuring the conversion of L-glutamic acid to mesaconic acid®.
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However, this method was not suitable for determining glutamate mutase 
activity in the crude enzyme extract as its specific activity was so low that the 
absorbance from contaminating proteins masked any absorbance changes 
due to mesaconic acid production.
Other methods for detecting activity were investigated. Attempts to observe 
the formation of 3-methylaspartic acid by tic were not successful. Although a 
variety of solvent systems were evaluated, the two structural isomers, 
glutamic acid and 3-methylaspartic acid were not separable by tic.
An alternative approach was to detect ammonia, the other product of the 
conversion of L-glutami(i acid to mesaconic acid. Nessler's reagent^^s 
produces a yellow-brown colour on reaction with ammonia. Ammonia was 
detected qualitatively, but attempts to quantify the measurement by colour 
intensity comparison with standard solutions were not successful.
The conversion of L-glutamic acid to 3-methylaspartic acid and to mesaconic 
acid was followed successfully by 1H NMR spectroscopy. Sodium glutamate 
was incubated with partially purified protein in Tris buffer containing the 
cofactors required for glutamate mutase and 3-methylaspartase activity. 
Aliquots were removed a t  various time intervals. After several hours signals 
due to 3-methylaspartic acid and to mesaconic acid were observable. A 
similar incubation of (2S,3S)-3-methylaspartic acid using calcium chloride to 
Inhibit 3-methylaspartase activity showed some conversion to L-glutamic 
acid.
ZZ  PudflcatiQn of Gimarnate Mutase
In contrast to 3-methylaspartase, where the specific activity of the partially 
purified extract was so high that no further purification was required for either 
the synthetic24i or kinetic studies^^s performed, glutamate mutase is much 
less active. Therefore the enzyme required further purification before any 
further investigations could be made. The aim was to purify both
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The purification of Component S with a reported molecular weight of 17 000 
Da was attempted first, as entire amino acid sequences can be obtained for 
proteins of this size. It was intended to obtain Component S via a 
modification of Barker’s protocol®^.
Component S containing fractions could not be identified by assaying for 
glutamate mutase activity, as the component was not active without 
Component E. Thus, molecular weight determination by SDS-PAG E
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components to allow our molecular biology collaborators to obtain N- 
terminal amino acid sequences. Hence they could construct gene probes 
and scan the C. tetanomorphum DNA library available from work on the 3- 
methylaspartase gene (MeAsp )28i. There is some evidence that the gene 
for mesaconase resides immediately 3 ’ (downstream) of MeAsp 248 jf 
sequential expression of the genes encoding for the enzymes of the 
methylaspartic acid pathway occurred, the glutamate mutase gene would lie 
5 ’ (upstream) to MeAsp. An incomplete open reading frame (ORF), of 1.2 kb, 
beyond the 5 ’ end of MeAsp has been identified and sequenced. This ORF 
was therefore too large to be the gene for Component S of glutamate 
mutase, but it was thought it could be the gene for Component E. This was 
confirmed recently by Marshal, who has sequenced both components. The 
gene for Component S was situated upstream of the gene for Component E, 
with a third gene of unknown function between the two.
Component S may not be expressed in an active form from the aerobe E .
CO//, as it contains air sensitive thiol groups which are active only when 
reduced®^. However genetic engineering could replace these thiol groups 4
with serine residues thus conferring air stability whilst, hopefully, retaining 
activity.
Over-expression of the glutamate mutase genes in E. coli is essential to 
give easy access to large amounts of protein. Repetitive full purification of 
the enzyme from C. tetanomorphum would be required to give access to 
sufficient enzyme for mechanistic experiments.
;i,.1
(polyacrylamide gel e l e c t r o p h o r e s i s ) 2 5 3 ^  using Barker’s molecular weight 
value (17 000 Da)®^, was the only guide to purification.
After lysis of the glutamate mutase containing cells, by sonication, isoelectric 
precipitation, at pH 4.6, removed many contaminating proteins®^. SDS- 
PAGE of the supernatant showed two strong bands of low molecular weight, 
one slightly below 17 200 Da (myoglobin molecular weight marker) and one 
just above 12 300 Da (cytochrome c molecular weight marker). The former 
was considered most likely to be Component S. However, later work, by Mr. 
Hartzoulakis, showed the molecular weight of Component S was 15 000^54 
This value was confirmed by Marsh®®-®^ Com ponent S from C . 
cochlearium had a molecular weight of 16 000 Da®®.
The next step involved ion exchange chromatography on DEAE-cellulose. 
Component S was reported to elute at 50 mM potassium phosphate 
concentration®^. Fractions that eluted at this concentration were pooled. 
The next purification step, gel exclusion chromatography gave two, well 
separated, protein peaks. Calibration of the column elution times with 
molecular weight standards and SDS-PAGE showed that neither of these 
proteins were Component S. Component S was not relocated after the 
DEAE-cellulose chromatography step.
The alternative approach of eluting the supernatant from the isoelectric 
precipitation step from a gel exclusion column in the next step, removed the 
higher molecular weight proteins (>50 000 Da). However the remaining 
fractions did not contain enough protein for detection by SDS-PAG E, 
staining with Coomassie Brilliant Blue R.
Only the initial steps of the purification of Component E were attempted.
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2A Mechanistic Probes
One approach to probing enzyme mechanism is the use of substrate 
analogues. However Barker reported that glutamate mutase was substrate 
specific, turning over only its natural substrates (see p. 30)®. Buckel showed 
isotopic labelling, introduced into the methyl group of 3-methylaspartic acid, 
was scrambled during the glutamate mutase catalysed rearrangement, 
probably by rapid rotation of the methylene radical intermediate®®. 
Therefore it was not possible to elucidate from which side of the molecule 
the adenosyl radical attacked, in the natural substrate. Thus it was 
imperative to find another substrate for the enzyme. (2S,3S)-3-Ethylaspartic 
acid (117) or 3-fluoromethylaspartic acid were structurally closest to the 
natural substrate. The latter compound is electronically different from the 
natural substrate and so may react in a different manner, possibly 
inactivating the enzyme. 3-Ethylaspartic acid had the advantage that it may 
actually be a slow substrate for the enzyme. Also replacing one of the 
hydrogens with a methyl group, as in 3-ethylaspartic acid, would present the 
enzyme with a larger group to bind to, thus locking the conformation at this 
centre. The two remaining hydrogens could then be distinguished by 
isotopic labelling. (2S,3S)-3-Ethylaspartic acid was therefore the preferred 
synthetic target.
Z3. Synthesis of (2S.3S)-3-Ethvlaspartic Acid (117)
The putative substrate analogue, (2S ,3S )-3 -eth ylasp artic  acid was 
synthesized in four steps from ethyl acetoacetate (118) (Scheme 2.1)241. 
Treatment with freshly prepared sodium ethoxide, followed by alkylation with 
ethyl bromide or ethyl iodide gave 2-ethylacetoacetate ethyl ester (119), 
which was isolated and purified by distillation. 2-Bromo-2-ethyl-4-bromo- 
acetoacetate ethyl ester (120) was prepared by reaction with bromine. A 
Favourskii r e a r r a n g e m e n t 2 5 5  of the dibromide, effected with potassium 
hydroxide as base, gave ethylfumaric acid (121).
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In the literature synthesis of isocrotonic acides®, Rappe showed potassium 
hydrogen carbonate gave significantly higher yields than potassium  
hydroxide, when used as the base in the Favorskii rearrangement (77 % cf. 
21 %). However the reaction time was noticeably slower (2.5 h of. 30 min). 
In our hands, there was no substantial improvement in the yield of 
ethylfumaric acid when potassium hydrogen carbonate was used.
Purification by steam distillation to remove the volatile impurities, diethyl 
ether extraction of the acidified aqueous solution and successive  
recrystallizations gave ethylfumaric acid as a white solid. This was 
incubated, for several days, with 3-methylaspartase and ammonia, to give
(2S,3S)-3-ethylaspartic acid (117).
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o o
(118)
Hi)
o o
(120)
O O
(119)
iv)
HOgQ y '
H COgH
(121)
V)
HgN pOgH
HOgC H
(117)I) NaOEt, EtOH
II) EtBr, reflux, 2 h
ill) Br2, EfgO, reflux, 3 h
iv) K O H /EtO H , reflux, 30 min
v) fC, H2O, NHg, methylaspartase
Scheme 2.1 Synthesis of {2S,3S)-3-Ethylaspartic acid
23. Experiments Using (2S.3S)-3-Ethyla§partig.Agid
{2S,3S)-3-Ethylaspartic acid was incubated with adenosylcobalamin and a 
crude preparation of glutamate mutase.  ^H NMR spectra of aliquots 
removed at various time intervals during the incubation were recorded at 
500 MHz. Signals attributable to an amino acid with a linear three carbon 
side chain and electron-withdrawing group on C-5, accumulated with time. 
Total correlation spectroscopy confirmed that the signals were linked.
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Incubations in the absence of added coenzyme showed a two-fold decrease 
in production of this compound. The remaining turnover observed was 
attributed to active coenzyme still bound to the enzyme. A 1,3 carbon 
skeleton rearrangement of 3-ethylaspartic acid, initiated by removal of a 
hydrogen from C-2’ of the ethyl group, would give such a six carbon amino 
acid.
Comparisons were made of the  ^H NMR spectra of the incubation product
(122) with aminoadipic acid (123) and ornithine (124), in an attempt to 
identify the 0-5 substituent (see Table 2.2).
Table 2.2 NMR Data For 5-Substituted Amino Acids
HOpC
(122)
Substituent X Chemical Shift - C-5 Hs 
(ppm)
-X (122) 3.04
-GO2H (123) 2.25
-NH2 (124) 3.40
Based on these chemical shifts 5-hydroxynorvaline (125) was proposed as 
the incubation product (122). This compound was synthesized to allow 
comparison of its  ^H NMR spectrum with that of the incubation product.
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ZJ. Synthetic Routes to 5-Hydroxvnorvaline 
Four synthetic routes were examined.
Nitrosation of N-acetyl ornithine with perchloric acid and sodium nitrite was 
u n s u c c e s s f u | 2 5 7 ,  Hydroboration of DL-allylglycine methyl ester with 
disiamylborane^®® was also unsuccessful, even when 3 equivalents of 
disiamylborane were used to compensate for any possible complexation 
between the amine and the borane.
Reduction of the y-methyl ester of L-glutamic acid (126) with lithium 
aluminium hydride proved more successful. Protection of the a-carboxylic 
acid and amine groups was required, before the reduction step. Two 
protection methodologies were followed (Schemes 2.2 and 2.3).
In the first method, isobutyl chloroformate was used to protect the nitrogen 
(127) (Scheme 2.2). Protection of the a-carboxylic acid as the 4,4,-dimethyl-
2-oxazoline (128)^59 proceeded smoothly, although care was required to 
ensure the oxazoline ring closed. However, the ester reduction, giving the 
protected alcohol (129) and subsequent deprotection reactions gave a 
mixture of products. Preparative tic however gave a small amount of the 
required 5-hydroxynorvaline (125).
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HOoC
(126)
G02Me
OCONH
HOpC
(127)
C0 2 Me
ii)
OCONH
C02Me
(128)
OCONH
iv)
Hi)
HO2C
(125)
(129)
i) isobutyichioroformate, H20/toiuene
ii) 2-amino 2-methyl 1-propanoi, p TSA 
Hi) UAIH4, E t f i
iv) 6 M  HCI, reflux, 4 h
Scheme 2.2 Synthesis of 5-Hydroxynorvaline via the Oxazoline
The second route to 5-hydroxynorvaline used trityl chloride to protect the 
amine of glutamic acid in a one pot reaction (Schem e 2.3) 260,261 
Trimethylsilyl chloride was added first to protect the carboxylic acid groups.
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Trityl chloride afforded protection of the amine and the trimethylsilyl groups 
were removed under mild acid conditions, to give N-trityl glutamic acid (130). 
In our hands, lithium aluminium hydride reduction to give N-trityl 5- 
hydroxynorvaline (131) did not go to completion and deprotection with 95 % 
acetic acid gave a mixture of 5-hydroxynorvaline (125) and glutamic acid (1).
HOgC
PhgCNH
ih llh Hi), iv)
COgH HOpC
V)
COgH
(130)
PhgCNH
HOpC
(131)
Vi)
HOgC
(125)
i) TMSCI, DCM, EtsN
ii) MeOH
Hi) EtgN, PhaCCI 
iv) MeOH  
V) UAIH4, THE 
Vi) A C O H /H 2O  (95 / 5 )
Scheme 2.3 Synthesis of 5-Hydroxynorvaline Using Trityl Protection
The chemical shift of the 5-Hs of 5-hydroxynorvaline was 3.02 ppm. Addition 
of a sample to the incubation mixture confirmed the signal was not 
coincident with that from the incubation product (Table 2.3).
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2.8 Synthesis of S-N-Formyi Ornithine
It seemed likely that the incubation product (122) possessed a nitrogen 
containing electron withdrawing group at C-5. One such compound was 6- 
N-Formyl ornithine (132). This compound was therefore synthesized, in 
order to allow the chemical shift of its 5-Hs to be compared with that of the 
incubation product. 0-N-Formyl ornithine (132) was synthesized from a-N- 
acetyl ornithine (133) (Scheme 2.4). Formic acetic anhydride, made from 
acetyl chloride and sodium formate^®^, was added to a-N-acetyl ornithine in 
glacial acetic acid. The product, a-N-acetyl-Ô-N-formyl ornithine (134), was 
obtained as a racemate at the a-centre. The enzyme acylase was used to 
remove the a-acetyl protection. Although the resultant a-N-acetyl-Ô-N- 
formyl-D-ornithine (135) and 0-N-formyl-L-ornithine (132) mixture could not 
be separated, subtraction of the a-N-acetyl-ô-N-formyl-D-ornithine signals 
from the 1H NMR spectrum of the mixture gave the 1H NMR spectrum of 6-N- 
formyl-L-ornithine.
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HOpC
il)
(133)
OA NH
0
(135)
YO H
OANH
HOpC
(134)
Y
O
H
HOpC
i) formic acetic anhydride, AcOH 
H) acylase
(132)
î
Scheme 2.4 Synthesis of ô-N-Formyi-L-Ornithine
2.9 Further NMR Data
The Chemical shifts obtained from ^H and NMR spectroscopy of arginine 
(136), citrulline (137) and ô-N-formyl-L-ornithine (132) were compared to 
those of the incubation product (Table 4.3).
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Table 2.3 and NMR Data for 5-Substituted Amino Acids
HOpC
Substituent X  ^H-Chemical Shift
5-Hs (ppm)
^^C-Chemical Shift (ppm) 
C-5 X
-X (122) 3.04 42.0 158.0
-COpH (123) 2.25
-NHp (124) 3.40
-OH (125) 3.02
0NHp
-N  NHa 
H
(^37)
H
- N ^ H  (132)
H
3.04
3.05 
2.90
41.7 157.9
39.8 162.3 
38.0 176.6
2.1 Q Attempted Isolation of Incubation Product
Isolation of the incubation product proved unsuccessful by both preparative 
tic and ion exchange chromatography. However, acidification of the
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incubation mixture and extraction with diethyl ether removed both 
ethyIfumarie acid and mercaptoethanol from the mixture. This essentially left I
a mixture of ethylaspartic acid, the compound in question and another !
unknown compound typified by a doublet at 1.37 ppm. Subtraction of the 3- |
ethylaspartic acid signals from a NMR spectrum of this mixture left 
signals identical to those of arginine (136). I
I
II2.11 Conclusions
However, further incubations showed arginine was also produced in the 
absence of substrate. Thus, it would seem likely that it is produced by some 
protease action in the crude enzyme extract.
Mr Hartzoulakis has since shown, in similar incubations with purified 
glutamate mutase that (2S,3S)-3-ethylaspartic acid is indeed a substrate for 
glutamate mutase254. 1h NMR spectra suggested that L-erythro -methyl 
glutamic acid was the initial rearrangement product, but that further 
rearrangement gave 3,3-dimethyl aspartic acid, typified by two singlets at ^
1.37 ppm, as observed in incubations with crude enzyme and interpreted as 
a doublet.
2.12 Synthesis of (2S.3S)-[^H^]-3-Ethvlaspartic Acid
In order to follow in more detail any rearrangement of 3-ethylaspartic acid, 
access to appropriately labelled compounds was required. (2S,3S)-3- 
Ethylaspartic acid completely deutehated in the ethyl group was synthesized 
via the route for unlabelled 3-ethylaspartic acid discussed previously 
(Scheme 2.1). The deuterium labelling was introduced by using [^Hg]-ethyl 
iodide in the alkylation of ethyl acetoacetate. The 2-[^Hg]-ethylacetoacetate 
ethyl ester (138) produced in a small scale reaction, was brominated. A 
Favourskii rearrangement of the dibromide gave H5]-3-ethyIfumarie acid
(139), typified by only one signal in ^H NMR spectroscopy, a singlet at 6.59
99
ppm. This was enzymically aminated to (2S,3S)-[^Hs]-3-ethylaspartic acid
(140), which displayed ‘‘ H NMR signals due to 2-H and 3-H at 2.71 and 3.90 
ppm, respectively.
2.13 Synthesis of (2S.3S)-[1 ’-^H]-3-Ethvlaspartic Acid
3-Ethylaspartic acid chirally labelled at the 1’ C of the ethyl group was 
required to attempt to establish from which side the 5 ’-deoxyadenosyl 
radical abstracted a hydrogen. In order to utilize the synthetic route 
previously employed (Scheme 2.1) a chirally labelled ethyl halide was 
required. Simple alkyl halides are extremely volatile compounds and 
therefore difficult to purify. The low melting point solid, ethyl tosylate (m. p. 
33 -34 was, therefore, substituted for ethyl bromide /  iodide in the
reaction with the ethyl acetoacetate anion. The harder, bulkier oxygen- 
based leaving group proved not to be as efficient an electrophile as the alkyl 
halides. A m ixture of compounds was obtained, from which 2- 
ethylacetoacetate ethyl ester (119 b) was isolated in 40 % yield by column 
chromatography on silica gel, eluting with ethyl acetate / petroleum ether (15 
/ 85). Access to chirally labelled ethyl tosylate was to be via the 
appropriately labelled ethanol.
2.13.1 Methods Available for the Synthesis of Chirally Labelled Ethanol
Loewus, W estheimer and Vennesland’s classic demonstration of the 
stereospecificity of enzyme catalysed reactions^^^ was also the first 
synthesis of chirally labelled ethanol. They showed that nicotinamide- 
(NAD+) dependent yeast alcohol dehydrogenase stereospecifically reduced 
[1 -2H ]-aceta ld eh yd e  (141 ) to [1 -^H ]-ethanol (1 4 2 ) (Schem e 2 .5 ). 
Reoxidation of the alcohol regenerated [1-^H]-acetaldehyde. Similarly 
unlabelled acetaldehyde (143) was converted to [1-^H]-ethanol (144) by 
reduction with deu teria ted  nicotinam ide coenzym e, again with  
stereospecificity. Walden inversion of the tosylate using sodium hydroxide
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cleanly converted one enantiomer to the other.
2H
\ =  O
HoC
i)
(141)
ii)
H-
(143)
OH
2h — c  H
CH3
(142)
Hi)
iv)
OHI- C  2h
CH3
(144)
i) NADH, h t, alcohol dehydrogenase
ii) NA[fhi, h t, alcohol dehydrogenase 
Hi) TsCI, pyr
iv) NaOH
Scheme 2.5 The Stereospeclfic Nature of the 
Alcohol Dehydrogenase Reaction
A number of syntheses of [l-^Hj-ethanol of known stereochemistry followed, 
thus allowing the configuration of the ethanols produced enzymically to be 
established265. Several of these routes merit investigation.
W eber’s synthesis of (S)-[1-2H]-ethanol from [l-^HJ-glyoxylic acid^GG
employed NAD+-dependent muscle lactate dehydrogenase to convert [1-
2H]-glyoxylic acid (145) to (S)-[1-2H]-glycolic acid (146). The methyl ester
was then formed and the alcohol protected as the benzyl derivative (147).
Reduction of the ester with UAIH4 gave the alcohol (146) which was
activated with p -bromobenzenesulphonyl chloride. Reduction with UAIH4
introduced the methyl group and hydrogenation deprotected the alcohol to
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give (S)-[1-^H]-ethanol (149) (Scheme 2.6).
HOpC OH OCHgPh
i) I ii), Hi)  ^ I
: 0  -------------- 2h — c — H  ► H
COgH COgMe
(145) (146) (147)
OCHgPh OH
iv) I v), Vi), vii)
^H—C— H ------------- 2h — c — H
I ICHgOH OHs
(148) (149)
i) NADH, lactate dehydrogenase
ii) Me2C(OMe)2, h t  
Hi) PhCH2Br, Aq20
iv) UAIH4
v) p -BrPhSOaCI, pyr 
Vi) UAIH4
vii) H2, Pd/C
Scheme 2.6 Synthesis of (S)-[1 -^H]-Ethanol from [2-^H]-Glyoxylic acid
An attempt to introduce stereospecificity by the asymmetric hydroboration of
2 -c/s -butene (150) with deuteriated diisopinocampheyiborane, giving 
(2R,3S)-[3-^H]-butan-2-ol (151), was not entirely successful as the reaction 
gave some of the alternative, erythro isomer^^^. However, oxidation to the 
aldehyde (152), followed by a Baeyer-Villiger rearrangement gave [2-^H]- 
ethylacetate (153), and hydrolysis to (S)-[1-^H]-ethanol (149) proceeded 
smoothly (Scheme 2.7),
1 0 2
(150)
iv)
OH O
Hi)
(151)
v VO 2»
V)
(153)
(152)
OH 
2H— C— H
ICHg
(149)
i) H- diisopinocampheyiborane
ii) H ^ 2  
Hi) Pt, O2
iv) CF3CO3H, Na2HP04
v)KOH
Scheme 2.7 Synthesis of (S)-[1-^H]-Ethanol from cis -But-2-ene
Prochirality was also induced chemically, by a Grignard type reaction 
between acetaldehyde and a-deuteriated isoborneol (154), produced by 
reduction of (+)-camphor (155) with lithium aluminium deuteride. The 
magnesium bromide salt of (S)-[1-^H]-ethanol (156) resulted (Scheme 
2.8)268.
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(155)
i)
V
MgBr
DH
OH
(154)
iih ili)
\ /
OMgBr
CH3
i) LiA^H^
H) Mg, G/g
iii) MeCOH
Scheme 2.8 Synthesis of (S)-[1-^H]-Ethanol using (+)-Camphor
Enzymic syntheses of [1-^H]-ethanol offer higher stereochemical purity, but 
are limited by the cost of the enzymes and NAD+ cofactor. The isolation of 
the ethanol produced from the aqueous medium also proved difficult. 
Catalytic amounts of cofactor can be used, if it is regenerated in situ by a 
coupled reaction. Levi et al used an alcohol dehydrogenase /  glucose 
dehydrogenase system^^Q. Glucose dehydrogenase made an ideal 
recycling enzyme as the reaction equilibrium favoured reduction of NAD+, 
and non-enzymic hydrolysis of the gluconic acid product drove the reaction 
to completion.
The alcohol dehydrogenase reaction was also coupled to the flavin enzyme,
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diaphorase (Scheme 2.9)270, This coupling allowed the deuterium label to 
be introduced from the solvent. Solvent deuterium exchanged into the flavin 
(157) and was, thus, transferred to the nicotinamide (158). The opposite 
enantiom er was produced by stereospeclfic loss of deuterium  from  
dideuteroethanol ([1,1-2H]-ethanol).
Flavin-Ha + —  Flavin-^Hg + HgO
(157)
Flavin-^Hg + NAD+ -  NAD^H + + Flavin
(158)
CH3 CHO + NAD^H + H+ - — CHgCH^HOH + NAD*
Scheme 2.9 Diaphorase Coupled Synthesis of (R)-[1-^H]-Ethanol
2.13.2 Attempted Synthesis of Chirally Labelled Ethanol
It was decided to employ a new chemical synthesis of [l-^HJ-ethanol. The 
route devised is shown in Scheme 2.10. The appropriate enantiomer of 
alanine (159) was the starting material. Chirality was introduced into the 
molecule using the reducing agent, lithium triethylborodeuteride (Super 
Deuteride). Subsequent steps involved activation of the acid group, 
formation of the methyl ketone and a Baeyer-Villiger rearrangement. 
Cleavage of the acetate then gave ethanol.
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NH, Br
r  0 ,  r
H a C 'y ^ C O g H  H a C 'y ^ C O g H
H H
(159) (160)
ii)  » _
H« ’!!) H ,HoC/o.ll^COoH ^^0 /W
H3C" X O C I
2H
(161) (168)
V),CHN
H
O O
(169) (170)
H. iH  9  ... K  3Hvn)
CH3 ^ O H
i) KBn NaNOs, HBr
ii) LiEtsBD, THF
iii) PCI5, CHCI3
iv) CH2N2 
V) HI, DCM
vi)m-CPBA, 1, 1, 1-IC E
vii) N2H4
Scheme 2.10 Synthetic Route to Chiral Ethanol
(2 S)-Alanine (159) was first converted to (2S)-bromopropanoic acid (160), 
via a nitrosation / bromination reaction^^i, which gave retention of 
configuration. A double inversion of stereochemistry actually occurred. The 
amine was nitrosated and then displaced by an intramolecular reaction
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to give the internal a-lactone. The lactone was then attacked by the 
bromide, again by a mechanism, opening up the lactone, to give (2S)- 
bromopropanoic acid with overall retention of configuration. Lithium 
triethylborodeuteride^^^ was then used to reduce the (2S)-bromopropanoic 
acid to (2R)-[2-^H]-propanolc acid (161), with a further inversion of 
configuration273. Triethyl borate was produced as a side product of this 
reaction and proved difficult to remove. Attempted removal in vacuo  
resulted in loss of the low boiling propanoic acid as well. Separation by 
short path distillation was also unsuccessful, as was chelation with 1,1,1- 
tris(hydroxymethyl)ethane. The problem was noted in a similar literature 
synthesis^^"^ where spinning band column distillation was used, giving pure 
ethyl [2-^H]-propanoate in only 10 % yield, the rest being contaminated with 
triethylborate.
The (2R)-[2-^H]-propanoic acid produced by reduction with lithium triethyl­
borodeuteride was not purified any further at this stage and the triethylborate 
carried through to the next step. It was expected not to interfere with 
subsequent reactions and might be removed more easily in a later step.
An alternative two step route from (2S)-bromopropanoic acid to (2R)-[2-^H]- 
propanoic acid used by Prescott and Rabinowitz^^^ in their synthesis of [2- 
^H]-propionyl-CoA was considered. They used LiAID^ to introduce 
deuterium at C-2 with inversion of configuration and also to reduce the acid 
to an alcohol with the introduction of deuterium at C-1, giving [1,1,2-^H]-n - 
propanol. This was oxidised to [2-^H]-propanoic acid with chromic acid. 
However a number of purification steps were required to obtain the pure 
deuteriated acids, using preparative GC techniques that were not available 
in the group.
As unlabelled propanoic acid and other intermediates were available, the 
reaction conditions for the following steps were investigated without using 
labelled material.
Several attempts were made to synthesize propionyl chloride (162).
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Treatment of propanoic acid with thionyl chloride yielded the acid chloride, 
as was confirmed by the distinctive C =0 stretch in the IR spectrum at 1790 
cm"i and by comparison of spectral data with that for the authentic 
compound. However, the excess thionyl chloride could not be removed in  
vacuo as the boiling points of thionyl chloride and propionyl chloride were 
very similar (thionyl chloride: b.p. 75 - 76 and propionyl chloride: b.p. 
80 Vogel described the decomposition of excess thionyl chloride by
addition of formic acid^^®. Accordingly, 96 % formic acid was added but the 
propionyl chloride was not isolable and seemed to have decomposed. The 
alternative oxalyl chloride had a lower boiling point (oxalyl chloride: b.p. 62 
°C276). However, despite the greater difference In boiling points between 
oxalyl chloride and propionyl chloride, the excess oxalyl chloride still co­
distilled with the propionyl chloride. Formation of the acid chloride using 
triphenylphosphine and carbon tetrachloride^^^ was also pursued. 
However removal of the triphenylphosphine oxide by-product and unreacted 
triphenylphosphine proved difficult.
An alternative was to activate the acid as an anhydride instead of the acid 
chloride. Ethyl chioreformate was used to form the mixed anhydride, which 
was converted directly to the diazoketone without isolation. This reaction 
was partially successful in yielding the required diazoketone but there were 
a number of side products which could not be fully identified, so introducing 
a purification problem.
Synthesis of the acid chloride was readdressed. This was accomplished 
using phosphorus pentachloride^^o with chloroform as solvent. Propionyl 
chloride was co-distilled off with the chloroform, leaving the by-product, 
phosphorus oxychloride (b.p. 107.2 and any unreacted phosphorus
pentachloride behind.
Diazomethane added to a solution of propionyl chloride in chloroform gave 
the diazoketone cleanly. Two equivalents of diazomethane were required; 
one equivalent was used to form the diazonium intermediate and the other 
to remove HCI from the intermediate, giving the diazoketone, chloromethane
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and nitrogen. The diazoketone was fairly non-volatile (57 °C at 12 mm 
Hg2Si) and hence removal of the solvent in vacuo allowed the product to be 
isolated. It displayed a N=N stretching peak at 2105 cm"i in the IR spectrum 
and, by 1H NMR spectroscopy, a distinctive singlet at 5.23 ppm.
■i
The diazoketone was dissolved in dichloromethane and reduced using 
aqueous hydrogen iodide to give butanone (164). The excess Hi was 
removed using aqueous sodium thiosulphate (50 %). Such a concentrated 
sodium thiosulphate solution was used to prevent the butanone from I
partitioning into the aqueous layer. The material was purified by co- 
distillation of the butanone and dichloromethane. The C = 0  stretching peak I
observed by IR spectroscopy had shifted 30 cm'i lower to 1710 cm i.
Baeyer-Villiger oxidation, using m- chloroperbenzoic acid then gave ethyl 
acetate (165). 1 ,1 ,2-Trichloroethane was used as solvent (1 ,1 ,2 -
trichloroethane: b.p. 113.7 The reaction was followed by ^H NMR
spectroscopy in which the shift of the methylene group from 2.45 ppm in 
butanone, to 4.13 ppm in ethyl acetate was particularly indicative. The 
reaction was cooled to cause precipitation of the contam inating  
chlorobenzoic acid and the solid filtered off. The ethyl acetate and 1,1,2- 
trichloroethane were co-distilled away from any further chlorobenzoic acid.
The higher boiling solvent ensured that the ethyl acetate co-distilled over in 
the early part of the distillation. An alternative purification procedure, namely 
removal of chlorobenzoic acid by washing with aqueous bicarbonate 
solution, resulted in significant losses of ethyl acetate into the aqueous layer.
The ethyl acetate was also purified by silica gel column chromatography, 
eluting with low boiling petroleum ether (b.p. 30 - 40 °C), which could be at 
least partially removed by distillation, to allow concentration of the ethyl 
acetate.
The acetate group was removed by reaction with hydrazine hydrate to give 
the required ethanol (166). Dioxane (b.p. 101 °C at 750 mmHg282) vvas 
initially used as solvent as ethanol (b.p. 78.5 co-distllled with it, |
leaving the non-volatile acetic hydrazide behind. However, the 1,1,2-
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îrichloroethane used in the previous step worked equally well.
The solvent /  ethanol mixture was dried thoroughly and the ethanol 
converted to the tosylate (167), by reaction with tosyl chloride in pyridine^®^.
However, when attempting the synthesis with labelled m aterial, the 
diazoketone reaction failed to proceed smoothly. It was thought hydrogen 
chloride, present in the solution of (2R)-[2-^H]-propionyl chloride (168) in 
chloroform, was disrupting the reaction. Using a larger excess of 
diazomethane did not improve the yield. Therefore a number of techniques 
were employed to remove hydrogen chloride. Firstly the freshly distilled 
chloroform was passed down an alumina column immediately prior to use. 
The reactions were also shielded from light and the solution of propionyl 
chloride in chloroform was distilled off N,N-dimethylaniline. This step 
successfully removed the hydrogen chloride, but some propionyl chloride 
was thought to have reacted with the N,N-dimethylaniline, lowering the yield. 
Potassium carbonate was added to the reaction of propionyl chloride with 
diazomethane immediately prior to concentration in vacuo, to quench any 
acid, preventing attack of the diazoketone as the solution was concentrated. 
The diazoketone was then redissolved in diethyl ether and the solid 
potassium carbonate removed by filtration. These precautions together 
ensured the smooth production of (3R)-[3-^H]-1 -diazobutan-2-one (169).
Reduction of (3R)-[3-^H]-1 -diazobutan-2-one with hydrogen iodide gave 
(3R)-[3-^H]-butan-2-one (170). However, spectral analysis revealed that, in 
some reactions, up to 50 % of the deuterium label was lost. In the i H NMR 
spectrum extra splitting of the signals and inconsistent integrations were 
observed and two molecular ion peaks of equal intensity were revealed by 
mass spectroscopy. Loss of label presumably occurred by enol formation in 
the presence of a trace of acid. However, no procedural error could be 
linked to the loss of label. This step, therefore, proved unreliable.
Due to the large number of technical difficulties experienced with the 
synthesis and the build up of impurities caused by the non-isolable nature of
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the volatile intermediates, it was decided not to pursue this route to chiral 
ethanol. If preparative GC were available the route might prove viable.
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CHAPTER THREE
3-METHYLASPARTASE
RESULTS AND DISCUSSION
aJ. Introduction
3-M ethylaspartase catalyses the conversion of (2S,3S)-L"f/?reo -3- 
methylaspartic acid to mesaconic acid®. It has also been shown to turnover 
a number of 3-alkyl- and 3-halogeno- substituted fumaric acids^^®»®^^, to 
give the L-f/?reo-3-substituted aspartic acids in each case. The enzyme was 
considered to be the archetypal enzyme to operate via a carbanion 
mechanism^®®. The evidence for this mechanism included the lack of a 
primary deuterium isotope effect and that the rate of 3-H exchange  
exceeded the rate of mesaconic acid formation^®®. Also no labelled 
ammonia was incorporated into the product, from the solution. It was also 
noted that both the erythro - and three - isomers of 3-methylaspartic acid 
were substrates for the enzyme®. In a carbanion mechanism the two 
substrates would have a common intermediate upon loss of 3-H^®®.
However, a re-examination of the enzyme by Sotting and Gani showed there 
was a primary deuterium isotope effect of 1.7 on 1 mM potassium ion
concentration, for the natural s u b s t r a t e ® ^ ^  Thig implied that C-H bond 
cleavage was at least partially rate limiting. A isotope effect on (V/K) of
2.5 % was also measured^^e. Hence C-N bond cleavage was also partially 
rate limiting. The reaction showed identical isotope fractionation,
when deuterium was substituted for hydrogen at C-3. This result indicated a 
concerted mechanism was operating and hence a carbanion mechanism 
was ruled out.
Given that the enzyme operated via a concerted mechanism, the ability of 
the enzyme to process the (2S,3R)-L-eryf/?ro- isomer of 3-methylaspartic 
acid required investigation. The assumption that both isomers gave rise to 
the same carbanionic intermediate was clearly no longer valid.
1 1 2
Confirmation that 3-MethyiaspMase-.C.atalyse.s,the Elimination of 
Ammooia^from_(2S.3RT3-M Acid
Confirm ation was required as to w hether 3 -m ethy laspartase  was  
responsible for the conversion of (2S,3R )-L-e/yfW  -3-methylaspartic acid to 
mesaconic acid, or whether the reaction was due to a contaminating 
enzyme. Such a contaminating enzyme could either be an L-erythro /  threo- 
epimerase or L-erythro -3-methylaspartase. Support for the latter notion 
came from the early studies on Acetobaoter suboxydans^^, which showed 
the micro-organism was able to synthesis L-glutamic acid via a pathway 
which was essentially the reverse of the catabolic pathway used in 
Clostridium tetanomorphum  (see p. 10). It seemed that A cetobaoter 
suboxydans produced L-erythro -3-methylaspartic acid and not the L-threo - 
isomer used in Clostridium tetanomorphum. This implied the presence of L- 
e /y fW  -3-methylaspartase and an L-erythro - specific glutamate mutase.
Barker sought to address the existence of a contaminating enzyme, in 
Clostridium tetanomorphum, by measuring the ratio of L-erythro - to L- 
threo- activity at various stages of the purification of 3-methylaspartase®. 
The ratio remained constant throughout. He also noted that the rates of 
deamination of both L-threo - and L-erythro -3-methylaspartic acid were 
dependent on potassium and magnesium ion concentration and inhibited by 
calcium ions. Sotting recently confirmed that incubations of diammonium 
mesaconate, performed in the presence of potassium and magnesium ions 
at pH 9.0, with both partially purified clostridial 3-methylaspartase and 
clostridial 3-methylaspartase purified to homogeneity, gave, first, L-threo -3- 
m ethylaspartic acid and, after prolonged incubation, L-erythro  - 3 - 
methylaspartic acid, in similar ratios independent of enzyme purity®® .^
Cloning and over-expression of the 3-methylaspartase gene in E. coil ^32 
produced pure recombinant enzyme, free of any clostridial contaminants. 
Sotting and Gani showed that incubations of diammonium mesaconate with 
enzyme from this source also produced L-erythro -3-methylaspartic acid^^®. 
Thus, L-threo -3-methylaspartase was capable of synthesizing the L-erythro
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- isomer from mesaconic acid.
Given that one enzyme was responsible for both activities, it was of interest 
to investigate the L-erythro -3-methylaspartic acid reaction in more detail. 
The reaction could occur via epimerization of the L-erythro -isomer to the L- 
threo -isomer, from which ammonia could be eliminated, via a concerted 
anti -elimination mechanism, or direct syn -elimination of ammonia could 
occur. As the kinetics and mechanism of the reaction with the natural 
substrate were now so well understood®^®, a study of the L-erythro - 
substrate would prove enlightening.
2l3l Possible Routes to (2S,3B).--3.:Me,thyla§partlc Acid
To investigate the reaction further, (2S,3R)-L-eryf/ïro -3-methylaspartic acid
(171) was required. Barker incubated disodium m esaconate with 
Clostridium tetanomorphum cell-free extract, to obtain a mixture of L- 
glutamic acid, L-f/?reo-3-methylaspartic acid and L-eryf/?ro-3-methylaspartic 
acid®. The L-glutamic acid was removed by elution through a Dowex 1- 
acetate column with 0.05 M acetic acid which gave a mixture of the two 3- 
methylaspartic acid isomers. This mixture was incubated with pure 3- 
methylaspartase until the rate of mesaconic acid production approached that 
expected for conversion of the L-erythro -isomer. The 3-methylaspartic acid 
remaining was isolated, to give L-erythro -3-methylaspartic acid, with less 
than 5 % contamination by L-threo -3-methylaspartic acid and L-glutamic 
acid. He also separated the two 3-methylaspartic acid isomers by paper 
electrophoresis in 0.1 M sodium formate buffer at pH 3.85, applying 1700 
volts for 1 hour. The L-threo - isomer travelled faster than the L-erythro - 
isomer, having a Rp of 0.86 compared with 0.73 for the L-erythro -isomer®.
it was decided however to utilize a synthetic route to (2 S ,3 R )-3 -  
methylaspartic acid. The route needed to be diastereoselective and flexible 
enough to allow the synthesis of (2S,3R)-[3-®H]-3-methylaspartic acid as 
well.
114
a J ü  Seebach’s Synthesis of (2S,3R)-3-Met!iy}asparti.c..Aclci
Seebach’s alkylation of di-ferf-butyl-N-formyl-aspartic acid (172)®®® was 
considered (Scheme 3.1). In this synthesis, lithium diethylamide effected a 
clean double deprotonation of di-fe/ï>butyl-(S)-N-formyl-aspartic acid in THF  
(-78 °C, 2 hours). The dilithio derivative (173 and 174) was then alkylated 
with iodomethane (-78 °C, 12 hours). This gave a mixture of a- and (3- 
substituted aspartic acid derivatives (175 and 176) in a 2 : 7 ratio (60 - 70 % 
yield). The isomers could be separated chromatographlcally to give the 
diastereomerically and enantiomerically pure (2S,3R)-3-methylaspartic acid 
derivative (175), which was hydrolysed to give the free amino acid. 
However, the yields associated with this synthesis were intrinsically low.
115
o
y— NH
H " ;^ — \  
/BuOgC COgfBu
(172)
LiO
LiO COofBu
LiO
O f Bu 
(173)
O f Bu
LiO
O
ii)
y — NH
H3C " ’/  \
fBuOgC COgfBu
(175)
2 : 7
t DUO2C COgfBu
ca. 6 0 % e .e .
(176)
> 95 % d e . & e.e.
i) LINEt2, THF, - 78 2  hr
ii) Mel, - 78 2  hr
Scheme 3.1 Synthesis of (2S,3R)-3-Methylaspartic Acid 
from Di-fed -butyl-N-formylaspartic Acid
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43.3.2 SchoHkopf’s Synthesis of (2S^B)-3-Methylaspartic Acid
Schollkopf’s bis -lactim ether methodology (Scheme 3 .2)286 offered a 
potentially higher yielding synthesis. This methodology involved alkylation 
of the lithiated bis -lactim ether (177) of cycio -(D-Val-Gly) (178) (or variants) 
at the glycine a-centre. Cycio -(D -Val-G ly) (176) was produced by 
cyclization of the dipeptide (179), formed from the appropriately protected 
amino acids (180 and 181). Méthylation gave the bis -lactim ether (182 a), t
which could be deprotonated with n- butyl lithium. The bis -lactim ether 
anion (177) (Scheme 3.3) produced was relatively flat and hindered on one 
face by the valine side chain /so- propyl group. Thus the stereochemistry of 
alkylation at the glycine a-centre was controlled. The alkylating agent 
approached from the sterically less hindered face opposite to the iso- propyl 
group. Mild acid hydrolysis gave cleavage of the bis -lactim ether to yield 
alkylated amino acid derivatives of high enantiomeric excess.
This methodology was used, with aldehydes or ketones as the electrophile, 
to give compounds with two adjacent chiral centres. Thus 3-substituted 
serines were obtained with good selectivity at C-3, when the lithium ion was 
substituted with ths -dimethylaminotitanium in situ. However, formation of 
the threo - product was favoured^Q^.
This approach to generating two adjacent chiral centres was, therefore, not 
appropriate. An alkylating agent, with one of the chiral centres already in 
place, was required. The stereochemistry at the second chiral centre could 
then be introduced by the stereospecific nature of this reaction (see above).
Methyl (2R)-bromopropanoate (183) was used as the alkylating agent 
(Scheme 3.3). This material was synthesized from D-alanine (184), by a 
nitrosation / bromination reaction (see p. 107) to give (2R)-bromopropanoic 
acid (185)272 followed by estérification using diazomethane. Thus the bis - 
lactim ether ring (177) was alkylated to give (3S,6R)-2,5-d imethyoxy-3- 
((2 ’R)-2'-methoxycarbonylethyl)-6-isopropyl)-3,6-dihydropyrazine (186 a).
Cleavage of the alkylated bis -lactim ether ring gave the required (2S,3R)-3- 
methylaspartic acid dimethyl ester (187) and D-valine methyl ester.
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Scheme 3.2 Synthesis of Schollkopfs Bis -Lactim Ether
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Scheme 3.3 Synthesis of (2S,3R)-3-Methylaspartic Acid Using 
Schollkopfs Bis -Lactim Ether Methodology
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M Jâ Hanessian’s Synthesis of (2S.3Ry-3j\/lelhy_lasD^Jlic_Acki_
A further methodology was published, by Hanessian^®®, during the course 
of this work (Scheme 3.4). This route used (S)-1-fert-butyldimethylsilyl-4- 
carboxy-2-azetidinone (188) as a chiral template. Treatment with 2.1 
equivalents of LDA in THF at 0 °C produced the dianion. Reaction with 
methyl iodide gave the 3-methylated product (189) with the methyl group 
anti- to the carboxyl group. Acid hydrolysis gave (2S,3R)-3-methylaspartic 
acid hydrochloride (171). However, only a 37 % yield of (S )- l- fe r f -  
butyldimethylsllyl-4-carboxy-3-methyl-2-azetidinone (189) was reported.
^ COgH
■N
O' \ TBDMS
(188)
Me, XO pH
w
J — N,o \ TBDMS
(189)
iv) H,N H
HOgC
CHg
COgH
(171)
i) LDA, 0 °C
ii) Me! (Z 2  eq), 0 °C, 2h
iii) aq. KHSO4
iv) 6 N  HCI, reflux 10 h
Scheme 3.4 Synthesis of (2S,3R)-3-Methylaspartic Acid from 
N-f -Butyldimethylsilyl (S)-4-carboxy-2-azetidone
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3,3,4 Introduction of Deutérium into (2S.3R)-3-Melby.iaspartig Add viâ 
Seebach s and-tiaaes,s.i.an’s Routes.
Both Seebach’s and Hanessian’s methodologies used L-aspartio acid as 
starting material. Hence (2S,3S)-[3-^H]-aspartic acid (190) was required for 
the synthesis of (2S ,3R )-[3 -^H ]-3 -m eth ylasp artic  acid (1 9 1 ). The  
stereochemical control was introduced enzymically (Scheme 3.5). Firstly, 
reduction of dimethyl acetylenedicarboxylate (192) with triphenylphosphine, 
under deuteriating conditions, gave dimethyl dideuteriofumarate (193)289, 
as a red/brown tar. Sublimation gave pure white dimethyl dideuterio­
fumarate, with one signal by NMR, at 3.81 ppm, due to the methyl ester.
This was hydrolysed under basic conditions to dideuteriofumarate (194). |
Incubation of diammonium dideuteriofumarate with 3-methylaspartase, 
ammonia and potassium and magnesium ions, in water, for two days gave 
(2S,3S)-[2,3-2H]-aspartic acid (195) in high enantiomeric excess, displaying 
a singlet by NMR, at 2.85 ppm, due to the 3-H. (2S,3S)-[3-2H]-Aspartic 
acid (190) was obtained by incubation with aspartate aminotransferase, a 
PLP-dependent enzyme. The 2-H proton was observed at 4.12 ppm in the 
NMR spectrum.
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Scheme 3.5 Synthesis of (2S,3S)-[3-^H]-Aspartic acid
3.3.5 Introduction of Deuterium Label into (2S.3R)-3-Methyiaspartic Acid 
via Schollkopfs Synthesis
For the synthesis of (2S,3R)-[3-2H]-3-methylaspartic acid (191) via the 
Schollkopf route, methyl (2R)-[2-2R]-bromopropanoate (196) was required. 
A method for the race mi c introduction of deuterium into a-amino acids was 
available298. Accordingly, Mr. Hartzoulakis produced the a-deuteriated 
racemate of N-acetyl-alanine (197), by the reaction of acetic anhydride and 
deuteriated acetic acid on L-alanine (198) (Scheme 3.6). The reaction
122
proceeded via an oxazolidine intermediate (199), from which hydrogen was 
abstracted, by acetate. Quenching with deuterium gave racemic [2-2|H]-N- 
acetyl-a lan ine. The enzym e acylase was then used to selectively  
deacetylate the L-enantiomer^^'i giving a mixture of [2-2|H]-L-alanine (200) 
and [2-2H]-N-acetyl-D-alanine (201). The two enantiomers were separated 
by preferential crystallization of the [2-2|H]-L-alanine. The D-enantiomer was 
then chemically deacetylated to [2-2H]-D-alanine (202).
[2-2H]-D-alanine was then converted to [2-2H]-(2R)-bromopropanoic acid
(203) and hence methyl (2R)-[2-2H]-bromopropanoic acid (196), as outlined 
for the non-labelled reagent (p. 117).
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Scheme 3.6 Synthesis of [2-^H]-D-Alanine
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l A  Synthesis of (2S.3R)-3-Methvlaspartic Acid Using Schollkopfs 
Methodolofly
The Schollkopf route to (2S,3R)-3-methylaspartic acid and (2S,3R)-[3-^H]-3- 
methylaspartic acid was pursued as it seemed the potentially highest 
yielding synthesis. Previous members of the group had also already had 
experience of this chemistry.
3JL1 Synthesis of the Bis
Two methods were available for the synthesis of cycio -(D-Val-Gly) (178). 
The first involved coupling of D-valine N-carboxyanhydride with glycine 
methyl ester and then refluxing in toluene to complete cyclization. However, 
the formation of D-valine N-carboxyanhydride required the use of 
phosgene^®^, so a mixed anhydride route^^^ was favoured. In this route D- 
valine was protected as the N-carbobenzoxy derivative (180) using benzyl 
chloroformate. ^H NMR spectroscopy showed benzyl signals at 5.13 and 
7.35 ppm. Glycine was protected as the methyl ester hydrochloride (181) 
using thionyl chloride in methanol. This compound was typified by a methyl 
signal at 3.85 ppm in its ^H NMR spectrum. The protected amino acids were 
then coupled using isobutyl chloroformate and N-methyl morpholine to give 
the dipeptide, N-Cbz-D-valine-glycine methyl ester (179). This was 
deprotected by catalytic hydrogenation and cyclization completed by 
refluxing in toluene, to give cycIo -(D-Val-G ly) (178). The two 6-Hs 
contributed from the glycine moiety exhibited considerably different chemical 
shifts, by '•h NMR spectroscopy, (3.76 and 3.95 ppm) as a result of the two 
different environments above and below the ring. Care had to be taken to 
ensure the cyclic dipeptide was completely dry {in vacuo, 60 °C, 3 days) to 
achieve good yields in the next step.
The methylating agent, trimethyloxonium tetrafluoroborate, in the solid form,
was initially used to convert cycio -(D-Val-Gly) to the dihydropyrazine |
product (182 a). However, the moisture and air sensitivity of trimethyl-
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oxonium tetrafluoroborate precluded that bottle's use in further reactions, 
once the contents had been subjected to the air contact required for 
weighing out. Therefore triethyloxonium tetrafluoroborate, which could be 
bought as a 1 M solution in dichloromethane, and hence transferred to the 
reaction vessel under anhydrous conditions, was used instead. This 
reagent was more soluble and so reacted quicker than trimethyloxonium 
tetrafluoroborate^^^. (3R)-2,5-D iethoxy-3-isopropyl-3,6-dihydropyrazine 
(182 b) was successfully synthesized and reacted with (R)-m ethyl-2- 
bromopropanoate in an alkylation reaction to give (3S,GR)-2,5-diethoxy-3- 
((2R')-m ethoxycarbonylethyl)-6-isopropyl-3,6-dihydropyrazine (186 b). 
However it proved cheaper to purchase the (3R)-2,5-dimethoxy-3-isopropyl-
3,6-dihydropyrazine (182 a).
3.4.2 Optimization of the Alkylation Reaction
The literature method, for the formation of the b/s -lactim ether anion and its 
subsequent alkylation, involved addition of n -butyl lithium to a stirred 
solution of the bis -lactim ether in THF at - 70 Stirring was continued
at this temperature for 10 minutes and then a solution of the alkylating agent 
in THF added dropwise. After stirring for 5 hours at -70 °C the reaction was 
worked up. However, Thomas found that unless the reaction was allowed to 
warm up to - 65 °C, before the alkylating agent was added, the bis -lactim 
ether anion did not form^^®. Nonetheless the reaction still proved to be 
messy and low yielding. A detailed investigation was pursued in an attempt 
to improve the yield.
Unfortunately the reaction progress could not be followed by tic, as the 
lithium salts prevented the formation of clear spots, even after quenching 
aliquots of the reaction mixture with phosphate buffer. ‘‘ H NMR  
spectroscopy of an aliquot of reaction mixture was also unsuccessful without 
complete workup first.
Initial experiments utilized the 48 hour reaction times of Thomas^^^, but
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reinvestigation of the time scale of the reaction showed that the long reaction 
times reported were not necessary and may even have led to greater 
formation of an unwanted pyrazine side product (204) (Schemes 3.7 and 
3.8). Interestingly, even when the reaction was performed at - 105 °C 
compared with the - 55 °C of Thomas (using an ethanol / liquid nitrogen bath 
with cryocool assistance), the reaction was complete after only 7 hours.
The required dihydropyrazine (186) and unwanted pyrazine (204) were 
easily distinguishable by NMR spectroscopy. The doublet signals from 
the Isopropyl methyl groups of the valine side chain of the dihydropyrazine 
came upfield of the equivalent signals from the pyrazine (0.70 and 1.03 ppm 
af. 1.17 ppm). The signal from the hydrogen at the tertiary isopropyl centre 
of the dihydropyrazine was well separated from any other signals (at 2.25 
ppm) and the triplet from the 6-H was downfield of any other signals (at 4.40 
ppm). The pyrazine was most easily distinguished by the signal from the 
hydrogen at the tertiary isopropyl centre at 3.34 ppm.
Two mechanisms were proposed for the formation of 2,5-dimethoxy-3- 
propionyl-6-isopropylpyrazine (204) (Schemes 3.7 and 3.8). The bis -lactim 
ether anion could attack at the ester centre of methyl bromopropanoate 
(205), as shown in Scheme 3.7. Removal of the second proton from C-6 of 
the bis -lactim ether, would give the enolate (206). Loss of the proton from 
C-3 would lead to elimination of the bromide (207), thus forming the 
pyrazine (204). In the second mechanism (Scheme 3.8), bromine is 
eliminated first (208). However removal of the second proton from C-3 of the 
bis -lactim ether (209) gives an anion at 0-3. Hence intramolecular attack of 
the ester can occur (210). Loss of the proton from 0-6 of the bis -lactim ether 
would cause opening of the ring (211) to give the pyrazine (204).
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Scheme 3.8 Pyrazine Formation by Attack at the Bromide
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Excess base is required for both these mechanisms. However as the 
reaction produces base (OMeVBr") little control can be exercised here. 
Indeed, in reactions performed with less than 1 equivalent of n -butyl lithium, 
pyrazine formation was still high. However the n -butyl lithium in hexanes 
solution was titrated to determine its accurate molarity, thus ensuring only 
1.1 equivalents of n- butyl lithium were added. Varying the quantity of 
alkylating agent (methyl (2R)-bromopropanoate) added from 5 equivalents 
through to 1.5 equivalents had no effect on the amount of pyrazine formed.
Both mechanisms indicate that enhancing the susceptibility of the C-2 centre 
of the alkylating agent to attack would be advantageous.
An attempt was made to make iodopropanoate, as iodide would be a 
superior leaving group to bromide, competing more favourably with the 
ester. However the nitrosation / iodination of D-alanine was not successful, 
due to the reaction of nitrous acid on hydroiodic acid.
Attack at C-2 of the alkylating agent would be favoured by increasing the 
steric bulk of its ester, due partially to simple steric reasons and also by 
reducing the rate of ester elimination. For example, isopropoxide is a poorer 
leaving group than methoxide, due to the larger inductive effect of the 
secondary alkyl group over the primary. Accordingly, the synthesis of 
isopropyl (2R)-bromopropanoate (212) was undertaken.
(2R)-Bromopropanoic acid was prepared via the nitrosation / bromination of 
D-alanine (see p. 107). The reaction occurs without racemization below 10 
°C. Various reaction conditions were then employed in an attempt to 
prepare isopropyl (2R)-bromopropanoate (212) in good yield. However the 
reaction of isopropanol and thionyl chloride with (2R)-bromopropanoic acid 
always gave side products, which could not be removed. Decolourization of 
the brown oil produced and removal of excess isopropanol was achieved by 
column chromatography on silica gel, eluting with 10% diethyl ether in 
petroleum ether. However the contaminants were not separable.
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Activation of the acid functionality by mixed anhydride methods, using N- 
methyl morpholine and isobutyl or ethyl chloroformate gave none of the 
required product.
No attempt was made to optimize the reaction further, but the isopropyl 2- 
bromopropanoate prepared was used to investigate how effective the 
isopropyl group was in reducing formation of the pyrazine. The ratio of 
alkylated bis -lactim ether to pyrazine formation was not improved in 
alkylation reactions with isopropyl 2-bromopropanoate over that for methyl
2-bromopropanoate.
There was also some doubt as to the chiral integrity of the isopropyl 2- 
bromopropanoate. Unfortunately the material was never pure enough to 
m easure its optical activity. H ow ever synthesis of m ethyl 2- 
bromopropanoate by the thionyl chloride route proceeded cleanly and gave 
material with an optical rotation consistent with that from the diazomethane 
route ([a]Q + 55.6 ° (neat)). However the 3-methylaspartic acid produced 
from (3S,6R)-2,5-dimethoxy-3-((2’R)-isopropoxycarbonylethyl)-6-isopropyl-
3 ,6-dihydropyrazine (213) was racemic. Alkylation of the bis -lactim ether 
anion with isopropyl 2-bromopropanoate gave two isolable products. The 
1H NMR spectra of both products displayed the correct splitting for the 
product molecule but slightly different chemical shifts. The triplet assigned to
3-H was most different, occurring at 4.58 ppm in one compound and 4.34 
ppm in the other. Other differences of 0.08 ppm were seen in the septet 
signals from the hydrogen on the tertiary carbon of the isopropyl ester, and 
of 0.02 ppm in the methyl groups of the valine side chain. Other chemical 
shift differences were difficult to identify due to the complexity of the spectra. 
The mixture of compounds may be due to a mixture of stereochemistry at C- 
2 ’ .
In order to ensure that the alkylating agent was added to the bis -lactim ether 
anion whilst still at the low temperature of the ethanol bath, it was contained 
in a side arm to the flask containing the anion. Turning the side arm allowed 
a quick addition of the alkylating agent, without warming up. Transfer by
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syringe or catheter would allow the solution to warm up during addition. 
These conditions gave better ratios of product to pyrazine, although the 
yields were still only modest.
3.4.3 Purification of the Alkylated 8/s-Lactim Ether
It was reported^®^ that the alkylated bis -lactim ether (186) could be 
separated from the pyrazine (204) and un reacted bis -lactim ether (182) by 
column chromatography on silica gel, eluting with 15 % ethyl acetate in 
petroleum ether. However this solvent system was unsatisfactory. A system 
of 25 % diethyl ether in petroleum ether performed better. However the 
silica gel required pretreatment with triethylamine to prevent decomposition 
of the alkylated bis -lactim ether. Decomposition did not occur on neutral 
alumina, eluting with 10 % diethyl ether in petroleum ether. However 
although both systems separated the un reacted bis -lactim ether from the 
other two components, neither separated the alkylated bis -lactim ether and 
pyrazine well. As pure alkylated bis -lactim ether could not be obtained from 
one elution, only a short column of silica gel was used to remove baseline 
material.
3.4.4 lSQj.atLQn.Qf,thg±rgg_A.mi,no-Ac.ids
Schollkopf used acid hydrolysis to cleave the alkylated bis -lactim ether^94^ 
giving the two amino acid esters, which Thomas reported were separable by 
column chromatography on silica gel, eluting with 50 % acetone in ethyl 
acetate^^®. However, this proved unsuccessful and no alternative solvent 
systems were found.
Base hydrolysis of the external ester left the bis -lactim ether ring intact. The 
pyrazine was removed by extraction with diethyl ether. Acidification of the 
aqueous layer to pH 5 allowed the (3S ,6R )-2 ,5  d im ethoxy-3-((2 ’R)- 
carbonylethyl)-6-isopropyl 3,6-dihydropyrazine to be extracted back into the
132
1
i
diethyl ether layer. However the product was not very clean and only 
achieved in 20 % yield from the bis -lactim ether, therefore this method was 
not pursued.
Acid hydrolysis of the alkylated bis -lactim ether /  pyrazine mixture cleaved |
the alkylated bis -lactim ether, to give the D-valine methyl ester and (2S,3R)-
3-methylaspartic acid dimethyl ester (187), whilst leaving the aromatic 
pyrazine intact. Extraction with toluene removed the pyrazine. The amino 
acid esters were then hydrolysed in 1 M NaOH, to give the free amino acids, 
which were separated by preparative tic on cellulose plates, using 80 % 
methanol in ammonia as solvent. This solvent system was chosen over the 
standard 26 : 6 : 5 isopropanol : ammonia: water system as it gave a better 
separation of the two amino acids, taking them further off the baseline, in a 
shorter time.
The 3-methylaspartic acid obtained was a mixture of isomers. The degree of 
L -f/7reo-contamination varied with preparations from 5 to 20 %. All samples 
were of high salt concentration and the (2S,3R)-3-methylaspartic acid would 
not crystallize out of solution.
It was not clear whether the contaminating isomer, (2S,3S)-3-methylaspartic 
acid, was formed due to poor stereoselective control of the alkylation 
reaction or during base hydrolysis of the esters. Therefore an acid 
hydrolysis (6 M HCI, 2 hour reflux) of the amino acid esters was also 
performed. However this also gave a mixture of the two isomers. This 
mixture did however contain less salt than the base hydrolysis product and 
therefore ran better on preparative tic plates.
Nitrogen protection of the amino acid esters, obtained from cleavage of the 
bis  -lactim  ether ring, as carbobenzoxy derivatives, gave N -C bz-3- 
methylaspartic acid dimethyl ester and N-Cbz valine methyl ester which 
could be separated by silica gel column chromatography, eluting with 50 % 
diethyl ether in petroleum ether. Acid hydrolysis of the N-Cbz methylaspartic 
acid dim ethyl ester yielded (2S ,3R )-3 -m e th y lasp artic  acid as the
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hydrochloride salt.
Some separation was also achieved between the L-erythro - and L-threo 
isomers of N-Cbz-3-methylaspartic acid dimethyl ester, with the L-erythro 
isomer eluting just before the L-fhreo - isomer.
3 .6  A New Route to (2S.3m-3-Methvlaspaftic Acid and (2S.3R)-[3-^H]-3- 
Methvlaspartic Acid
It has been shown that the two L-isomers of 3-methylaspartic acid were 
separable as their N-Cbz dimethyl esters. It was also known that prolonged 
incubation of diammonium mesaconate with 3-methylaspartase, magnesium 
and potassium ions and ammonia gave a mixture of both isomers. Thus 
(2S,3R)-3-methylaspartic acid could be produced by incubation with the 
enzyme and then separated from the (2S,3S)-isomer as a N-Cbz dimethyl 
ester. Furthermore incubation of diammonium mesaconate, with the 
enzyme, cofactors and ammonia, in deuterium oxide, would give [3-^H]-3- 
methylaspartic acid.
Prolonged incubation (several weeks) of mesaconic acid (3) with 3- 
methylaspartase gave 80 - 85 % conversion to the 3-methylaspartic acid 
diastereomeric mixture (214) (Scheme 3.9). A ratio of up to 1 to 1 was 
achieved between the two diastereomers, distinguishable by their chemical 
shifts in i H NMR spectra. The L-erythro- isomer displayed signals at 1.31 
and 3.81 ppm from the methyl and 2-H groups respectively, whereas the L- 
threo- isomer was characterized by signals at 1.20 and 4.06 ppm. The 3-H 
multiplet signals from the each isomer were coincident. The mixture of 
isomers of 3-methylaspartic acid was isolated from the incubation and the N- 
C bz derivatives  (215 ) form ed using N -(b en zy lo xycarb o n y lo xy)- 
succinimide^^®. This reagent performs well in aqueous salt containing 
solutions. Conversion of the mixture of N-Cbz-3-methylaspartic acid 
diastereomers, to the diester (216) occurred cleanly with diazomethane and 
the two diastereomers (217 and 218) separated by column chromatography
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on silica gel, eluting with 50 % diethyl ether in petroleum ether. Fractions 
were analysed by ‘‘ H NMR spectroscopy as no separation was observable 
between the two isomers by tic. Signals from the 3-Hs were separated by 
0.3 ppm and the 2-Hs by 0.12 ppm. Fractions containing a mixture of I
isomers were recycled. Acid hydrolysis gave the hydrochloride salt, from 
which the free amino acid (171) was obtained, by addition of one equivalent 
of ammonia.
(2S,3R)-[3-^H]-3-methylaspartic acid (191) was obtained by a similar route.
Prolonged incubation of diammonium mesaconate with 3-methylaspartase, |
magnesium and potassium ions and ammonia, in deuterium oxide, gave a 
mixture of the L-diastereomers of [3-^H]-3-methylaspartic acid (219), with 
greater than 95 % incorporation of deuterium. The mixture of diastereomers 
were protected as their N-Cbz dimethyl esters (216 b) and separated by 
column chromatography, as with the non-deuteriated analogue. Acid 
hydrolysis gave (2S,3R)-[3-^H]-3-methylaspartic acid hydrochloride, from 
which the free amino acid was obtained.
.m g
^ HOgC COgH(3) (213)
H
Cbz-N H
i'),iii) \  i^ C H a  'W
H " y
Me02C C02Me
(215)
H H
Cbz-N COoMe Cbz-N COoMe
MeOgC H MeOgC; CHg
(216) (217)
V) H2N CO2H
HO2C CH3
(171)
i) 3-methylaspartase, NH3, MgCl2, KCI, H2O
ii) Z-OSu, K2CO3 (aq)
iii) CH2N2, Et2Û
iv) chromatography 
V) AcOH/HCI
Scheme 3.9 Synthesis of (2S,3R)-3-Methylaspartic Acid
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3.S ^H-NMR Experiments Usina (2S.3RV3-Methvlaspartic Acid and (2S.3RV  
[3-^H1-3-Methylaspartic Acid
The deamination of (2S,3R)-L-e/yfhro-3-methylaspartic acid was followed by 
1H NMR spectroscopy. The experiment was designed to investigate 
whether direct deamination, of the substrate, to mesaconic acid occurred, or 
whether the substrate epimerized first, to the (2S,3S)-L-f/?reo- isomer and 
then deaminated to mesaconic acid.
It was required that the reamination of mesaconic acid to L-threo -3- 
methylaspartic acid was slow, in order to observe any epimerization of the L- 
erythro -substrate to the L-threo- isomer. Thus, ammonium-containing 
buffers were avoided and sodium hydroxide used to adjust the pD of the 
buffer. Imidazole was used as a buffer, as its 1H NMR spectrum gave proton 
signals well downfield of any of the signals of interest (7.07 and 7.72 ppm). 
As this buffer had not previously been used in 3-m ethylaspartase  
incubations, it was confirmed that imidazole had no effect on the reaction by 
performing an incubation in Tris buffer for comparison. A substrate 
concentration of 5 mg /  ml (34 mM) and cation concentrations of 1 mM 
potassium and 20 mM magnesium were used. Hence, for the deuterio- 
substrate, incubations were run above / 2 and for the protio- substrate 
at approximately V^ax / 2 (see p. 147 and p. 151). The incubations were 
performed in deuterium oxide. Spectra were recorded at T = 0 and at one 
hourly time intervals thereafter, for 15 hours. Further spectra were obtained 
at longer time intervals (Figures 3.1 and 3.2).
Some incubations of protio-substrate seemed to be contaminated by a small 
amount of L-threo -3-methylaspartic acid (ca. 2 %) at T = 0, typified by 
signals at 1.05 and 3.95 ppm, which remained in the incubation and was not 
deaminated immediately. This appeared to be in direct contradiction with 
UV spectroscopy results (see p. 142 - 143). However a 1H NMR experiment, 
in which the signal at 3.95 ppm, coincident with the 2-H of L-threo -3- 
methylaspartic acid, was irradiated, showed no change in the signal at 1.05 
ppm, coincident with the methyl group of L-threo -3-methylaspartic acid.
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This confirmed the signals were not linked and, therefore, suggested they 
were not due to L-fhreo-3-methylaspartic acid contamination.
The ‘•h  NMR tim e course experim ents showed that L-erythro  -3 - 
methylaspartic acid was deaminated directly to mesaconic acid (see Figure 
3.1). Hence 3-methylaspartase would seem to have a true L-erythro -3- 
methylaspartase activity. The L-threo - isomer was detected only after 
several hours, presumably on conversion of enough material to ammonia 
and mesaconic acid to allow the back reaction to take place. The L-threo-3- 
methylaspartic acid formed was completely deuteriated at C-3, as expected 
from amination of mesaconic acid in deuterium oxide.
It can be concluded that, if epimerization of the L-erythro -isomer to the L- 
threo - isomer had occurred, the intermediate L-threo - isomer produced was 
not released before it was deaminated.
It should be noted that, there was no detectable exchange of solvent 
deuterium into the L-erythro - substrate. As proton signals on carbons 
adjacent to those bonded to deuterium are shifted slightly upfield from their 
un labelled  positions, the m ethyl signal from L-erythro  -[3 -^ H ]-3 - 
methylaspartic acid would be expected to be coincident with the upfield 
portion of the methyl doublet, thus reducing or even inverting the signpost 
effect on this signal. Even at long incubation times (17 hrs), the signal 
displayed a strong signpost effect, indicating that less than 2 % deuterium 
had been incorporated. Epimerization would be expected to be faster than 
the loss of ammonia. Indeed C-3 hydrogen exchange in the reaction of the 
L-threo -substrate with 3-methylaspartase occurs at a rate 5.1 times faster 
than that for the overall reaction, at pH 7.6^^^. Therefore, some 
incorporation of deuterium into the substrate would be expected if an 
epimerization /  deamination reaction was occurring without release of the L- 
threo - intermediate. Thus the evidence suggested direct syn- elimination 
was taking place.
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T = 0
T =  1.2 h
T = 7 h
T = 17 h
8 7910 6 235
Figure 3.1  ^H NMR Spectra Showing Time Course of the Deamination of
(2S,3R)“3-Methylaspartic Acid 
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Similar incubations of the deuteriated substrate with 3-methylaspartase 
were also followed by NMR spectroscopy. They showed a similar pattern 
of product formation, but at a much slower rate (Figure 3.2). It therefore 
seemed likely that a deuterium isotope effect was operating.
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T  =  0
«I *>■ * 4' * # * * * W ' ^ HM' t j i i i r t  T r  •fTT'iT'i*  ^ n H nfiiH m'
T = 3.4 h
T = 8 h
T = 19.3 h
Figure 3.2 ‘•h  NMR Spectra Showing Time Course of the Deamination of 
(2S,3R)-[3-^H]-3-Methylaspartic Acid 
141
An incubation of equal quantities of deuteriated and non-deuteriated  
substrate with 3-methylaspartase was followed by NMR spectroscopy. 
This competition experiment showed 2.3 times more protiated substrate was 
deaminated in a given time than deuteriated substrate. This was further 
evidence of a substantial deuterium isotope effect.
a Z  Determination of Kinetic Parameters
The values of K^and V^axWere measured for the deamination of (2S,3R)-3- 
methylaspartic acid with 3-methylaspartase. A UV spectroscopic method for 
measuring the rate of production of mesaconic acid was available^. 
Mesaconic acid has a UV maximum, due to conjugation between its acids 
and the double bond, which occurs at less than 190 nm. However, the 
absorbance at 240 nm was chosen to give optical density (OD) changes of 
up to 2 OD units in a few minutes for the substrate concentrations used. The 
rate of production of m esaconic acid (deam ination of (2 S ,3 R )-3 -  
methylaspartic acid) was determined for a range of substrate concentrations. 
The conditions chosen were those used to determine the kinetic parameters 
of 3-methylaspartase with the natural substrate, (2S,3S)-3-methylaspartic 
acid, by Sotting and Gani244,245 (2S,3R)-3-Methylaspartic acid was 
dissolved in Tris buffer (0.5 M, pH 9.0) containing magnesium chloride (20 
mM) and potassium chloride (1 mM) to give the required substrate 
concentration. Rates were measured at 30 ±  0.1 °C.
An initial burst of activity occurred and then a slower but steady rate was 
observed. One explanation for this behaviour was the formation of an 
enzyme-bound intermediate, which would react further, only slowly^^^. 
Thus the first equivalent of substrate would react quickly with the enzyme to 
produce stoichiometric amounts of the enzyme-bound intermediate and 
product (mesaconic acid). Subsequent turnover would be slower, as it 
would depend on the slow breakdown of the enzyme-bound intermediate to 
generate free enzyme, before further catalysis produced more product. 
However the size of the initial burst was shown to be independent of enzyme
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concentration. Thus burst phase kinetics were not occurring.
The size of burst was, in fact, shown to be dependent on substrate 
concentration. Thus product inhibition could be responsible for this burst 
phenomenon. This seemed unlikely as a linear rate was achieved, rather 
than a sustained deceleration of rate as product concentration increased. 
Ammonia was shown not to deactivate the enzyme. Addition of 0.5 nmol 
ammonia gave a rate increase by a factor of 4.2 on the second steady rate. 
Confirmation that the cloned enzyme from E. coli had no contaminating 
enzymes which turned over mesaconic acid, thus giving an apparently 
suppressed rate of mesaconic acid formation, was obtained from incubation 
of a solution of mesaconic acid with enzyme. The absorbance at 240 nm 
remained constant over several hours.
The initial burst was due to turnover of the small amount (1 -2 %) of L-threo - 
3-methylaspartic acid present. This was confirmed by doping samples with 
a further 1 % of the L-threo - isomer prior to addition of the enzyme. The size 
of the burst doubled. Also addition of L-threo -3-methylaspartic acid to an 
incubation which had already reached the second steady rate caused a 
second burst. The size of the burst was consistent with complete conversion 
of the L-threo - isomer to mesaconic acid. The rate of the initial burst was 
also consistent with the rate expected from the L-threo -3-methylaspartic 
acid concentration calculated to be present.
Using 3 ml cuvettes (path length of 1), it was difficult to measure the second 
steady rate, i.e. the rate of reaction of L-erythro -3-methylaspartic acid. At 
high substrate concentrations the second steady rate was not achieved 
within the absorbance range of the spectrophotometer, as absorbance due 
to the production of mesaconic acid from the contaminating L-threo -isomer 
was too high (1.93 OD units for 50 mM solution).
This problem was overcome by using 0.3 ml cuvettes with a path length of 
0.1. Change in absorbance is related to the path length by the following 
equation:
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AOD = Cel
where AOD Is change in absorbance (optical density), C is concentration, e 
is the extinction coefficient and I, the path length. Therefore at a shorter path 
length, larger concentrations are measurable for the same OD change. By 
measuring the absorbance every 10 minutes, the distortion due to the initial 
high rate was minimised, as the L-threo -isomer was essentially consumed 
within the first 10 minutes. However, due to mixing problems 0.3 ml cuvettes 
did not give very consistent results.
In order to use 1 ml cuvettes (path length of 1), the rates at higher 
concentrations were measured at a wavelength of 270 nm, where the 
extinction coefficient was much lower (Ggyq = 482.5, af. 6340 = 3850). For 
the lower substrate concentrations absorbtion measurements at 240 nm 
using 1ml cuvettes (with a path length of 1) were satisfactory.
Rates were obtained for the deamination of L-erythro -3-methylaspartic acid 
over a range of substrate concentrations at both 1 and 50 mM potassium ion 
concentrations. The data are presented graphically.
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Thus, values of and were determined for the deamination of 
(2S,3R)-3-m ethylaspartic acid by 3-methylaspartase, at pH 9.0 in the 
presence of 20 mM magnesium chloride and at both 1 and 50 mM 
potassium chloride concentrations. These values are tabulated below 
(Table 3.1) with those obtained for the L-threo - isomer, by Betting and 
Gan|244^ for comparison (Table 3.2).
Table 3.1 Kinetic Parameters for f2S.3m-3-Methvlaspartic Acid
[KOI] ^max
(mM) (mM) (10"® mol dm"® min"iunit enzyme"l)
1 40 ±  0.6 17.2 ± 0 .3
50 5.2 ±1.1 41,1 ± 4 .0
Table 3.2 Kinetic Parameters for (2S.3ST3-Methylaspartic Acid
[KCI] ^max
(mM) (mM) (1 O'® mol dm"® min’ iunit enzyme'i)
1 2.37 ± 0 .2 654 ±  65
50 0.67 ± 0.07 2089 ± 209
Thus, at 1 mM potassium ion concentration for the L-erythro - substrate 
was 38 times less than for the natural substrate and at 50 mM potassium ion 
concentration, 51 times lower. Barker’s values of 2.5 pmoles min-1 mg 
protein-1 for V^gx i^nd 0.65 mM for the of (2S,3R)-3-methylaspartic acid® 
were obtained at pH 9.76 in ethanolamine chloride buffer with 10 mM 
potassium chloride and 1 mM magnesium chloride and are, therefore, not
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directly comparable with the values obtained from this work. However 
Barker’s data showed a rate difference of 106 between deamination of the 
L-erythro - substrate and the L-threo - substrate, a much greater variation 
than that obtained here. He gave the same value for both the L-erythro - 
and L-threo - substrates, whereas the values obtained from this work 
were 17 times higher at 1 mM potassium ion concentration and 7.8 times 
higher at 50 mM potassium ion concentration, for the L-erythro - substrate . 
Barker made no mention of an initial burst due to contaminating L-threo - 
material but claimed no more than 95 % purity for his L-erythro -3- 
methylaspartic acid samples. Without repeating Barker’s experimental 
conditions exactly, it is difficult to rationalize his results in the light of the 
findings of this work. However, the purpose of this work was to allow 
comparisons to be made with the kinetics data obtained, by Botting and 
Gani®44^ for L-threo - isomer.
The kinetic param eters were also determined for (2S ,3R )-[3 -® H ]-3 - 
methylaspartic acid at pH 9.0, 20 mM magnesium chloride and both 1 and 
50 mM potassium chloride concentrations. At 50 mM potassium chloride 
concentration, an initial burst of activity, from the contaminating L-threo- 
isomer, was not discernible at low substrate concentrations. The rate of 
mesaconic acid formation due to deamination of the L-erythro - substrate 
tended to fall off with time, unlike with the undeuteriated substrate where the 
rate was linear. Thus, at higher substrate concentrations it was difficult to 
ascertain the point at which all the L-threo - substrate had been consumed. 
However, by taking tangents from the same part of the curve each time 
consistent data points were achieved.
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Thus the V , ^  and values for the deuteriated substrate were calculated 
for the reaction carried out at pH 9.0 with 20 mM magnesium chloride and 
both 1 and 50 mM potassium chloride concentrations (Table 3.3). The 
values obtained, by Botting and Gani^^^, for the L-threo- isomer are also 
presented (Table 3.4).
Table 3.3 Kinetic Parameters for (2S.3R)-(3"^H1-3-MethylasDartic Acid
[KCI]
(mM) (mM)
^max
(10'® mol dm"  ^min'^unit enzyme"'*)
1 18.8 ± 8 .4 2.4 ± 0 .7 8
50 3.14 ± 0 .2 9 6.05 ± 0 .2 3
Table 3.4 Kinetic Parameters for (2S.3S)-[3-^Hl-3-MethvlasDartic Acid
[KCI] ^max
(mM) (mM) (10"® mol dm"  ^min'^unit enzyme""*)
1 2.35 ± 0.25 385 ±  39
50 0.67 ± 0.07 2089 ±  209
From these data the isotope effects (V^ / Vq) and ^(V/K) ((V^ / Vq)/(Kh /  
Kp)) were calculated at each potassium ion concentration (Table 3.5). Again 
the values for the L-threo -isomer under the same conditions are shown for 
comparison (Table 3.6).
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Acid
[KCI](mM) □v D(V/K)
1 7.15 ±2 .7 4 3.39 ± 1 .6
50 6.79 ±  0.92 4 .1 0 ± 1 .3
Table 3.6 Primary Deuterium Isotope Effects for (2S.3S)-3-Methylaspartic
Acid
[KCI](mM) Dv D(V/K)
1 1.7 1.68
50 1.0 1.00
3.8 The implications for the Mechanism of Elimination of Ammonia from 
(2S^ .B)iaiMe.th^ iasp.aflic,Ag.id
A very large isotope effect was observed on at 1 mM potassium ion 
concentration which was diminished only very slightly at 50 mM potassium 
ion concentration. Hence C-H bond cleavage was almost completely rate 
limiting. The effect was not masked by any binding or debinding steps. 
Therefore, the values obtained, apply directly to the rate of C-H bond 
cleavage. These results showed that the chemical steps involved in the 
deamination of the L-erythro - substrate were of much higher energy than for 
the L-threo - substrate.
Two mechanisms are consistent with these data; a concerted mechanism or 
a carbanion mechanism in which C-H bond cleavage is rate limiting. These
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mechanisms are equivalent to the chemical E2 and (Et^.^)! mechanisms.
In the E2 mechanism, both bonds cleave in the same step. The reaction is 
second order; first order with respect to substrate and first order with respect 
to base. In the (E1qb)i mechanism, the first step (the proton leaving) is the 
slow step of the reaction, and the formation of the product is faster than the 
return of the carbanion to the starting material. Hence the first step is 
essentially irreversible. This mechanism has an identical rate equation to 
the E2 mechanism: Rate = k[substrate][B]. Hence the two mechanisms are 
difficult to distinguish.
An E2 mechanism normally requires an periplanar conformation, where 
the two groups involved in the reaction are trans- to one another with a 
dihedral angle of 180 This is the lowest energy conformation. However, a 
syn- elimination from a syn- periplanar conformation is also possible. Here 
the dihedral angle between the two groups is 0
In purely chemical reactions syn- elimination can be favoured for steric 
reasons. Two examples are given below (Figure 3.7 and 3.8). In the first 
example (Figure 3.7) four conformations are shown^^s, in conformation 
(220) the asterixed proton is shielded on both sides by groups R and R’, thus 
making it difficult for the base to approach. Conformation (221) is shielded 
only on one side. Therefore, an anti- elimination in this system would give 
mainly cis- product. Of the syn- periplanar conformations, conformation 
(222) is less eclipsed than (223) and hence the trans- product is favoured.
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R'
NMe-
CHH
(220)
Anti
NMe
•CHjNfH
CHH
(221)
NIVIe
CH
R
Syn
(222)
NMe
CH
r .R
(223)
Figure 3.7 Conformations for Elimination of the Trimethylammonium Ion (I)
In the second example (Figure 3.8)299 the anti- periplanar conformation
(224) is more strained than the syn- conformation (225) due to the gauche 
interactions between the bulky groups R^, R2, and NMe3+.
NMe
H*
(224)
NMe
2H
(225)
Figure 3.8 Conformations for Elimination of the Trimethylammonium Ion (II)
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In the enzymic case, the natural L-threo - substrate adopts an a n ti-  
conformation (226) (Figure 3.9). As L-erythro -3-methylaspartic acid also 
gives the trans- elimination product, mesaconic acid, it must adopt a syn- 
conformation (227), if concerted elimination is to occur. The cis- product, 
itaconic acid, would be formed from an anf/-elimination (228).
NK NK
,CHHOpC
H*
NK
H COpH
H*
L-threo
(226)
L-erythro - 
(227)
L-erythro - 
(228)
Figure 3.9 Conformations for the 3-Methylaspartic Acid Isomers
^  Measurement of the Isotope Effect
In order to ascertain whether G-N bond cleavage was also rate limiting, the 
isotope effect on (V/K) was measured, using natural abundance L- 
erythro -3-methylaspartic acid. The ratios of ^^N to were measured at 
the start of the reaction, and after 20 % conversion of L-erythro -3- 
methylaspartic acid to mesaconic acid and ammonia^®®. The methods used 
ae discussed below. As C-^^N bond cleavage is faster than C-^^N, the 
ammonia produced initially contains a higher proportion of the lighter 
isotope. At 20 % conversion a sufficient proportion of each isotope has been 
turned over to allow the ratio to be determined satisfactorily.
The ratio of to ^^N in the starting material was obtained by degradation 
of L-erythro -3-methylaspartic acid, by Kjeldahl digestion^®"*, to release
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ammonia. This digestion procedure involves boiling the amino acid in 
concentrated sulphuric acid and mercury sulphate, with potassium sulphate 
to raise the boiling temperature. The ammonia produced stayed in solution 
as the ammonium ion, in the acidic mixture. The ammonia was then distilled 
out into dilute sulphuric acid and oxidized to dinitrogen with hypobromite, by 
Professor Alan Jackson at the University of Southampton. The ratio of 
to was measured by mass spectrometry, using a dual-inlet isotope ratio 
mass spectrometer. This ratio represented the initial ratio of isotopes.
To determine the isotope effect, L-erythro -3-methylaspartic acid, from the 
same batch, was incubated in Tris buffer (0.5 M, pH 9.0) containing 1 mM 
potassium chloride and 20 mM magnesium chloride with sufficient enzyme 
to convert 20 % of the starting material to mesaconic acid and ammonia in 
approximately 4 hours. The reaction was followed by measuring the OD, at 
240 nm, of 20 pi aliquots removed from the reaction at various time intervals 
and added to 3 ml of buffer. Once approximately 20 % of the material had 
been converted, the reaction was quenched by the addition of concentrated 
hydrochloric acid. The experiment was repeated a number of times. The 
ammonia was again extracted from the samples by Professor Alan Jackson 
and after oxidation to dinitrogen, the to n ratio measured by mass 
spectrometry. The isotope effect, ^^(V/K), was calculated using the following 
equation:
15(V/K) = log (1 - f)/log [1 - (fR/Ro)]
where f is the fraction of the reaction and R and Rq are the isotope ratios in 
the substrate and the ammonia product respectively. This gave an isotope 
effect of 1.0028 ± 0.0040 for the reaction of L-erythro -3-methylaspartic acid 
with 3-methylaspartase. This value for ^^(V/K) is small and indicates that the 
isotope effect is very close to unity.
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3.10 Double Isotope Fractionation Experiment
A second isotope fractionation experiment, which measured the ^®(V/K) 
isotope effect with [3-^H]-(2S,3R)-3-methylaspartic acid as substrate, was 
also performed at the same time to investigate the effect of the presence of 
deuterium at C-3 on the isotope effect. The two experiments together 
constituted a double isotope fractionation experiment.
Such experiments are usually used to distinguish between a concerted and 
non-concerted mechanism, for example, a balanced stepwise carbanion 
mechanism, where C-N bond cleavage is rate limiting. In a concerted 
mechanism, isotopic substitution at C-3 should have no effect on the kinetic 
isotope effect for C-N bond cleavage. However, for a balanced stepwise 
carbanion mechanism the ^^(V/K) isotope effect would be reduced, in the 
presence of deuterium at C-3, if the C-N bond cleavage step is cleanly rate 
limiting and the forward commitment is low or zero. Figure 3.10 is a 
diagrammatic representation of the transition state energies for the chemical 
steps of the two reaction mechanisms. No binding or debinding steps are 
shown. Although the isotope effect is not just due to changes in transition 
state energy, but also effects the ground state energies, consideration of only 
the transition state energy changes simplifies the discussion (Figure 3.10).
In a concerted mechanism, where C-N bond cleavage is rate determining, 
isotopic substitution at C-3 does not alter the ‘’^(V/K) effect. The energy 
difference in the transition state between the completely unlabelled  
substrate (“• H,^^N) and the deuteriated substrate (^H,"(^N) is the same as the 
energy difference between the nitrogen labelled substrate (^H, ^^N) and the 
doubly labelled substrate (^H, ’•^N).
However a balanced stepwise carbanion mechanism shows a reduced 
kinetic isotope effect for C-N bond cleavage in the presence of deuterium at 
C-3. Here the energy difference between C-H and C-^H bond cleavage is 
greater than the difference between C-'^^N and C-^^N bond cleavage. 
Therefore the C-N bond cleavage step becomes less important to the overall
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reaction, in the presence of deuteriated substrate and so the isotope effect 
decreases.
G
Reaction Coordinate
Concerted Mechanism
G
Reaction Coordinate
Balance Stepwise Mechanism
Figure 3.10 Transition State Energy Diagrams for
and^^N Labelled Compounds
The double isotope fractionation experiment was performed as for the 
unlabelled substrate, by incubating (2S,3R)-[3-^H]-3-methylaspartic acid 
with 3-methylaspartase until 20 % conversion to mesaconic acid and
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ammonia had occurred. The ammonia was oxidised to nitrogen with 
hypobromite. The ratio of to in the ammonia produced during the 
reaction was compared with the ratio of nitrogen isotopes in a portion of 
un reacted substrate, which had undergone Kjeldahl digestion. A 
isotope effect of 1.0033 ± 0.0043 was obtained. This result is essentially 
identical, within experimental error, to the ‘’^(V/K) value obtained for the 
protio substrate.
The fact that the ^^(V/K) values are the same for the protio and deuterio 
substrates supports the notion that elimination occurs via a concerted 
mechanism. However the lack of a substantial observed ^^(V/K) effect , in 
the presence of a very large deuterium isotope effect, does not support this 
hypothesis. C-N bond cleavage seems not to be kinetically significant, 
whilst C-H bond cleavage is. It is therefore unlikely that both bond 
cleavages occur in the same step. This result can be rationalized by 
considering the differences between this substrate and the natural one. With 
the natural substrate C-H and C-N bond cleavage occur concertedly and 
fast. The chemical reaction occurs faster than the binding /  debinding steps, 
as evidenced by the relatively small deuterium isotope effects obtained for 
both V and V/K, compared to those obtained with the L-erythro- substrate. 
With the latter substrate C-H bond cleavage is completely rate limiting. This 
would be expected as the C-H bond in the L-erythro- substrate is not 
positioned favourably for removal of the proton. However the amino acid 
portion remains the same in both substrates and so presumably both 
substrates experience the same binding interactions at this end of the 
molecule. In the reaction with the L-erythro- substrate, the hydrogen must 
be removed with difficulty from C-3, in a slow step, thus giving a large 
deuterium isotope effect. However once C-H bond cleavage has occurred, 
C-N bond cleavage could occur quickly. The enzyme is optimized to 
catalysis the latter cleavage, but is struggling with the first. Thus any isotope 
effect on C-N bond cleavage would be masked by the large isotope effect on 
C-H bond cleavage.
Another possible explanation for the lack of a ^^(V/K) effect can be found by
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invoking a dehydroalanine residue at the active site of the enzyme, as 
proposed by Gani (see p. 82). If the substrate amine does indeed bind to 
this residue at the active site, then a C-N bond formation step and a further 
C-N bond cleavage step would be involved, as well as the substrate C-N 
bond cleavage step. The‘’^(V/K) effects on these steps could mask any 
isotope effect due to substrate C-N bond cleavage. However, although there 
is some indirect support for the dehydroalanine mechanism, unequivocal 
evidence remains elusive.
3.11 Prolonged Incubation of Fumaric Acid and Ethylfumaric Acid with 3- 
Methyiaspartase
Fumaric acid was incubated, in deuterium oxide, with 3-methylaspartase, 
ammonia and potassium and magnesium ions, for a number of weeks. ^H- 
NMR spectra were recorded directly using aliquots of the incubation solution 
at various time intervals. The spectra initially showed conversion of fumaric 
acid to (2S,3R)-[3-^H]-aspartic acid, as indicated by doublets of equal 
intensity, at 2.50 and 3.70 ppm. As the incubation progressed the intensity 
of the 3-H signal at 2.50 ppm decreased, relative to the 2-H signal. It 
seemed likely this was due to incorporation of deuterium into the second 
hydrogen position at C-3. A second signal at 3 .60 ppm, which was 
attributable to (2S,3S)-[3-^H]-aspartic acid, also appeared and showed a 
time dependent increase in intensity. All signals became broad singlets at 
long incubation times. It can be concluded that 3-methylaspartase also 
shows 'L-erythro - activity with the substrate analogue, fumaric acid.
An incubation of 3-ethylfumaric acid, with 3-methylaspartase in buffered 
water containing the necessary cofactors, did not give any evidence for the 
formation of a second isomer of 3-ethylaspartic acid. The ^H-NMR spectra 
were complicated by signals from both the substrate and product, however 
there was no indication of a second shifted 2-H proton in the 2-H region, 
which remains free of other signals. Therefore 3-methylaspartase seems not
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to show L-erythro - activity with the ethyl analogue.
These results can be rationalized by considering the active site of 3- 
methylaspartase. The enzyme should have a binding pocket which 
specifically binds a methyl group and only be able to accomodate a 
hydrogen on the other side at C-3. However Gani showed that the enzyme 
accepted a number of other groups in place of the methyl functionality, 
indicating a degree of flexibility of binding at this centre. Also we have 
shown the enzyme can turn over the other 0 -3  isomer. The second 
(hydrogen) binding pocket must therefore just be able to accomodate a 
methyl group. It will therefore have no difficulty accomodating aspartic acid /  
fumaric acid. The reaction is slow as the substrate is not held at the optimum 
orientation for reaction, due to poor interactions with the methyl binding 
pocket (see p. 77). It would be unlikely that the enzyme could accomodate 
an ethyl group in its hydrogen binding pocket.
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CHAPTER FOUR
CONCLUSIONS
AND
FURTHER WORK
Some evidence has been obtained which implies that glutamate mutase 
turns over the substrate analogue {2S,3S)-3-ethylaspartic acid. Improved 
access to the enzyme, through cloning of the genes for the two components 
of the enzyme and overexpression in E. coli, would allow more detailed 
studies on this enzyme. Further investigation of the nature of the reaction 
with (2S,3S)-3-ethylaspartic acid should yield important information about 
the mechanism of the reaction and the structure of the enzyme active site. 
One of the priorities would be the synthesis of methylglutamic acid and 
dimethylaspartic acid, in order to confirm whether these products are 
produced by the reaction of glutamate mutase with (2S,3S)-3-ethylaspartic 
acid. The reversiblity of the reaction can also be probed with these putative 
substrates. Labelling of the methylene of the ethyl group with deuterium will 
allow the stereochemical course of the reaction to be defined and will 
determine from which side the coenzyme abstracts a hydrogen. Initial 
studies on a route to chirally labelled ethanol were performed
S tereochem ically pure (2S,3R)-3-m ethylaspartic acid and the [3-^H]- 
analogue have been synthesized. Schollkopfs bis- lactim ether chemistry 
was explored as a possible route to these compounds but did not prove 
satisfactory. An alternative route based on enzymic synthesis of the (2S,3S) 
and (2S,3R )-isom ers of 3-methylaspartic acid and their subsequent 
separation, was used.
It has been shown that 3-methylaspartase catalyses the deamination of 
(2S,3R)-3-methylaspartic acid at 1/38 the rate of the (2S,3S)-isomer. The 
for the substrate was also determined and was much higher than that of 
the natural substrate indicating poorer binding. The deamination reaction 
was demonstrated to proceed by syn- elimination and not via epimerization 
of the (2S,3S)-isomer. A large deuterium isotope effect was measured for 
the deamination of (2S,3R)-3-methylaspartic acid, indicating that C-H bond 
cleavage was rate limiting. It was shown that the deamination of (2S,3R)-3- 
methylaspartic acid does not display a isotope effect on V/K. Hence 0 - 
N bond cleavage was not rate limiting.
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Experiments suggest that 3-methylaspartase also shows ‘erythro activity’ 
with fumaric acid as substrate. This phemomenon should be investigated 
further, in both the amination and deamination directions. [3-^H]-Labelled 
aspartic acids would be useful for probing the latter.
Identification of the active site base, by labelling experiments with 3- 
bromoaspartic acid, together with the crystal structure of the enzyme, should 
provide vital information about the enzyme active site. In particular, with 
reference to the ‘erythro activity’, it is necessary to determine whether a 
second active site base is responsible for removing the 3-H proton from 
(2S,3R)-3-methylaspartic acid.
163
CHAPTER FIVE
EXPERIMENTAL
Melting points were determined using an Electrothermal melting point 
apparatus and are uncorrected.
Elemental analyses were carried out in the departmental microanalytical 
laboratory and by the University College, London laboratory.
Optical rotations were measured at room temperature using Optical Activity 
Ltd. AA 100 and AA 1000 polarimeters. 10 cm Path-length cells were used. 
All optical rotations were recorded at ambient temperature.
Infrared spectra were recorded on a Perkin-Elmer 1500 series FT IR 
spectrometer or Perkin-Elmer 1310 and 1330 IR spectrometers. The 
samples were prepared as thin films between sodium chloride discs or as 
solutions in sodium chloride cells (thickness 0.1 nm). Absorption maxima 
are given in wavenumbers (cm*"') relative to polystyrene standard.
Nuclear magnetic resonance spectra were recorded at 90 MHz on a Jeol 
FX90Q, at 200 MHz on a Varian Gemini-200, at 270 MHz on a Jeol JNM- 
GX270, at 300 MHz on a Bruker AM-300, at 400 MHz on a Bruker ACP400 
(by the SERC service at Warwick) and at 500 MHz on a Varian VXR500 
instrument. NMR spectra are described in parts per million downfield shift 
from TMS or are referenced using the CHCI3 signal (at 7.27 ppm), HOD 
signal (at 4.61 ppm) or the sodium salt of 3-(trimethylsilyl) propionic-2,2,3,3- 
2H4 (at 0.00 ppm) and are reported consecutively as position (6^), relative 
integral multiplicity (s-singlet, d-doublet, t-triplet, q-quartet, qn-quintet, m- 
multiplet, dd-double doublet, sp-septet and br-broad), coupling constant (J 
Hz), and assignment (numbering according to lUPAC nomenclature for the 
compound).
Nuclear magnetic resonance spectra were recorded at 22.6 MHz on a 
Jeol FX90Q, at 50.3 MHz on a Varian Gemini-200, at 67.8 MHz on a Jeol 
JNM-GX270 and at 75.47 MHz on a Bruker AM-300 and at 100.61 MHz on a 
Bruker ACP400 instrument by the SERC service at Warwick. Chloroform (at 
77.20 ppm) or methanol (at 47.00 ppm) were used as reference signals.
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2h Nuclear magnetic resonance spectra were recorded at 61.44 MHz on a 
Bruker ACP400 instrument, by the SERC service at Warwick, and are quoted 
in ppm relative to CDCI3 at 7.27 ppm.
Mass spectra and accurate mass measurements were recorded on a VG 70 
250 SE, a Kratos MS 50, or by the SERC service at Swansea using a VG 
ZAB E. Major fragments are given as percentages of the base peak intensity 
(100 %). Fast atom bombardment (FAB) spectra were recorded using 
glycerol as a matrix.
15n  / I4fsj isotope ratios were measured, by Professor Alan Jackson at the 
University of Southampton, using a VG SIRA 10 dual-inlet isotope ratio mass 
spectrometer.
UV /  vis spectra were obtained using a Pye-Unicam SP8-500 or SP8-100  
UV /  vis spectrometer.
Flash chromatography was performed according to the procedure of StilP^s 
using Sorbsil C 60 (40 - 60 pm) silica gel or Macherey-Nagel silica gel N.
Analytical thin layer chromatography was carried out on 0.25 mm precoated 
silica gel plates (Macherey-Nagel SIL G/UV254), on 0.1 mm precoated 
cellulose plates (M acherey-Nagel CEL 400-10 UV254) or precoated  
aluminum oxide plates (Macherey-Nagel F-284 (type E)). Compounds were 
visualised by UV fluorescence, iodine vapour, phosphomolybdic acid in 
ethanol, aqueous potassium permanganate or ninhydrin.
Protein concentrations were measured by UV absorption at 280 nm or by the 
method of Bradford^®^.
Sonication was carried out with a Heat Systems-Ultrasonics Inc. Europa W- 
220F sonicator.
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Centrifugation was carried out in a Beckman J2-21 centrifuge.
All equipment used in protein purification (peristaltic pumps, UV detectors, 
fraction collectors, FPLC pumps etc.) were purchased from LKB.
Electrophoresis was carried out with a discontinuous tris-glycine system 
according to the method of Laemmeli^^^. Gels were visualized with a 
Coomassie Brilliant Blue R stain.
Standard proteins for calibration of FPLC columns and gel electrophoresis 
were obtained from Sigma and BDH.
Solvents were dried and purified according to the methods of Perrin and 
Armarego.^o^
Enzymes other than 3-m ethylaspartase and glutamate mutase were 
obtained from Sigma Chemical Co., Poole, UK. and were used without 
further purification.
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Partial Purification of 3-Methvlaspartase from Clostridium tetanomorphum
Clostridium tetanomorphum strain H1 (ATCC 15920) was grown according 
to the method of Barker^^®, using a modification of literature procedures, by 
Prof. C. Greenwood and Mr. A. Thompson, University of East Anglia.
1 . Clostridium tetanomorphum cell paste (112 g) was added to potassium 
phosphate buffer (110 ml, 50 mM, pH 7.6). The mixture was stirred until 
thawed. Charcoal (10 g) was added and the mixture sonicated (power 
setting: 40) in bursts for 10 minutes, with care being taken not to allow the 
temperature to exceed 10 °C. The cell debris was spun down (30 000 g, 50 
minutes) and discarded.
2. To the supernatant was added 12 ml buffer (200 mM MgCIg.OHgO, 200 
mM NH4CI, 200 mM mesaconate, pH 7.6 with potassium hydroxide). The 
supernatant was divided into four portions and shaken in a water bath for 10 
minutes at 52 °C, The debris was removed by centrifugation (48 400 g, 40 
minutes).
2. To the supernatant was added, over 15 minutes, protamine sulphate (1 %  
solution) in potassium phosphate buffer (100 ml, 50 mM, pH 7.6) at 0 °C. 
The mixture was left to stir for a further 15 minutes, at 4 °C. The debris was 
removed by centrifugation (48 400 g, 45 minutes).
1 . To the supernatant was added, slowly, precrushed solid ammonium 
sulphate to 50 % saturation, at 4 °C. This was left stirring for 30 minutes. 
The precipitated protein was removed by centrifugation (48 400 g, 30 
minutes).
&. The supernatant was collected and ammonium sulphate added slowly to 
a final saturation of 75 %. The mixture was stirred for a further 30 minutes, at 
4 °C. The supernatant was removed by centrifugation (48 400 g, 30 
minutes).
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s2- The precipitate from above was suspended in potassium phosphate 
buffer (10 ml, 50 mM, pH 7.6) and dialysis conducted overnight in potassium #
phosphate buffer (6 I, 50 mM, pH 7.6) at 4 °C. The solution was centrifuged 
(3 020 g, 15 minutes) to remove any debris and gave 3-methylaspartase 
solution in a final volume of 29.9 ml, with an activity of 91 units / ml.
Assav to Determine 3-Methvlaspartase Activity
To assay buffer (3 ml) containing Tris (0.5 M), magnesium chloride 
hexahydrate (2 mM), potassium chloride (1 mM) and 3-methylaspartic acid 
(4 m M), adjusted to pH 9.0 with sodium hydroxide was added 3- 
methylaspartase solution (20 pi), diluted if necessary. The change in 
absorbance at 240 nm was measured. One unit of enzyme catalyses the 
formation of 1 pmol of mesaconic acid min*  ^ at pH 9.7 and 25 °C, under 
assay conditions®.
Detection of Glutamate Mutase Activity
To an incubation containing Tris buffer (1 ml, 1 M, pH 8.2), sodium glutamate 
(6.5 ml, 1.36 mM), potassium chloride (0.2 ml, 1 M), magnesium chloride 
hexahydrate (0.1 ml, 0.2 M), pre-incubated partially purified enzyme solution 
(10 ml) and unincubated partially purified enzyme extract (2 ml) was added 
adenosyl cobalamin (0.2 ml, 6 mM) to initiate the reaction. (The pre- 
incubated partially purified enzyme solution consisted of partially purified 
enzyme extract (2 ml) in aqueous mercaptoethanol (2 ml, 0.1 M) and 
potassium phosphate buffer (6 ml, 30 mM, pH 8.2) incubated at 25 °C for 15 
minutes). Aliquots (1 ml) were removed at various time intervals. The 
protein was denatured at 100 °C and removed by centrifugation. The 
supernatant was concentrated in vacuo, the residue taken up in deuterium 
oxide /  deuterium chloride and ^H NMR spectra recorded. The conversion of 
L-glutamate to mesaconate was detected. The presence of ammonia was 
also detected using Nessler's reagent^^®.
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i ^H NMR spectra of aliquots from a similar incubation containing 3- 
methylaspartate as substrate and calcium chloride (0.1 ml, 0.05 M) to inhibit 
3-methylaspartase, showed a small amount of glutamate was produced.
Attempted Purification of Component S
1. Sonication
Clostridium tetanomorphum  cell paste (50 g) was added to sodium 
phosphate buffer (100 ml, 20 mM, pH 7.6, 2 mM mercaptoethanol) and 
stirred until thawed. The mixture was sonicated (power setting: 40), in 
bursts, for 10 minutes, keeping the temperature as close to 4 °C as possible. 
The mixture was then centrifuged (10 000 g, 30 minutes) to remove cell 
debris. The protein concentration of the supernatant was estimated by UV 
absorption at 280 nm, at 40 mg / ml, volume 130 ml.
£. Isoelectric Precipitation
The supernatant was diluted with distilled water to give a protein 
concentration of 10 mg / ml. The pH was lowered to 4.60 with 5 M acetic 
acid and the precipitate removed by centrifugation (15 000 g, 30 minutes). 
The pH of the supernatant was taken back up to 7.60 with concentrated 
ammonia.
a. Ammonium Sulphate Precipitation
Pre-crushed ammonium sulphate was added slowly to the supernatant to 
give 80 % saturation. The solution was then stirred for a further 30 minutes 
and the proteins spun down to give a pellet (15 000 g, 30 minutes). The 
supernatant was discarded.
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1- Desalting bv Gel Filtration
The precipitated pellets were redissolved in a minimum volume of sodium 
phosphate buffer (20 mM, pH 7.50, 5 mM mercaptoethanol, 1 mM EOTA). 
This was applied to a Sephadex G-50 column (5 x 1 0  cm), which was eluted 
with the above buffer at a flow rate of 50 ml / hour. This yielded various 
desalted protein fractions which were pooled into 4 portions and each 
subjected to further purification.
Ion-exchange Chromatography - Low Pressure Chromatography
The portions were separately applied to a DEAE-52 column (5 x 1 0  cm) at a 
flow rate of 25 ml /  hour. The column was washed with sodium phosphate 
buffer (10 mM, pH 7.50, 5 mM mercaptoethanol, 1 mM EDTA) for one column 
volume. Then, a linear gradient of 10 to 200 mM sodium phosphate buffer 
(pH 7.50, 5 mM mercaptoethanol, 1 mM EDTA) (total volume 500 ml) was 
applied. Component S was expected to elute at about 50 mM salt 
concentration.
ion Exchange Chromatography - FPLC
The high resolution FPLC equivalent column, DEAE-5PW was also used. 
Before application the fractions were re-concentrated by ammonium  
sulphate precipitation and dissolved in a minimum volume of buffer. The 
protein solution was desalted on small (10 ml) Sephadex G-50 or G-25 
columns, or, dialysed and then re-concentrated by ultrafiltration using a YM- 
10 filter.
â- FPLC gel exclusion column
Fractions eluted at 50 mM ionic strength were pooled, concentrated by 
ultrafiltration and applied to the FPLC gel exclusion column. The protein
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was eluted with potassium phosphate buffer (10 mM, pH 6.5, 1 mM 
mercaptoethanol). Molecular weight standards were also applied to the 
column for calibration.
7. SDS-PAGE
The m olecular weight of isolated proteins was determ ined by gel 
electrophoresis (SDS-PAGE).
Attempted Purification of Component E
1. Sonication
Clostridium tetanomorphum  cell paste (50 g) was added to sodium 
phosphate buffer (100 ml, 10 mM, pH 7.6, 2 mM mercaptoethanol) and 
stirred until thawed. Charcoal (20 g) was added and the mixture sonicated 
(power setting: 40), in bursts, for 10 minutes, keeping the temperature as 
close to 4 °C as possible. The mixture was centrifuged (13 000 g, 30 
minutes) to remove cell debris.
2 . Nucleic Acid Removal
To the supernatant was added, over 15 minutes, protamine sulphate (1 % 
solution) in potassium phosphate buffer (100 ml, 40 mM, pH 7.0) at 0 °C. 
The mixture was left to stir for a further 15 minutes, at 4 °C and the debris 
removed by centrifugation (13 000 g, 30 minutes).
Ammonium Sulphate Precipitation f1)
To the supernatant was added potassium phosphate buffer (20 ml, 1 M, pH
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7.0) and EDTA (0.5 ml, 1 M). Precrushed solid ammonium sulphate was 
added, slowly, at 4 °C, to give 45 % saturation. The solution was stirred for 
a further 30 minutes and the precipitated protein removed by centrifugation 
(48 400 g, 30 minutes).
É. Ammonium Sulphate Procip.iiatLQi}.,(£).
The supernatant was collected and ammonium sulphate added slowly to a 
final saturation of 70 %. The mixture was stirred for a further 30 minutes, at 4 
°C. The supernatant was removed by centrifugation (48 400 g, 30 minutes).
D l.alysi,s .(1),
The precipitated protein was suspended in potassium phosphate buffer (5 
ml, 10 mM, pH 7.0) and dialysis conducted overnight in potassium  
phosphate buffer (6 I, 2 mM, pH 6.5) at 4 °C.
The solution was redialysed against potassium phosphate buffer (6 1,10  
mM, pH 8.0) containing mercaptoethanol (10 mM).
7. Ion-exchange Chromatography
The protein solution was applied to a DEAE-52 column, which had been 
prewashed with potassium phosphate buffer (0.3 M, pH 8.0) containing 
mercaptoethanol (10 mM) and then potassium phosphate buffer (10 mM, pH
8.0) containing mercaptoethanol (10 mM). The column was eluted with 
potassium phosphate buffer (10 mM, pH 8.0) containing mercaptoethanol 
(10 mM), followed by potassium phosphate buffer (10 mM, pH 6.65)
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containing mercaptoethanol (10 mM) and finally potassium phosphate buffer 
(50 mM, pH 6.7) containing mercaptoethanol (10 mM). Any fractions 
containing protein were concentrated by ammonium sulphate precipitation 
(80 % saturation) and centrifugation (14 000 g, 25 minutes). The protein 
pellet was dissolved in a minimum volume of distilled water and dialysed 
against sodium aceta te  buffer (6 I, 5 mM, pH 5 .2 ) con tain ing  
mercaptoethanol (5 mM).
Incubations of (2S.3S>3-EthvlasDartic Acid with Crude Enzyme Extract
(2S,3S)-3"E thylaspartic  acid (100 mg) was added to an incubation 
containing enzyme solution from the partial purification of 3-methylaspartase 
(2 ml), potassium phosphate buffer (0.8 ml, 0.3 M, pH 7.6; 0.38 M ammonium 
chloride), adenosyl cobalamin (0.2 ml, 6 mM) and a preincubated enzyme 
solution (2 ml) in potassium phosphate buffer (1 ml, 0.18 M, pH 7.6; 0.2 M 
mercaptoethanol). Aliquots were removed at various time intervals and 
concentrated in vacuo. The residue was dissolved in deuterium oxide and 
1H NMR spectra recorded at 500 MHz.
173
2- Ethylacetoaçetate Ethyl. Ester ( l lR a )
o o
Sodium ethoxide solution was prepared by dissolving sodium (9.6 g, 0.42 
mol) in anhydrous ethanol (150 ml). Ethyl acetoacetate (47.75 g, 36.7 mmol) 
was added dropwise with stirring. After 5 minutes further stirring, 
bromoethane (53.7 g, 0.49 mol) was added slowly dropwise. The reaction 
mixture was then refluxed for 2 hours and allowed to cool. The solution was 
poured into water (200 ml) and extracted with diethyl ether (3 x 200 ml) and 
dried (MgSO^). The solvent was removed in vacuo to give a yellow oil 
(48.97 g, 84.5 %) which was distilled under reduced pressure to give 2-ethyl 
acetoacetate ethyl ester as a colourless oil (46.09 g, 79.5 %), b.p. 103-104 
°C /1 0  mmHg; (neat)/cm"l ggOO (C-H), 1725 (CO ester) and 1715 (CO 
ketone); 6^ (90 MHz; CDCI3) 0.91 (3H, t, J 7.0 Hz, 2 '-CHg), 1.25 (3H, t, J 7.0 
Hz, -OCHgCHg), 1.86 (2H, qn, J 7.0 Hz, I'-CHg), 2.20 (3H, s, 4-CHg), 3.30 
(1H ,t, J 7.0 Hz, 2-CH) and 4.18 (2H. q, J 7.0 Hz, -OCHgCHg); 0c(67.8 MHz; 
CDCI3) 12.35 (2 ’-CH3), 14.57 (-OCHgaH3), 22.07 (I'-CHg), 23.87 {Q.H^CO),
29.28 (CH), 61.87 (-OCHgCHg), 170.29 (-COg-) and 173.02 (CO); m/z (El) 
158 (M +, 2 %). 130 (13, [M  - CgH^M, 116 (68, [M - C3H6M , 101 (55. [M  - 
C3H5O D , 73 (69, [M  -C5H9O M , 43 (100, C2H3O+) and 29 (59, C2H5+).
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Ethylfumaric Acid (1££)
H O g C ^  y --------
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H COgH
Bromine (18.0 g, 113 mmol) was added slowly to a vigorously stirred 
solution of 2-ethyl acetoacetate ethyl ester (9.0 g, 56.7 mmol) in dry diethyl I
ether (75 ml). The resulting solution was refluxed for 3 hours. The solvent 
and hydrogen bromide were removed in vacuo to give the dibromide as a 
yellow oil. This was added slowly to rapidly stirred ethanol (60 ml) 
containing powdered potassium hydroxide (18.0 g, 0.32 mol). The mixture 
was refluxed for 30 minutes.
Steam distillation was performed until 250 ml of distillate had been 
collected. The undistilled material was acidified with concentrated  
hydrochloric acid and extracted with diethyl ether (4 x 150 ml). The pooled 
organic extracts were dried (IVIgSO^). The solvent was removed in vacuo to 
give an orangey-yellow solid. This was recrystallized from diethyl ether / 
petroleum ether to give ethylfumaric acid as an off white solid (2.9 g, 36 %), 
m.p. 198-200 "C ( l i t . ,255 1 9 4 . 1 9 5  °C); (nujol)/cm-i 2400-3500 (COQhl) 
and 1740 (CO): 5h (270 MHz; DgO/NaOD) 0.86 (3H, t, J  7 Hz, CH3), 2.31 
(2H, q, J  7 Hz, CHg) and 6.20 (1H, s, C=CH); Sg (75.47 MHz; DgO/NaOD)
13.77 (CH3), 22.77 (CHg), 128.01 (0-3), 148.01 (0 -2), 174.37 and 175.44 
(OOgHs); m/z (El) 126 {[M  - HgO]+, 48 %) and 98 (100, [M  - OHgOg]+).
(2S.3SV3-Ethvlaspartic Acid (US)
HgN COgH
HOgCf H
Ethylfumaric acid (1.44 g, 10 mmol) was suspended in water (15 ml) and the 
pH adjusted to 9.0 with concentrated ammonia solution. The solution was 
reduced in vacuo to give the diammonium salt. This was redissolyed in 
water (15 ml) and potassium chloride (6 mg, 3.9 mmol) and magnesium 
chloride hexahydrate (30 mg, 7.5 mmol) added. The pH was readjusted to
9.0 with concentrated ammonia solution. 3-Methylaspartase (100 pi, 10 
units) was added and the absorbance of the solution at 240 nm was 
measured. The solution was then incubated at 30 until absorbance 
measurements showed no further decrease in absorbance. The protein was 
denaturated by heating to 80 °C for 2 minutes and removed by filtration. The 
filtrate was acidified to pH 1.0 with concentrated hydrochloric acid and 
extracted with diethyl ether (3 x 1 5  ml). The aqueous layer was adjusted to 
pH 4.0 and the w ater removed in vacuo. The resulting solid was 
recrystallized from water / ethanol to give a white solid (1.22 g, 76 %), m.p. > 
240-242 °C (lit.,241 245-246 °C); [a][, +13.9 ° (c 1.0 in 6 M HCi) (lit.,241 
+15.0 ° (c 0.6 in 6 M HCi)); D^ax (nujoi)/cm-l 2400-3500 (COQH) and 1630 
(CO); Sh(270 MHz; DgO/NaOD) 0.70 (3H, U  7 Hz, -CHgCHg), 1 22  (2 H, m, 
J  7 Hz, -CM2CH3), 2.34 (1H, m, J  4 Hz, 3-H) and 3.38 (1H, d, J  5 Hz, 2-H); 
5c (50.3 MHz, DgO/NaOD) 13.5 (CH3), 22.1 (CHg), 50.8 (C-3), 57.6 (C-2), 
174.9 and 182.0 (COgHs); m/z (Ei) 116 ([M - CHOg]+, 12% ).
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N-lsobutvloxv Carbonvl (2S)-Glutamic Acid-5-Methyl Ester (12&)
HOgd CO2M6
(2S)-Glutamic acid-y- methyl ester (2.0 g, 12.4 mmol) was dissolved in water 
(25 ml) and toluene (30 ml) and the mixture stirred very vigorously. Iso- 
butylchloroformate (5.2 g, 38 mmol) was added slowly and the pH of the 
reaction mixture maintained above 7.5 by the periodic addition of sodium 
bicarbonate. Stirring was continued for 90 minutes. The reaction mixture 
was extracted with chloroform (3 x 60 ml). The aqueous layer was adjusted 
to pH 2.0 with hydrochloric acid and re-extracted with chloroform (3 x 25 ml). 
The pooled chloroform extracts were dried (IVIgSO^) and evaporated to 
dryness to give N-isobutyloxy carbonyl (2S)-glutamic acid-5-methyl ester as 
a hygroscopic white solid (2.6 g, 84 %), m.p. 35-37 °C; 0^ (270 MHz; CDCI3 ) 
0.92 (6H, d, J 7.9 Hz, (CJd3)2CH-), 1.92 and 2.06 (2H, sp and qn, J  5.6 Hz,
3-CH2), 2.28 (1H, m, J 4.5 Hz, (CH3)2CH-), 2.48 (2H, m, J  6.2 Hz, 4-CH2), 
3.67 (3H, s, CO2CH3), 3.87 (2H, d, J 7.9 Hz, (CH3)2CHCH2-), 4.40 (1H, m, 
J  4.9 Hz, 2-CH) and 5.40 (1H, d, J  9.8 Hz, NH); Ôq (22.6 MHz, GDCI3) 19.13 
((^H 3)2CH-), 27.53 (C-3), 28.07 ((CH3)2^1H-), 30.25 (C-4), 52.10 (CO2Û H 3),
53.28 (C-2), 71.77 ((CH3)2C H (IH 2-). 156.82 (CO2NH), 173.73 (ÛO2CH3) 
and 176.05 (CO2H); m/z (Cl) 262 ([M  + H]+, 100 %), 216 (15, [M  - C O gH ^, 
205 (8 , [M + H - C^HgM and 116 (12, [M - C^ngO^M.
1
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2 ’-(N-lsobutvloxv Carbonyl (2 ’S)-Glutamic Ac id-5’-M ethvl Esteh-4.4- 
Dimethvl-2-Oxazoline (12^)
COoM©
N-lsobutyloxy carbonyl {2S)-glutamic acld-5-methyl ester (0.7 g, 2.68 mmol) 
was dissolved In toluene (40 ml). p-ToluenesulfonIc acid (40 mg, 0.2 mmol) j;
and 2-amino-2-methyl-1-propanol (0.26 g, 2.92 mmol) were added. The 
reaction mixture was refiuxed with azeotropic removal of water for 36 hours.
The toluene and unreacted alcohol was removed in vacuo to give 2’-(N- |
isobutyloxy carbonyl (2 ’S)-glutamic acld-5’-methyl ester)-4,4-dimethyl-2- 
oxazoline as a colourless oil (0.83 g, 99 %); (nujol)/cm'^ 3300 (N-H),
1715 (CO), 1675 (ON) and 1250 (CO); 8^ (270 MHz; CDCI3) 0.90 (6H, d, J
8.0 Hz, (CH3)2CH-), 1.30 (6H, s, (CH3)2C(N)CH2-), 1.92 and 2.05 (2H, m, J
6.4 Hz, O’-CHg), 2.25 (1H, m, J 8.0 Hz, (CH3)2CM-). 2.46 (2H, m, J  6.4 Hz, 4- 
CH2), 3.65 (3H, s, CO2CH3), 3.85 (2H, d, J  8.0 Hz, (CH3)2C H C Ë2-), 4.0 (2H, 
s, (CH3)2C(N)CH.2-), 4.45 (1H, m, J 6.0 Hz, 2'-CH) and 5.45 (1H,d, J  10 Hz,
NH); 8c (67.8 Hz; CDCI3) 18.93 ((£H 3)2CH-), 23.37 (NC(£.H3)2), 27.81 (C- 
3 ’), 28.23 ((CH3)2ÜH-), 29.54 (C -4 ), 32.90 (N^1(CH3), 51.60 (CO2Ü H 3),
54.16 (C-2 ), 67.05 (0£H2C(CH3)2), 71.14 ((CH3)2C H £H 2-), 156.64 (OCN),
164.50 (CO2NH) and 173.74 (ÜO2CH3); m/z (Cl) 315 {[M + H]+, 100 %),
241 (8 , [M - C4HgO]+) and 90 (37, C4H12NO+).
;
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a-N-Acetvl-6-N-Formyl"(2S/R)-Ornithine (134)
HOpC
a -N “Acetyl-(2S/R)-ornithine (200 mg, 1.15 mmol) was dissolved In glacial 
acetic acid. To this solution, stirred at 8 °C, was added formic acetic 
anhydride (0.3 g, 3.45 mmol). Stirring was continued at this temperature for 
40 minutes and then for a further 80 minutes at room temperature. The 
solvent and excess reagent was removed in vacuo yield a white solid which 
was recrystallized from ethanol / ethyl acetate, to give a-N-acetyl-Ô-N-formyl- 
{2S/R)-ornithine (0.16 g, 69 %), m.p. 141-143 °C; (Found: m/z [M  + H]+ 
203.103. requires 203.103); 6^ (270 MHz, DgO) 1.40 (2H, m, J
9.2 Hz, 4-CH2), 1.52 and 1.65 (2H, ms, J 8.2 and 5 Hz, S-CHg), 1.80 (3H, s, 
CH3CO), 3.00 (2H, t, J 8.2 Hz, 5-CH2), 4.10 (1H, dd, J 5 Hz, 2-CH) and 7.80 
(1H, s, NHCOH); Ôq (67.8 MHz, D2O) 22.36 (aHgCO), 25.73 (C-4), 28.78 (C- 
3), 38.16 (C-5), 53.36 (C-2), 164.93 (CHg^O), 175.06 and 176.55 (CHO and 
CO2H); m/z (Cl) 220 {[M + NH^r, 14 %), 203 (100, [M + H]+), 185 (69, [M  - 
O H M , 157 (20, [M  - C0 2 H]+) and 98 (10, [M - CsH^NOgM-
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5-N-Formyl-(2$)-Qrnithine (122)
HOpC
180
4
%
a-N-Acetyl-ô-N-formyl-(2S/R)-ornithine (70 mg, 0.35 mmol) was dissolved in 
water (5 ml) and the pH adjusted to 6.80 with dilute sodium hydroxide 
solution. Acylase (1 mg, 2300 units) was added and the reaction mixture |
incubated at 25 °C for 24 hours. Charcoal was added and the solution 
filtered through celite to remove the enzyme. Concentration in vacuo gave 
a-N-Acetyl-ô-N-formyl-(2 R)-ornithine and ô-N-formyl-(2S)-ornithine (62 mg,
99 %). Attempts to separate these two compounds were unsuccessful; Ôh 
(270 MHz, DgO) 1.42 and 1.75 (8H, 2m, J  9.2 and 5.0 Hz, 3,4-CHg), 1.80 
(3H, s, CH3CO), 3.05 (4H, t, J 9.2 Hz, S-CHg), 3.88 (1H, t, J  7.4, 2-CH), 4.10 
(1H, dd, J  5 Hz, 2-CH) and 7.80 (2H, 2s, NHCOHs); 0-N-formyl-L-ornithine;
ÔQ (67.8 MHz, DgO) 25.06 (C-4), 28.14 (C-3), 37.98 (C-5), 53.18 (C-2),
172.51 (COgH) and 176.55 (CHO).
r^H^]-Ethvlfumaric Acid (132)
COpH
Ethyl acetoacetate (1.3 g, 8.28 mmol) was added dropwise to a stirred 
solution of sodium ethoxide in anhydrous ethanol (2.54 ml, 2.8 M, 7.1 mmol). 
After 5 minutes further stirring, [^Hg]-iodoethane (1.0 g, 6.2 mmol) was 
added slowly dropwise. The reaction mixture was then refluxed for 2 hours 
and allowed to cool. The solution was poured into water (3.4 ml) and 
extracted with diethyl ether (3 x 3.5 ml) and dried (IVIgSO^). The solvent was 
removed in vacuo to give [^H5]-2-ethylacetoacetate ethyl ester as a yellow 
oil (0,83 g, 82 %).
Bromine (5.0 g, 31.3 mmol) was added slowly to a vigorously stirred solution 
of the pHg]-2-ethylacetoacetate ethyl ester (0.83 g, 5.2 mmol) in dry diethyl 
ether (20 ml). The resulting solution was refluxed for 3 hours. The solvent 
and hydrogen bromide were removed In vacuo to give the dibromide as a 
yellow oil. This was added slowly to rapidly stirred ethanol (17 ml) 
containing powdered potassium hydroxide (5 g, 87.7 mmol). The mixture 
was refluxed for 30 minutes and then acidified with concentrated  
hydrochloric acid and extracted with diethyl ether (4 x 35 ml). The pooled 
organic extracts were dried (IVIgSO^). The solvent was removed in vacuo to 
give a yellow solid. This was recrystallized from diethyl ether / petroleum 
ether to give pHg]-ethylfumaric acid as an off white solid (0.275 g, 36 %); 
m.p. 196-199 °C; o^ax (nujol)/cm-l 2400-3500 (COQhl) and 1740 (CO); 5h 
(270 MHz; DgO/NaOD) 6.59 (1H, s, -CH); ôp (61.4 MHz; DgO/NaOD) 0.94 
(3^H, s, C^Hg) and 2.53 (22h, s , C^Hg); Ôq (100.61 MHz; DgO/NaOD) 12.36 
(m, C^Hg), 21.15 (m, C^Hg), 127.17 (C-3), 148.98 (C-2), 171.10 and 172.23 
(^OgHs); m/z (El) 130 ([M - HgO]+, 77 %). 102 (97, [M  - CH^OgM, 57 (48, 
CgHOg+), 45 (38, CHOg+) and 28 (100, CO+).
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(2S.3S)-r^H^1-3-EthvlasDarticAcid (142)
H.N
H'
HOgC' H
[2Hg]-Ethylfumaric acid (0.20 g, 1.3 mmol) was suspended in water (2 ml) 
and the pH adjusted to 9.0 with concentrated ammonia solution. The 
solution was reduced in vacuo to give the diammonium salt. This was 
redissolved in water (2 ml) and potassium chloride (1 mg, 0.5 mmol) and 
magnesium chloride hexahydrate (4 mg, 1 mmol) added. The pH was 
readjusted to 9.0 with concentrated ammonia solution. 3-Methylaspartase 
(10 pi, 1.5 units) was added and the absorbance of the solution at 240 nm 
was measured. The solution was then incubated at 30 °C until subsequent 
absorbance measurements showed no further decrease in absorbance. 
The protein was denaturated by heating to 80 °C for 2 minutes and removed 
by filtration. The filtrate was acidified to pH 1.0 with concentrated  
hydrochloric acid and extracted with diethyl ether ( 3 x 2  ml). The aqueous 
layer was adjusted to pH 4.0 and the water removed in vacuo. The resulting 
solid was recrystallized from water / ethanol to give (2S,3S)-[2Hg]-3- 
ethylaspartic acid as a white solid (0.12 g, 53 %), m.p. 239-242 °C; (Found: 
(M  + H)+ 167.108. C6H7O4ND5 requires 167.108); [ajp +10.85 ° (c 1.0 in 
0.5 M HCI); Dmax (nujol)/cm-‘^ 2400-3500 (COQH) and 1630 (CO); (400
MHz; DgO/NaOD) 2.71 (1H, d, J 3.7 Hz, 3-CH) and 3.90 (1H, d, J  3.7 Hz, 2- 
CH); 0q(61.4 MHz; DgO/NaOD) 0.81 (O^H, s, C^Hg) and (22h, d, J  9.2 Hz. 
C2Hg); ÔC (100.61 MHz; DgO/NaOD) 11.18 (qn, C2Hg), 20.05 (qn, C2Hg), 
48.33 (C-3), 56.12 (C-2), 173.40 and 179.97 (COgHs); m/z (Cl) 167 ([M  + 
H]+, 100 %), 121 (9, [M  - CHOgM, 77 (20, [M - CgHO^M and 58 (9, [M  - 
C2H6NO4M.
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F.rQ.piooylX.h ( 1 ^ )
Propanoic acid (0.5 g, 6.75 mmol) was dissolved in chloroform (20 ml) and 
phosphorus pentachloride (1.41 g, 6.75 mmol) was added. The mixture was 
stirred at reflux for 24 hours. The propionyl chloride and solvent were co­
distilled to give propionyl chloride in chloroform (estimated yield 0.3 g, 48 
%); «max (CHCIg)/cm-l 1790 (CO); Sh (200 M Hz; CDGIg) 1.22 (3H, t, J  5.3 
Hz, CHg) and 2.93 (2H, q, J  5.3 Hz, CHg); Sq (75.47 MHz; CDCIg) 9.26 
(CHg), 41.30 (CHg) and 174.85 (COCI); m/z (GCMS, El) 92 (M + , 1 %), 57 
(38, [M  - Cl]+) and 29 (70, [M - COCI]+).
.1-DiazQbytan-2-(3in,ê (iga)
Propionyl chloride (0.5 g, 5.4 mmol)) in chloroform (20 ml) was added slowly 
dropwise to a stirred ethereal solution of diazomethane (11 mmol, as 
determined by titration) which was cooled in ice. Stirring was continued for 
2 hours, allowing the solution come up to room tem perature. The  
diazoketone was obtained on removal of the solvent in vacuo as a yellow oil 
(0.42 g, 80 %); D^ax (neat)/cm“l 2105 (NN) and 1740 (CO); 8^ (200 MHz; 
CDCI3) 1.12 (3H, t, J  7.5 Hz, CHg), 2.35 (2 H, q, J  7.5 Hz, CHg) and 5.23 
(1H, s, CHNg); ÔC (50.3 MHz; CDCIg) 9.55 (CHg), 34.48 (CHg), 54.46 (CHNg) 
and 196.36 (CO); m/z (El) 98 (M + , 32 %), 68 (27, [M  - NgHg]+), 57 (79, [M  - 
CHNg]+), 42 (27, CHgNg+) and 30 (100, NgHg+).
Butan-2-one (164)
1-Diazobutan-2-one (1.0 g, 10.2 mmol) was dissolved in dichloromethane 
(30 ml) and hydroiodic acid (55 %, 3 ml, 12.8 mmol) was added slowly to the 
stirred diazoketone solution. The reaction mixture was left stirring for 10 
minutes to ensure complete reaction. The mixture was then washed with 50 
% aqueous sodium thiosulphate (5 x 30 ml), until complete decolourization 
had occurred. The organic layer was washed with water ( 2 x 5  ml) and dried
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(NaSO^). The filtrate distilled to give butan-2-one in dichloromethane (0.34 
g, 46 %); «max (CHgClgVcm-l 1710 (CO); 5h (200 MHz; CDCIg) 1.05 (3H, t, J
7.5 Hz, CHgCHg), 2.14 (3H, s, CHgCO) and 2.45 (2H, q, J  7.5 Hz, CHg); Ôq 
(75.47 MHz; CDCIg)7.05 (GHgCHg), 27.52 (CO£.Hg), 35.23 (CHg^Hg) and 
207.64 (CO); m/z (GCMS, El) 73 ([M + H]+, 14 %), 58 (25, [M  + H - CHg]+) 
and 31 (100, CgHgO+).
EthvI Acetate 1165)
Butan-2-one (1.0 g, 13.5 mmol) was dissolved in dry 1,1,2-trlchloroethane 
(30 ml) and 3-chloroperbenzoic acid (50 %, 10 g, 28 mmol) was added. The 
mixture was stirred at 50 °C for 48 hours. The reaction mixture was allowed 
to cool and the precipitated add was filtered off. The solvent and ethyl 
acetate were co-distllled, to give ethyl acetate In 1,1,2-trichloroethane (1.21 
g, 99 %); «max (1,1,2-trlohloroethane)/cm-f 2950 (CH) and 1740 (CO); 8^ 
(200 MHz; CDCIg) 1.27 (3H, t, J 7.5 Hz, ChgCHg), 2.05 (3H, s, CHgCOg) 
and 4.13 (2H, q, J  7.5 Hz, CHg); 8c (50.3 MHz; CDCIg) 9.16 (£HgCHg), 
27.21 (CHgDHg), 49.96 (ÜHgCOg) and 173.27 (CO); m/z (GCMS, El) 88 
(M + , 7 %), 73 (5, IM  - CHgM, 61 (15, [M  - CgHg]*), 43 (100, CgHgO+), 29 
(12, CgHg+) and 15 (5, CHg+).
Ethanol (166)
Ethyl acetate (1.0 g, 11 mmol) was dissolved in dioxane (5 ml) and 
hydrazine hydrate (34 mmol, 1.10 g) was added slowly dropwise. The 
reaction was stirred at 50 °C for 24 hours. Phthalic anhydride (0.81 g, 5.5 
mmol) was added to destroy the excess hydrazine. The ethanol and 
dioxane were co-distiiied off from the acetate by-product, to give ethanol In 
dioxane (0.47 g, 90 %); «max (dioxane)/cm'^ 3400 br (OH); 8^ (200 MHz; 
CDCIg) 1.20 (3H, t, J  7.5, CHg) and 3.70 (2H, q, J 7.5 Hz, CHg); 8g (50.3 Hz; 
CDCIg) 18.32 (CHg) and 57.95 (CHg); m/z (GCMS, El) 45 ([A4 - H]+ , 100 %), 
31 (100, CHgO+) and 15 (10, CHg+).
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Ethyl ÏQsylatg (1£Z)
\  /
Ethanol (0.5 g, 11 mmol) in dioxane (8 ml) was dried (IVIgSO^) and dry 
pyridine (3.5 ml, 43.3 mmol) added. The mixture was cooled in ice. Tosyl 
chloride (5.03 g, 26 mmol) was added in small portions, whilst maintaining 
the temperature below 10 °C. The reaction mixture was stirred for a further 4 
hours, it was, then, tipped into ice water (22 ml) containing hydrochloric acid 
(6.6 ml). Trituration gave solid ethyl tosylate, which was filtered off. The 
product was dissolved in diethyl ether (10 ml) and the resulting solution 
dried (IVIgSO^). Concentration in vacuo gave the product as a white solid. It 
was recrystallized from diethyl ether / petroleum ether, to give ethyl tosylate 
(1.8 g, 83 %), m.p. 29-32 °G (lit.,263 33.34 «0); (nujol)/cm-l 1590 (Ar 0 -  
0) and 1180 (SO); 0^ (200 MHz; GDCI3) 1.30 (3H, t, J 7.5 Hz, GH3CH2), 
2.43 (3H, s. GHgAr), 4.10 (2H, q, J 7.5 Hz, GH3GM2), 7.35 (2H, d, J 7.5 Hz, 
Ar) and 7.80 (2 H, d, J  7.5 Hz, Ar); Sq (75.47 MHz; GDGI3) 14.5 (GH2ÇIH3), 
21.4 (Ar-iQH3), 66.6 (ÜH2GH3), 127.7 and 129.7 (Ar), 133.2 (AC-CH3) and
144.5 (Ar-S-); m/z (El) 200 (M+, 51 %), 172 (23, [M  - GgH^M, 155 (77, [M  - 
CgHgOM, 91 (100, IM  - GyHyM, 65 (45, [M  - GgHgn and 28 (21, G2H2+).
2-Ethylacetoacetate EthvI Ester (119 b)
Sodium (1.28 g, 55.7 mmol) was dissolved in dry ethanol (20 ml) to give 
sodium ethoxide, a portion (1.54 ml, 4.3 mmol) of which was placed in the 
reaction flask and ethyl acetoacetate (0.35 ml, 3.8 mmol) added. After 5 
minutes ethyl tosylate (1.0 g, 5.0 mmol), dissolved in a minimum volume of 
dry ethanol was added. The reaction mixture was refluxed for 5 hours. 
Water (10 ml) was added and the mixture extracted with diethyl ether (3 x 30
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ml). The combined organic extracts were dried (IVIgSO^) and the solvent 
rem oved in vacuo, to give an oil which was purified by column  
chromatography on silica gel (15 % ethyl acetate / petroleum ether) to give 
2-ethylacetoacetate ethyl ester (0.32 g, 40 %), b.p. 103-104 °C /1 0  mmHg; 
'^ max (neat)/cm-^ 3000 (CH), 1725 (CO ester) and 1715 (CO ketone); 6^ (200 
MHz; CDCIg) 0.91 (3H, t, J 7.5 Hz, 2'-CHg), 1.25 (3H, t, J  7.5 Hz, - 
OCHgCHg), 1.86 (2H, qn, J 7.5 Hz, I'-CHg), 2.20 (3H, s, 4-CHg), 3.30 (1H,t, 
J  7.5 Hz, 2 -CH) and 4.18 (2 H, q, J 7.5 Hz, -OCUgCHg); 5q (50.3 MHz; 
CDCIg) 12.35 (C-2 '), 14.57 (OCHgüHg), 22.07 (C-V), 23.87 (^HgCO), 29.28
(CH), 61.87 (O^HgCHg), 170.29 (-COg-) and 173.02 (CO); m/z (El) 158 (M  
+, 2 %), 130 (13, [M  - CgH^M, 116 (6 8 , [M - CgHg]+), 101 (55, [M  - 
CgHgOM, 73 (69, [M  -CgHgO]+), 43 (100, CgHgO+) and 29 (59, C2 H5 +).
(2S)-2-Bromopropanoic Acid (IM )
Br
H g C " y  ^ C O g H
H
(2 S)-Alanlne (4.0 g, 45 mmol) was added to a saturated solution of 
potassium bromide (10 ml), followed by the dropwise addition of hydrogen 
bromide (15 ml of a 48 % solution). The resulting solution was, then, cooled 
to 0 °C and sodium nitrite (6.21 g, 90 mmol) was added over 1 hour. The 
reaction mixture was maintained below 5 °C for a further hour and then 
allowed to warm to room temperature. The resulting solution was extracted 
with diethyl ether (3 x 25 ml) and the combined ether extracts were then 
dried (MgSO^) and concentrated in vacuo to give a pale yellow oil (6.67 g, 
97 %). This was distilled under reduced pressure to give pure (2S)-2- 
bromopropanoic acid, b.p. 68-70 °C /0.1 mmHg; [ajg - 28.6° (c 2.0 in CHCIg) 
(lit.,30® -45.2 ° (neat)); (neat)/cm-i 3000 br (COQH) and 1710 (QQOH); 
ÔH (300 MHz; GDGI3 ) 1.85 (3H, d, J 7 Hz, 3-GHg), 4.40 (1H, q .J  7 Hz, 2-GH) 
and 9.65 (1H, s br, l-GOgH); 5c (75 MHz; GDGI3 ) 21.26 (G-3), 39.34 (G-2 )
186
and 175,88 (COgH); m/z (El) 153 (M + , 25 %), 152 (26, [M - H]+), 108 (56, 
[M - COgH]+), 73 (51, [M  - Br]+), 55 (22, [M  - BrOH]+), 45 (73, COgH+) and 
28 (100, [M - BrCOgH]+).
(2RV[2-^H]-Propanoic Acid (161)
H
2H
A solution of 1 M Superdeuteride in THF (14 ml, 14 mmol) was added to 
(2S)-2-bromopropanoic acid (0.76 g, 5 mmol) dissolved in anhydrous THF  
(5 ml), under nitrogen at 0 °C. The mixture was heated under reflux for 2 
hours. The solution was allowed to cool and, then, the excess deuteride 
was decomposed by the addition of water (5 ml). The mixture was acidified 
(pH 1.0) and extracted with diethyl ether. The ether was removed in vacuo 
and the residue thus obtained treated with water (7 ml), followed by a 1:1 
mixture of hydrogen peroxide (100 vols) and 2 M sodium hydroxide, added 
until efferverscence ceased (approximately 30 ml). The reaction mixture 
was then stirred at room temperature for 15 hours. The resulting alkaline 
solution was extracted with diethyl ether (5 x 20 ml) and then the aqueous 
portion saturated with NagPO^ and sodium chloride and the pH adjusted to
6.0 with 1 M sulphuric acid. The saturated solution was extracted with 
diethyl ether (6 x 20 ml). The organic extract was dried (MgSO^) and the 
excess diethyl ether removed carefully in vacuo to give (2R)-[2-2H]- 
propanoic acid (0.36 g, 99 %) and triethyl borate; (neat)/cm"'* 3000 br 
(COQh); ÔH (200 MHz; CDCIg) 1.16 (3H, d, J 7.5 Hz, CHg) and 2.40 (1 H, m, 
J  2.5 Hz, CH2H); Ôq (50.3 MHz; CDCIg) 9.10 (CHg), 27.91 (CH^H) and 
179.90 (COgH); m/z (GCMS, El) 75 (M+, 100 %), 58 (33, [M  - OH]+), 45 (58, 
COgH+) and 28 (100, CO+).
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(2R)-[2-^H]-Propionvl Chloride (168)
V "/^ ^ co c i
(2R)“[2-2|H]-Propanoic acid (0.36 g, 5 mmol) was dissolved in chloroform (20 
ml) (which had been passed down an alumina column immediately prior to 
use) and phosphorus pentachloride (1.15 g, 5.5 mmol) was added. The 
mixture was stirred at reflux for 24 hours. The chloroform and propionyl 
chloride were co-distilled off, giving (2R)-[2-^H]-propionyl chloride (0.45 g, 
99 %) in chloroform; D^ax (CHCy/cm"'* 1790 (CO); Ôh (200 MHz; CDCIg)
1.22 (3H, d, J  7.5 Hz, CHg) and 2.93 (1H, m, J  3.0 and 7.5 Hz, CH^H); 6 ^ 
(75.47 MHz; CDCIg) 9.10 (CHg), 46.34 (CH^H) and 174.90 (COCI); m /z  
(GCMS, El) 93 (M+, 1 %), 58 (41, [M - Cl]+) and 30 (76, [M  - COCI]+).
,(3R)-[3i^H]"1 -Plazobutan-2-one (lüâ)
CHN
o
(2R)-[2-2H]“Propionyl chloride (0.45 g, 4.8 mmol) in chloroform (25 ml) was 
distilled off N,N-dimethyl aniline, to remove any phosphorus oxychloride and 
hydrogen chloride present. The solution was added slowly dropwise to a 
stirred ethereal solution of diazomethane (16.5 mmol, as determined by 
titration) cooled in ice. Stirring was continued for 16 hours, allowing the 
solution to warm up to room temperature. Potassium carbonate (0.35 g, 2.5 
mmol) was added to the solution and the solvent removed in vacuo. The 
residue was dissolved in diethyl ether and the solid potassium carbonate 
filtered off. The diazoketone was obtained by removal of solvent, in vacuo,
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as a yellow oil (0.42 g, 76 %); (neat)/cm'^ 2105 (NN) and 1740 (CO); 8^ 
(200 MHz; CDCIg) 1.10 (3H, d, J  7.5 Hz, CHg), 2.30 (1H, m, CH^H) and 5.22 
(1H, s, CHNg); ÔQ (50.3 MHz; CDCIg) 9.46 (CHg), 54.72 (CHNg) 34.43 
(CH^H) and 196.20 (CO); m/z (El) 99 (M + , 29 %), 69 (23, [M - NgHg]+), 56 
(82, IM  - CHNg]+), 42 (26, CHgNg]+) and 30 (100, NgHg+).
(3R)-[3-^H]-Butan-2-one (1ZÛ)
(3R)-[3-^H]-1 -D iazobutan-2-one (0.42 g, 3.6 mmol) was dissolved in 
dichloromethane (5 ml). Hydroiodic acid (55 %, 2.4 ml) was added dropwise 
to the diazoketone solution, with shaking (care: pressure). After 5 minutes, 
the reaction mixture was washed with 50 % aqueous sodium thiosulphate (5 
X 5 ml), until complete decolourization had occurred. The organic layer was 
dried (NaSO^). 1,1,2-Trichloroethane was added to the filtrate to facilitate 
co-distillation of the butanone. Distillation gave a mixture of (3R)-[3-^H]- 
butan-2-one and unlabelled butan-2-one (0.25 g, 95 %) in dichloromethane 
/  1,1,2-trichloroethane; (CHgClg / 1,1,2-trichloroethane)/cm"'* 1710 
(CO); ÔH (200 MHz; CDCIg) 1.05 (3H, d, J  7.5 Hz, CHgCH^H), 2.14 (3H, s, 
COCHg) and 2.44 (1H, m, J  7.5 and 2.5 Hz, CH^H); Ôq (50.3 MHz; CDCIg)
7.1 (C.HgCH2H), 27.6 (CO^Hg) 35.2 (CH^H) and 207.5 (CO); m/z (GCMS, 
El) 73 and 74 ([M  + H]+, 12% ), 58 and 59 (26, [M + H - CHg]+) and 31 (100, 
CgHgO+).
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Dimethyl Dideuterofumarate (19^)
IVIeOgC^  D
D COgMe
To a stirred solution of dimethyl acetylene dicarboxylic acid (5 g, 35 mmol) in 
anhydrous THF (72 ml) containing deuterium oxide (0.7 g, 35 mmol) was 
added dropwise a solution of triphenylphosphine (9.3 g, 35 mmol) in 
anhydrous THF (72 ml). The reaction temperature was maintained below 5 
°C during the addition. The reaction mixture was then allowed to attain room 
temperature and heated at reflux for 5 hours. The resultant solution was 
dried (IVIgSO^) and concentrated In vacuo to give a red-brown solid which 
was sublimed twice (80-100 °C /  1 mmHg) to give dimethyl dideutero­
fumarate as white crystals (2.11 g, 41 %), m.p. 103-104 °C (lit.,28^ 104-105 
°C); Dmax (nujol)/cm-l 2260 (C2H), 1730 (CO) and 1610 (CC); Ôh (270 MHz; 
CDCIg) 3.81 (6H, s, COgCHgS); Ôq (75.47 MHz; CDCIg) 52.10 (COgüHgS), 
133.12 (£l(2H)C0 2 CHgS) and 165.14 (ilOgCHgS); m/z (El) 146 (M +, 12 %), 
115 (100, [M - CHgO]+), 87 (95, [M  - CgHgOgM, 59 (91, CgHgOg^) and 28 
(86, CO+).
Dideuterofumaric Acid (194)
Dimethyl dideuterofumarate (2.0 g, 13.7 mmol) was added to 12 % aqueous 
sodium hydroxide solution (13 ml) and stirred at room temperature for 72 
hours. The pH of the solution was adjusted to 2.0 using 3 M HCI, causing 
dideuterofumarate to precipitate out of solution. The solid was filtered off 
and recrystallized from 8 % aqueous sodium hydroxide solution with 3 M 
HCI to give dideuterofumaric acid as a white solid (1.19 g, 66 %), m.p. 286-
287.6 °C; Dmax {nujoiycnr' 3400-2400 (OH), 2260 (C^H) and 1680 (CO); 5c 
(67.8 MHz; DgO) 158 (COgH); m/z (El) 118 (M+, 4 %), 101 (11, [/M - OH]+), 
73 (17, [M  - CHOgM, 57 (22, CgHOg+) and 44 (41, COg+).
190
(2S.3S.)-[2.3-^ ,Hl-Aspaûi£.Mcl (ia£)
H,N COgH
HOgC H
Dideuterofumaric acid {1.0 g, 8.5 mmol) was suspended in water (10 ml) and 
the pH adjusted to 9.0 with concentrated ammonia solution. The resulting 
solution was concentrated in vacuo to give diammonium dideuterofumarate. 
This was redissolved in water (10 ml) and magnesium chloride hexahydrate 
(20 mg, 0.01 mmol) and potassium chloride (4 mg, 0.05 mmol) was added. 
The pH was readjusted to 9.0 with concentrated ammonia solution. 3- 
Methylaspartase (900 pi, 40 units) was added and the absorbance at 240 
nm measured. The reaction mixture was incubated at 30 °C until the 
absorbance at 240 nm remained constant.
The protein was denatured by heating at 100 °C for two minutes and 
removed by filtration. The filtrate was acidified to pH 1.0 with 12 M HCI and 
extracted with diethyl ether ( 2 x 7  ml). The aqueous layer was adjusted to 
pH 4.0 and the addition of ethanol caused the precipitation of (2S,3S)-[2,3- 
2H]-aspartic acid. The solid was filtered off and recrystallized from hot water 
/  ethanol (60 : 40) to give (2S,3S)-[2,3-2H]-aspartic acid as a white solid 
(0.52 g, 51 %), m.p. >300 °C; (Found: (M  + H)+ 136.0579. C^HgNO^Dg 
requires 136.0577); [ajp +25.2 ° (c 0.5 in 6 M HCI); (nujol)/cm-i 2600  
(OH) and 1700 (CO); Ôh (270 MHz; DgO/DCI) 2.85 (1H, s, O-CH^H); Ôq 
(75 .47  MHz; DgO/DCI) 33.76 (C -3), 49.56 (C -2 ), 171.19 and 173.50  
(COgHs); m/z (Cl) 136 ([M + H]+, 92 %) and 45 (100, CHOg+).
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(2S.3S1-f3-2-H1-Aspartic acid (1901
HgN COgH
HOgC H
(2S,3S)-[2,3-2H]-Aspartic acid (0.75 g, 5.5 mmol) was dissolved in water (10 
ml) and the pH of the solution adjusted to 7.0 with concentrated ammonia 
solution. Pyridoxal 5-phosphate (1 mg, 4 pmol) was added and the solution 
incubated with aspartate aminotransferase (1 ml, 2000 units) for 48 hours.
The enzyme was denatured by heating at 100 °C for two minutes and 
removed by filtration. The filtrate was acidified to pH 1.0 with 12 M HCI and 
the addition of ethanol caused the precipitation of (2S,3S)-[3-2H]-aspartic 
acid. Recrystallization from hot water / ethanol (60 : 40) gave (2S,3S)-[3- 
2H]-aspartic acid as a white solid (0.38 g, 51 %), m.p. >300 °C; (Found: (M  + 
H)+ 135.0518. C4H7NO4D1 requires 135.0514); [ajp + 19.7 ° (c 1.0 in 6 M 
HCI); Dmax (nujol)/cm'1 2600 (OH) and 1700 (CO); Ôh (300 MHz; DgO/DCI) 
2.85 (1H, d, J  2.4 Hz, 3-CH^H) and 4.12 (1H, d, J  2.4 Hz, 2-CH); Ôq (75.47 
MHz; DgO/DCI) 33.80 (C-3), 49.53 (C-2), 171.11 and 173.44 (COgHs); m /z
(Cl) 135 (IM  + H]+, 100 %), 88 (7, [M  - CHgOg]+) and 45 (34, CHOg]+).
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N-Carbobenzoxv-(2RWaline (lao).
HOoC'"
Sodium bicarbonate (12.55 g, 0.15 mol) was suspended in water (100 ml) 
and (2R)-valine (5.0 g, 42.7 mol) added with vigorous stirring. Benzyl 
chioreformate (8.0 g, 47 mol) was added in five portions over 30 minutes 
and the resulting mixture left stirring overnight. The mixture was extracted 
once with diethyl ether (25 ml). The aqueous fraction was acidified to pH 2  
using 5 M HCI and extracted with ethyl acetate (3 x 25 ml). The pooled 
organic extracts were dried (IVIgSO^) and the ethyl acetate removed in  
vacuo at 40 °C, to give a colourless oil which was recrystallized from diethyl 
ether / petroleum ether. N-Carbobenzoxy-(2R)-valine was obtained as a 
white solid (2.0 g, 93 %), m.p. 63-65 °C; [a]Q +4.2 ° (c 1.0 in acetic acid); 
\>max (nujol)/cm-l 3400 (NH), 1725 (OCOH1. 1660 (OCONH) and 1550 
(OCONH1: ÔH (300 MHz; CDCIg) 0.93 (3H, d, J 8  Hz, 4-CHg), 1.02 (3H, d, J  
8  Hz, 4-CHg), 2.25 (1H, m, J 8 Hz, 3-CH), 4.38 (1H, dd, J  5 Hz, 2-CH), 5.13 
(2H, s, PhCJdg). 5.42 (1 H, d,  J 8 Hz, 2-NH) and 7.35 (5H, s, Ph); 8c (50.3 
MHz; CDCIg) 17.3 and 18.9 (CH(C.Hg)g), 31.0 (GH(CHg)g), 58.80 (PhCHg)
67.16 (C-2), 128.08, 128.18, 128.48 and 136.06 (Ar), 156.42 (HNCO) and 
176.48 (COgH); m/z (El) 251 (M +, 1 %), 126 (9, [M  - CyHgOg]+), 108 (100, 
C7 H8 O+), 91 (81, C7H7+), 79 (89, CgH7 +), 43 (49, CgH7 +) and 28 (32, CO+).
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Glycine Methyl Ester ( lâ i )
Glycine (7.0 g, 94.5 mmol) was suspended in dry methanol (70 ml) and 
cooled in ice. Thionyl chloride (7.7 ml, 0.105 mol) was added dropwise. 
The resulting solution was refluxed for 30 minutes and then allowed to return 
to room temperature. The excess methanol and thionyl chloride were 
rem oved in vacuo, leaving the required ester hydrochloride as a 
hygroscopic white solid (2.62 g, 78.5 %), m.p. 175 °C; (nujol)/cm-i 
1735 (COgh/le); Ôh (300 MHz; CDCI3) 3.85 (3H, s, COgCHg) and 3.97 (2H, s,
2-C H 2); ÔC (50.3  MHz; DgO) 41.1 (C -2), 54.4 (COgHHg) and 169.7  
{Qp2 0 H^y,m/z (El) 89 (M+, 11 %), 59 (2, CO2CH3+) and 30 (100, CH4N+).
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N-Carbobenzoxy-f2RVValine-Glvcine MethvI Ester (179)
MeOpC
N-Carbobenzoxy-(2R)“Valine (10.0 g, 40 mmol) was dissolved in THF (150 
ml) and cooled to -15 °C. N-Methyl morpholine (4.35 ml, 40 mmol) was 
added, followed by /so- butyl chloroformate (5.5 ml, 40 mmol). The resulting 
mixture was left to stir for 3 minutes before glycine methyl ester  
hydrochloride (5.0 g, 40 mmol) suspended in DMF (25 ml) containing N- 
methyl morpholine (4.35 ml, 40 mmol) was added. Stirring was continued 
for 2 hours, before a further 45 ml DMF was added. The reaction mixture 
was stirred for a further 15 hours. Water (100 ml) was added, which caused 
the precipitation of N-carbobenzoxy-(2R)-valine-glycine methyl ester, which 
was filtered and washed with further water. Recrystallization of the white 
solid from dichloromethane / petroleum ether, gave N-carbobenzoxy-(2R)- 
valine-glycine methyl ester (10.19 g, 77 %), m.p. 151-153 °C; (Found: (M  +
H)+ 323.1607. C16H23N2O5 requires 323.1601); [a]^ +8.32 ° (c 1.0 in 
CH2CI2) (lit.,307 +6.8 ° (c 1.0 in CH2Cl2):Dmax(nujol)/cm-l 3290 (NH), 1750 
(ÛCOCH3), 1690 (QCONH), 1650 and 1530 (OCNH): 8^ (300 MHz; CDCI3) 
0.95 and 1.00 (6H, 2d. J  7 Hz, 4 ’-CH3), 2.04 (1H, m, J 6 Hz, 3 ’-CH), 3.73 
(3H, s, I-OCH3), 4.05 (1H, m, J 7 Hz, 2'-CH), 5.10 (2H, s, 5 ’-CH2), 5.63 and 
6.90 (1H, d, J  9 Hz, NH) and 7.35 (5H, s, 5’-Ph); 5c (75.47 MHz; CDCI3)
18.61 and 19.99 (C-4's), 31.94 (C-3’), 41.88 (C-2), 53.14 (-CO2GH3), 61.07 
(C-2 ), 67.87 (Ar£H2-), 128.80, 128.98 and 129.34 (2-,3-,4-Ar), 137.04 (Ar-
I ) ,  157.33 (-OCONH-), 170.98 and 172.63 (CO2CH3 / -CONH-); m/z (Cl) 
323 {M+,  100 %), 279 (15, [M - C02]+), 215 (14, [M - C7H8O+), 108 (15, 
C7H8O+) and 91 (10, C7H7+).
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Çyçlo ,-(3E?)iValirifiz£il.yclDa (1Z&)
H
N-Cbz-(2R)-Valine-glycine methyl ester (5 g, 15.5 mmol ) was dissolved in 
methanol /  dichloromethane (25 ml / 75 ml) and 10 % Pd on charcoal (125 
mg) added. The resulting suspension was stirred under an atmosphere of 
hydrogen, until there was no evidence of starting material remaining (as 
judged by tic). The palladium on charcoal was removed by filtering through 
celite. The filtrate was concentrated in vacuo to give a white solid which 
was found to be a mixture of the dipeptide methyl ester and the cycle- 
dipeptide. Cyclisation was completed by refluxing the residue in toluene 
(180 ml), in which it did not fully dissolve, for 12 hours. The flask was cooled 
to 0 °C to ensure complete precipitiation of the required product. The solid 
was filtered off and washed with cold diethyl ether (30 ml) to remove the 
toluene. The cycle -(2R)-valine-glycine was recrystallized from water, and 
dried In vacue at 60 °C for 3 days to give cycle -(3R)-valine-glycine (1.91 g, 
79 %), m.p. 149 °C (decomp.): [aJo -27.2 ° (c 0.9 in HgO) (lit.294 (3S)- 
Isomer, + 20.2 ° (o 0.9 in HgO). iit.,295 (3R)-isomer, - 24.6 ° (c 0.9 in HgO)); 
•o^ax (nujoi)/om-l 3180, 3040 (NH) and 1660 fOCNHI: 5h (300 MHz; DgO) 
0.74 (3H, d, J  8Hz, 3-CH(Ct|g)2), 0.82 (3H, d, J  8 Hz, 3-CH(CJl3)2), 2.07 
(1H, dsp, J  4 Hz and 3 Hz, 3-CM(CH3)2). 3.73 (1H, d, 3-H), 3.76 (1H, dd, J  
19 Hz and 2.5 Hz, 6-H) and 3.95 (1H, dd, J  19 Hz and 2.5 Hz, 6-H); 8^ 
(75.47 MHz; D2O) 18.39 and 20.71 (3-CH(£H3)2), 35.73 (3-(%H(CH3)2),
51.67 (C-3), 62.74 (0-6), 171.65 and 173.09 (0-2 and 0-4); m/z (El) 156 {M  
+, 7 %), 114 (88. [M - O3H8M, 85 (20, OsHgO+), 72 (70, O4H10N+) and 57 
(100, O2H3NO+).
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- m .
(3R)-2.5-Ditnethoxv-3-lsoDropvl-3.6-DihvdroDvrazine (182 a)
H OMe
H
A suspension of cyclo- (3R )-vaiine-g lycin0 (1.5 g, 9 .6  mmol) and 
trimethyloxonium tetrafiuoroborate (3.54 g, 24 mmol) in dry dichloromethane 
(60 ml) was vigorously stirred for 3 days, with further trimethyloxonium 
tetrafiuoroborate (1.41 g, 9.6 mmol) being added after 24 hours. To the 
resulting mixture, a solution of disodium hydrogen phosphate (31.8 g) and 
dihydrogen sodium phosphate (8.4 g) in water (200 ml) was added. The 
layers were separated and the aqueous phase was extracted with 
dichloromethane (3 x 30 ml). The combined organic phases were dried 
(IVIgSO^) and the solvent removed in vacuo to give an oil, which was 
purified by short path distillation under reduced pressure, to give (3R)-2,5- 
dimethoxy-3-isopropyl-3,6-dihydropyrazine (1.42 g, 80 %), b.p. 100-102 °C /  
20 mmHg; [aj^ -102.6 ° (c 1.0 in ethanol) (lit.,294 (3S)-tsomer + 106.3 ° (c 1.0 
in ethanol)); (neat)/cm"”* 2920 (CH) and 1680 fNCOCH^k 8^ (300 MHz; 
CDCI3) 0.75 and 1.03 (6H, 2d, J  8Hz, 3-CH(CH3)2), 2.22 (1H,dsp, J 3 Hz 
and 8 Hz, 3-CH(CH3)2), 3.69 and 3.73 (6H, 2s, 2.5-OCH3) and 4.00 (3H, s,
3 ,6-H); ÔQ (75.47 MHz; CDCI3) 16.9 and 18.2 (3-CH(^H3)2), 32.42 (3- 
üH(CH3)2), 46.54 (C-6), 52.47 and 52.51 (2,5-OCH3), 61.02 (C-3), 162.28 
and 164.85 (C-2, C-5); m/z (El) 184 (M +, 2.8 %) and 169 (100, [M - C H3H .
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''1
(3R)-2,5-P.ie.th.oxy-3H§oprQpyi-3.,6.:Dlb.yçirc>pyra2mg (l&2..b)
OEX
Eto
Cyclo  - (3R)-valine-glycine (0.5 g, 3.2 mmol) was dissolved in dry 
dichloromethane (10 ml). The flask was flushed with argon and heated to a 
temperature of 33-35 °C. Triethyloxonium tetrafluroborate (9.6 ml of a 1 M 
solution in dichloromethane, 9.6 mmol) was added dropwise, with vigorous 
stirring. The reaction was stirred at this temperature for 10 hours. Further 
triethyloxonium tetrafiuoroborate solution (4.8 ml, 4.8 mmol) was added and 
stirring at this temperature continued for 14 hours. Another portion of 
triethyloxonium tetrafiuoroborate solution (4.8 ml, 4.8 mmol) was added and 
stirring at 33-35 °C continued for a further 24 hours. The solution was then 
added slowly dropwise to a vigorously stirred solution of sodium bicarbonate 
buffer (200 mM, pH 8.5, 50 ml). The pH was kept between 7.0 and 7.5 with 
additions of sodium hydroxide solution (10 M). The layers were then 
separated and the aqueous layer extracted with dichloromethane (3 x 30 
ml). The combined organic layers were dried (NaSO^) and the solvent 
removed in vacuo to give a brown oil which was distilled by short path 
distillation (40-42 °C /1 5  mmHg) to give pure (3R)-2,5-diethoxy-3-isopropyl-
3,6-dihydropyrazine (0.13 g, 19.6 %); (Found: (M  + H)+ 2 1 3 .1 60 3 . 
C11H21N2O2 requires 213.1598); [a lp  -74.5 ° (c 1.0 in ethanol); D^ax 
(neatycm'l 2920 (CH) and 1680 fNCOCH^CHjI: 5^ (200 MHz; CDCIg) 0.78 
and 1.02 (8H, 2d, J  7 Hz, -CH(CHg)2), 1.28 (6H, dt, J 6 Hz, CJlgOHg), 2.23 
(1H, dsp, J 8 Hz, -CH(CHg)2), 3.98 (3H, s, 3,8-H) and 4.13 (4H, m, 
OCH2CH3); 5c (75.47 MHz; CDCIg) 14.3 (ilHgCHg), 17.1 and 19.0 (- 
CH((IHg)2 ), 32.9 (£H(CHg)2 ), 46.8 (C-6 ), 80.7 (CHgGHgO), 61.1 (C-3), 161.9 
and 164.4 (OCNs); m/z (El) 213 ([M  + H]+, 11 %), 169 (35, [M + H - C O gD , 
141 (40, C7H,gN20+), 113 (83, CgH,oNO+), 85 (100, C5H9O+/  C4H7NO+) 
and 56 (96, C2H2NO+).
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(2R1-2-BromoproDanoic Acid (ISS)
Br
y ^ C O g H
CH
(2R)-A lanine (4.0 g, 45 mmol) was added to a saturated solution of 
potassium bromide (10 ml), followed by the dropwise addition of hydrogen 
bromide (15 ml of a 48 % solution). The resulting solution was then cooled 
to 0 °C and sodium nitrite (6.21 g, 90 mmol) was added over 1 hour. The 
reaction mixture was maintained below 5 °C for a further hour and then 
allowed to warm to room temperature. The resulting solution was then 
extracted with diethyl ether (3 x 25 ml) and the combined ether extracts were 
dried (IVIgSO^ )^ and concentrated in vacuo to give a pale yellow oil (6.67 g, 
97 %). This was distilled by short path distillation, under reduced pressure 
to give pure (2R)-2-bromopropanoic acid, b.p. 68-70 °C / 0.1 mmHg; [aJo 
+28.6 “ (c 2.0 in CHCI3 ) (Lit.3°6,307 + 24 “, + 44.2 ° (neat)); (neat)/cm''' 
3000 br (COQÜ) and 1710 (COOHI: 6^ (300 MHz; CDCIg) 1.85 (3H. d, J  7 
Hz, 3-CHg), 4.40 (1H, q, J  7 Hz, 2-CH) and 9.65 (1H, s br, COgH); Sg (75.47 
MHz; CDCIg) 21.26 (C-3), 39.34 (C-2) and 175.88 (COgH); m/z (El) 153 {M  
+, 25 %), 152 (26, [M  - H]+), 108 (56, [M  - COaHH, 73 (51, [M  - Br]+), 55 
(22, [M  - BrOH]+), 45 (73, CO2 H+) and 28 (100, [M  - BrC2H]+).
(R1-Methvl-2-Bromopropanoate 11831
Br
COglVIe
CH,
To an ethereal solution of (2R)-bromopropanoic acid (5.0 g, 33 mmol) was 
slowly added an ethereal solution of diazomethane until the solution
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remained permanently yellow. The excess diazomethane and solvent were 
removed in vacuo to give a pale yellow oil which was distilled from calcium 
hydride to give (R)-methyl-2-bromopropanoate as a colourless oil (4.18 g, 77 
%); [alo +69.1 ° (neat) (lit.,272 + 6 8 . 6  ° (neat)); D^ax (neat)/cm'^ 2920 (CH) 
and 1730 tOCOCHgl: 5h (300 MHz; CDCIg) 1.80 (3 H, d, J 8  Hz, 3-CHg), 
3.75 (3H, s, l-COgCHg) and 4.35 (1 H, q, J 8  Hz, 2-CH); 5c (75.47 MHz; 
CDCIg) 21.69 (3 -CHg), 39.76 (C-2 ) and 52.98 (COgCHg); m/z (El) 166 (M +, 
5 %), 135 (3, [M  - CHgO]+), 107 (27, [M  - CgHgOgM, 87 (41, [M  - Br]+), 59 
(39, C2 HgOg+), 43 (20, C2 HgO+), 27 (100, C2 Hg+) and 15 (70, CHg+).
t3S.6m -2.5-Dlmethoxv-3-tf2'R1-Methoxvcarbonvlethvl1-6-lsopropvl-3.6- 
DIhvdropvrazlne (186 a1
OMe
MeO'''’" ^ N
COpMe
(3R)-2,5-Dimethoxy-3-isopropyl-3,6-dihydropyrazine (0.5 g, 2.71 mmol) was 
placed in a two necked flask with side arm and dissolved in anhydrous THF  
(2 ml). Methyl (2R)-bromopropanoate (0.68 g, 4.07 mmol) in anhydrous THF  
(0.5 ml) was placed in the side arm. The apparatus was flushed with argon 
and the solution cooled to -95 °C, using an ethanol / liquid nitrogen bath with 
cryocool assistance, n- Butyl lithium (1.55 ml of a 2.0 M solution in hexane,
3.1 mmol) was added dropwise and the solution temperature was allowed to 
rise to -65 °C, causing the generation of the yellow bis- lactim ether anion. 
The solution was then cooled to -100 °C and the solution of methyl (2R)- 
bromopropanoate in THF added to the bis -lactim ether anion by turning the 
side arm. The resulting solution was stirred for 7 hours at -100 °C and was 
then allowed to warm up to room temperature. The solvent was removed in
2 0 0
1
vacuo, and the residual oil was partitioned between diethyl ether (10 ml) 
and potassium phosphate buffer (100 mM, pH 7.0; 10 ml). The organic 
phase was separated, and the aqueous phase extracted with diethyl ether (2 
X 10 ml). The combined organic phases were dried (MgSO^^) and then 
concentrated in vacuo to give a yellow oil containing both the required 
(3S,6R)-2,5-d im ethoxy-3-((2’R)-methoxycarbonylethyl)-6-isopropyl)-3,6- 
dihydropyrazine and the 2,5-dimethoxy-3-propionyl-6-isopropylpyrazine 
(0.81 g, 99 %). This material was partially purified by eluting from a short 
column of triethylamine-pretreated silica with 10 % diethyl ether / petroleum 
ether, to give an essentially pure mixture of the two major reaction products 
(0.53 g, 72 %). Column chromatography, on silica gel, eluting with 25 % 
diethyl ether /  petroleum ether, or on neutral alumina, eluting with 10 % 
diethyl ether / petroleum ether gave pure (3S,6R)-2,5-dimethoxy-3-((2'R)- 
methoxycarbonylethyl)-6-isopropyl)-3,6-dihydropyrazine as a colourless oil 
(0.25 g, 34 %), (Found: M +  270.1581. C13H22N2O4 requires 270.1580); 
[a]o +23.5 “ (c 1.0 in CHCI3) (111.295 + 24.6 ° (c 1.0 in CHCI3); (neat)/ 
cm-1 2970 (CH), 1734 (CO) and 1696 (CN); 5h (300 MHz; CDCI3) 0.70 and
1.03 (6H , 2d, J 7 Hz. 6 -CH(CJH3)2), 1.10 (3H , d, J 7 Hz, 3- 
(CH(CÜ3)C02CH3)), 2.25 (1H, dsp, J 3 and 7 Hz, 6-CJl(CH3)2), 2.99 (1H, 
dq, J  3 and 7 Hz, 3-(CJtl(CH3)C02CH3)), 3.67 (9H, s br, 2,5-OCH3, and 3- 
(CH(CH3)C02CH3), 3.96 (1H, t, J 3 Hz, 6-H) and 4.40 (1H, t. J  3 Hz, 3-H); 
8c (7 5 .4 7  MHz; CDC ig) 11.86 and 17.13 (6 -C H (£ .H 3)2 ), 19 .46  (3- 
(CH(£.H3)C02CH3)), 32.39 (6-£H(CH3)2), 43.74 (3-(C.H(CH3)C02CH3), 
49.98 (3-(CH(CH3)C02&H3), 52.09 and 52.89 (2 ,5-0CH 3), 58.26 (C-6), 
61.39 (C-3), 162.38 and 165.04 (2,5-OCN) and 174.30 (COgCHg); m/z (El) 
271 (M +, 55 %), 239 (8, [M - CH3OM, 227 (80, [M  - CH(CH3)2)+), 183 (28, 
[M  - C^HyOg]*) and 167 (100, [M - CgHi^OgM.
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(3 S .6R )-2 .5 -D ie th o xv -3 -»2 ’R VM ethoxvcarbonvlethvn-6-lsopropvl-3.6- 
Dihvdropvrazine (186 b)
OEt
CO2M6
This was prepared in an identicai manner to (3S,6R)-2,5-dimethoxy-3-((2’R)- 
methoxycarbonylethyl)-6-isopropyl)-3,6-dihydropyrazine (186 a) using the 
ethyl analogue (3R)-2,5-diethoxy-3-isopropyl-3,6-dihydropyrazine (182 b) 
(0.95 g, 5.1 mmol) as starting material, to give a yellow oil (1.25 g, 86 %) 
which was purified to give pure (3 S ,6 R )-2 ,5 -d ie th o x y -3 -((2 ’R )- 
methoxycarbonylethyl)-6-isopropyl)-3,6-dihydropyrazine as a colourless oil 
(0.29 g, 20 % ), (Found; (M  + H)+ 299.1971. C15H27N2O4 requires
299.1964): [a]o +16.0 ° (c 1.0 in CHCig); 5h (200 MHz; CDCl3)0.65 and 0.95 
(6H, 2d, J  8 Hz, 6-CH(CÜ3)2), 1.00 (3H, d, J  7 Hz, 3 -(CH(CÜ3)C02CH3)),
1.19 (6H, 2t, J  7 Hz, 2,5-0CH2CH3), 2.19 (1H, dsp, J  4 and 7 Hz, 6- 
CH(CH3)2), 2.89 (1H, dq, J  4 and 7 Hz, 3-(CJl(CH3)C02CH3), 3.60 (3H, s, 
3-(CH(CH3)C02CH3). 3.86 (1H, t, J  4 Hz, 6-H), 4.05 (4H, m, J 7 Hz, 2,5- 
OCM2CH3) and 4.35 (1H, t, J 4 Hz, 3-H); 5c (75.47 MHz; CDCI3) 9.98 and 
13.11 (6-CH(£LH3)2), 13.28 (CH(£.H3)C02CH3)), 15.79 and 17.96 (2,5- 
OCH2ÜH3), 31.09 (6-ilH(CH3)2), 42.55 (3-(£H(CH3)C02CH3), 50.53 (3- 
(CH(CH3)C02£H3), 56.61 (C-6), 59.77 (2,5-OÛH2CH3), 59.96 (0-3), 160.43 
and 163.02 (2,5-OCN) and 172.90 (ÛO2CH3); m/z (Cl) 299 ([/W - H]+, 100 
%), 271 (4. [M  - C2H3M, 255 (8, [M  - CH(CH3)2]+), 211 (4, [M - C^HyOgM, 
195 (5, [M -C s H , i0 2 n .
2 0 2
Isopropyl (2R)-2-BrQ.mQ.propanc>ate (212)
Br
CH;
203
■ J
(2R)-2-Bromopropanoic acid (3.0 g, 19.62 mmol) was dissolved in dry iso­
propanol (10 ml) and the solution cooled to 0 °C. Thionyl chloride (1.425 ml, 
58.86 mmol) was added slowly dropwise. The reaction was stirred at room 
temperature for 5 hours. This gave isopropyl bromopropanoate, and a 
chloro- or hydroxy-isopropyl ester of propanoic acid, in isopropanol. The 
excess isopropanol was removed by careful distillation, and the remaining 
traces of isopropanol were removed by column chromatography on silica 
gel, eluting with 10 % diethyl ether / petroleum ether. This gave isopropyl 
(2R)-2-brom opropanoate, which was inseparable from the chloro- or 
hydroxy- compound (2.57 g, 67 %); 6^ (200 MHz; CDGI3) 1.27 (6H, d, J  8 
Hz, (Cjl3)2CH), 1.80 (3H, d, J 8 Hz, 3-GH3), 4.33 (1H, q, J 8 Hz, 2-GH) and
5.05 (1H, q, J 8 Hz, (GH3)2GM); Ôq (50.3 MHz; GDGI3) 22.02 ((£H3)2GH), 
24.09 (3-GH3), 68.73 (2-GH) and 70.06 ((GH3)2<2H).
■'1
(3S.6RV2.5-DimethQxv-3-r(2'RVIsoDroDoxvcarbQnvlethvh-6-lsQPrQPvl-3...6.: 
Pi.hydfop.yrazi.qe (213)
.OMe
MeO CH
This was synthesized from (3R )-2 ,5 -d im e th o x y -3 -is o p ro p y l“3 ,6 -  
dihydropyrazine (0.25 g, 1.36 mmol) in an identical manner to (3S,6R)-2,5- 
dimethoxy-3-((2’R)-methoxycarbonylethyi)-6-isopropyl)-3,6“dihydropyrazine 
(166 a), using isopropyl (2R)-2-bromopropanoate as the alkylating agent, to 
give a yellow oil containing both the required (3S,6R)-2,5-d imethoxy-3- 
((2 ’R)-isopropoxycarbonylethyl)“6"isopropyl)-3,6-dihydropyrazine and the 
2,5-dimethoxy-3~propionyl-6-isopropylpyrazine (0.38 g, 95 %). This material 
was purified by column chromatography using triethylamine pretreated 
silica, eluting with 25 % diethyl ether / petroleum ether, to separate the 
required the (3S,6R)-2,5-d imethoxy-3-((2'R)-isopropoxycarbonylethyl)-6- 
isopropyl)-3,6-dihydropyrazine from the 2,5-dim ethoxy-3-propionyl-6- 
isopropylpyrazine. Further column chromatography on silica gel, eluting 
with 10 % diethyl ether / petroleum ether, separated the un reacted 
isopropylbromopropanoate and isopropylchloro- or hydroxy- propanoate 
from the (3S ,6R )-2 ,5-d im eth oxy-3-((2 ’R)-isopropoxycarbonylethyl)-6- 
isopropyl)-3,6-dihydropyrazine, to give (3S,6R)-2,5-d im ethoxy-3-((2’R)- 
isopropoxycarbonylethyl)-6-isopropyl)-3,6-dihydropyrazine as a colourless 
oil (0.05 g, 12 %), (Found: (M  + H )+ 299.1971. requires
299.1964); [aj^ -35.5 ° (c 1.0 in GHGI3): 6|_, (200 MHz; GDGI3) 0.71 and 0.93 
(6H , 2d, J 8 .5  Hz, 6-GH(GhL3)2), 1 0 7  (3H, d, J 8 .5  Hz, 3- 
(GH(GJl3)G02GH3), 1.25 and 1.26 (6H, 2d, J 8.5 Hz, G02GH(GJdo)2), 2.27 
(1H, dsp, J 4 and 8.5 Hz, 6-GH(GH3)2), 3.01 (1H, dq, J 4 and 8.5 Hz,
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3-(CH(CH3)C02CH3), 3.64 and 3.74 (6H, 2s, 2.5-OCH3S), 4.00 (1H, t, J 4 
Hz. 6 -H ), 4 .58  (1H . i. J  4 Hz, 3-H ) and 5.10 (1H , m, J  8 .5  Hz, 
C02C11(CH3)2); 5c (75.47 MHz; CDCI3) 9.89 and 16.57 (6-CH(£H3)2), 18.90 
(3 -{C H (£ .H 3)C 02C H 3)), 21.61 and 21.75 (C 02C H (£ .H 3)2), 31 .82  (6- 
ilH(CH3)2), 42.23 (3-(£IH(CH3)C02CH(CH3)2), 52.32 (2,5-OCH3), 57.35 (C- 
6), 60.81 (C-3), 67.46 (C02&H(CH3)2), 162.01 and 163.94 (2,5-OCN) and 
173.36 (CO); m/z (Cl) 299 {[M + H]+, 100 %), 255 (10, [M  - CH(CH3)2]+), 
239 (7, [M  - CH(CH3)20]+), 183 (12, [M  - C6H i,02]+) and 167 (7, [M  - 
C 5 H i ,0 2 n .
f2R1-f2-^H]-2-BromoproDanolc Acid (2Û3)
Br
| " 'y — -,^H '-'y^C O gH
CH,
This was prepared in an indentical manner to the unlabelled (2R )-2- 
bromopropanoic acid (185) using (2R)-[2-^H]-alanine (1.0 g, 11.3 mmol) as 
starting material. (2R)-[2-^H]-2-Bromopropanoic acid was obtained as a 
pale yellow oil (1.38 g, 81 %) which was distilled by short path distillation, 
under reduced pressure to give pure (2R)-[2-^H]-2-bromopropanoic acid, 
b.p. 68-70 °C / 0.1 mmHg; [a]Q +26.84 (c 2.0 in CHCI3); (neat)/cm“1 
3000 br (COQH) and 1710 (C 0 0H1: Ôh (200 MHz; CDCI3) 1.85 (3H, s, 3- 
CH3); ÔQ (75.47 MHz; CDCI3) 21.28 (C-3), 39.36 (C-2) and 175.90 (COgH); 
m/z (El) 154 (A4+, 30 %), 153 (29, [M - H]+), 109 (60, [M  - C O gH H , 74 (55, 
IM  - Br]+), 56 (24, [M  - BrOH]+), 45 (72, CO2H+) and 29 (100, [M  - 
BrCOgH]-^).
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(2m-Methvl-r2-2H]-2-Bromopropanoate (lâ â )
Br
2 H '"y ^ C 0 2 M e
CH.
This was prepared in an indentical manner to the unlabelled (2R)-methyl-2- 
bromopropanoate (183) using (2R)-[2-^H]-2-bromopropanoic acid (1.3 g, 8.4 
mmol) as starting material. (2R)-methyl-[2-2H]-2-bromopropanoate was 
obtained as a pale yellow oil which was distilled from calcium hydride to 
give a colourless oil (1.09 g, 77 %); [a]Q +8.74 ° (c 2.0 in CHCI3); o^ax 
(neat)/cm-1 1730 (OCOCH3): 5h (200 MHz; CDCI3) 1.82 (3H, s, 3-CH3) and 
3.78 (3H, S, I-CO2CH3); ÔC (75.47 MHz; CDCI3) 21.67 (3-CH3), 39.74 (C-2) 
and 52.96 (CO22.H3); m/z (El) 167 (M + , 5 %), 136 (2, [A4 - CH30J+). 108 
(25, [M  - C2H3O2M, 88 (43, [A4 - Br]+), 59 (37, C2H3O2+), 43 (20, C2H3O+), 
27 (100, C2H3+) and 15 (73, CH3+).
1206
'A
(2S.3S/R1-3-Methvlaspartic Acid (213)
HgN H
H - ) —
HOgC COgH
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Mesaconic acid (5 g, 38.5 mmol) was dissolved in water (5 ml) and ammonia 
solution added to adjust the pH to 9.0. The water was removed in vacuo to 
give the ammonium salt. This was redissolved in buffer (50 ml) containing 
0.2 M ammonium chloride, 20 mM magnesium chloride hexahydrate and 10 
mM potassium chloride, and the pH readjusted to 9.0. 3-Methylaspartase 
(0.5 ml, 50 units) was added and the mixture incubated at 30 °C. The 
reaction was monitored by removing 0.5 ml aliquots at various time intervals, 
which were concentrated in vacuo, redissolved in deuterium oxide and their 
 ^H NMR spectra recorded. Further aliquots of enzyme were added as 
required, until approximately half the 3-methylaspartate produced was in the 
L-erythro -form. The enzyme was, then, denaturated by heating at 80 for 
several minutes, and filtered off. The filtrate was acidified to pH 1.0 with 
concentrated hydrochloric acid and extracted with diethyl ether (2 x 30 ml). 
The aqueous layer was concentrated in vacuo to give (2S ,3S /R )-3 - 
methylaspartic acid and buffer salts (3.98 g, 85.6 %); (200 MHz; DgO)
1.20 (3H, d, J  7.6 Hz, (2S,3S)-CH3), 1.31 (3H, d, J 7.6 Hz, (2S,3R)-CH3),
3.01 (2H, m, J  7.6 and 5.0 Hz, 3-H), 3.81 (1H, d, J 5.0 Hz, (2S,3R)-2-H) and
4.06 (1H, d, J  5.0 Hz, (2S,3S)-2-H).
N-CarbobenzQxv-(2S.3S/RV3-Methvlaspartic Acid (2M)
COpHHOgC
(2S,3S/R)-3-Methylaspartic acid (3.98 g, 27 mmoles) was dissolved in 
potassium carbonate solution (10 %, 100 ml). N-(Benzyloxycarbonyloxy)- 
succinimide (13.5 g, 54 mmol) was added, and the reaction stirred for 16
hours. The reaction mixture was extracted with dichloromethane (2 x 100
ml) and the aqueous layer acidified to pH 2.0 and extracted with ethyl 
acetate  (5 x 100 ml). The organic layer was dried (M gSO ^) and 
concentrated in vacuo to give a yellow oil (7.53 g, 99 %), (Found: [M + NH4 
- H20]+, 281.1137. [C13H15NO6 + NH4 - H20]+ requires 281.1137); o^ax 
(C H C y/cm -l 3100 (COOH1 and 1720 (COOH1: 8^ (200 MHz; CDCI3) 1.22 
and 1.28 (6H, 2d, J  7.6 Hz, 3-CH3), 3.00 (1H, m, J  5.0 Hz, (2S,3S)-3-H), 
3.33 (1H, m, J  5.0 Hz, (2S,3R)-3-H), 4.58 (2H, m. J  3.6 Hz, 2-H), 5.07 and 
5.10 (4H, 2s, ArCHg) 6.71 (2H, 2 br d, d 10.0 Hz, NHs) and 7.30 (10H, s, 
Ars); 5c (50.3 MHz; CDCI3) 13.77 and 14.03 (3-CH3S), 41.65 ((2S,3S)-C-3), 
42.52 ((2S ,3R )-C -3), 55.87 and 56.04 (C-2s), 67.98 (AraHgS), 128.54,
128.67 and 129.04 (Ars), 136.40 (ArQ.-1), 157.12 and 157.71 (OCONHs), 
175.09, 175.66 and 178.73, 179.19 (COgHs); nVz (El) 263 ([/W - HaO]*, 7 
%), 108 (47, PhCHaOH-*-), 107 (51, PhCH20+), 91 (100, PhCH2+), 44 (37, 
CO2+); m/z (Cl) 281 ([M + NH4- H20]+, 60 %), 263 (14, [M  + H - H20]+),
192 (16, [M  - C2O4H3+) and 57 (6, [M + H - PhC4H40e]+).
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N-Carbobenzoxv-(2S.3S/R)-3-Methylaspartic Acid Dimethyl Ester 12151
COpMeMeOgC
N-Carbobenzoxy-(2S,3S/R)-3-methylaspartic acid (7.53 g, 27 mmoles) was 
dissolved in diethyl ether (50 ml) and an ethereal solution of diazomethane 
was added slowly dropwise, until the solution remained permanently yellow. 
The excess diazomethane was removed by purging the solution with 
nitrogen and the solvent concentrated in vacuo to give a yellowish oil (8.12 
g, 98 %), (Found: M  + 309.1212. CisH^gNOg requires 309.1212);
(CHCl3)/cm-l 3420 (NH) and 1730 (CO); 6^ (200 MHz; CDCI3) 1.22 (3H, d, 
J  7.5 Hz, (2S,3S)-CH3), 1.27 (3H, d, J  7.5 Hz, (2S,3R)-CH3), 3.00 (1H, m,J 
4.0 Hz, (2S,3S)-3-H), 3.30 (1H, m, J 4.0 Hz, (2S,3R)-3-H), 3.67 and 3.74 (2 x 
6H, 2s, CO2CH3S), 4.58 (1H, m, J  4 Hz, (2S,3R)-2-H), 4.70 (1H, m, J  4 and 
5 Hz, (2S,3S)-2-H), 5.12 and 5.18 (2 x 2H, 2s, ArCHg), 5.55 (1H, br d, J  7.6 
Hz, (2S,3S)-NH), 5.70 (1H, br d, J  10.0 Hz, (2S,3R)-NH) and 7.35 (10H, s, 
Ar); 8c (50.3 MHz; CDCI3) 12.29 ((2S,3S)-3-CH3), 14.19 ((2S,3R)-3-CH3),
41 .62  ((2S ,3S )-C -3 ), 41.80 ((2S ,3R )-C -3), 51.76 and 52.22  ((2S ,3S )- 
C02£H3S), 52.62 and 53.15 ((2S,3R)-C02£.H3), 55.44 ((2S,3S)-C-2), 56.34  
((2S ,3R )-C -2), 66.70 ((2S ,3S)-A rüH 2), 67.67 ((2S,3R )-A rnH 2), 127.70, 
127.79, 128.12 and 135.83 ((2S,3S)-Ar), 128.53, 128.69, 129.02 and 136.66 
((2S,3R)-Ar), 155.56 ((2S,3S)-OCONH), 157.13 ((2S,3R)-OCONH), 170.67 
and 173.08 ((2S,3S)-C.02CH3S), 171.70 and 174.67 ((2S,3R)-aÛ2CH3S); 
m/z (El) 309 (M +, 8 %), 250 (19, [M - C2H3021+), 206 (31, [M  - C3H304]+) 
174 (7, [A4 - PhCH2C02]+), 108 (41, PhCH20H+) and 91 (100, PhCH2+).
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N-Carbobenzoxv-f2S.3R>-3-MethvlasDartic Acid Dimethyl Ester (217)
rCOpMeMaOgC
N-Carbobenzoxy-{2S,3S/R)-3-methylaspartic acid dimethyl ester (1 g, 3.4 
mmoles) was dissolved in diethyl ether and adsorbed onto silica (tic grade), 
this was applied to a silica chromatography column and eluted with 50 % 
diethyl ether /  petroleum ether. N-Carbobenzoxy-(2S,3R)-3-methyiaspartic 
acid dimethyl ester was eluted first (0.35 g, 35 %); (Found: A4 + 309.1212. 
CigH^gNOg requires 309.1212); (CHCl3)/cm-l 3420 (NH) and 1730 
(CO); 5h (200 MHz; CDCI3) 1.27 (3H, d, J  7.5 Hz, 3-CH3), 3.30 (1H, m, J  4.0 
Hz, 3-H), 3.67 and 3.74 (2 x 3H, 2s, COgCHgS), 4.58 (1H, m, J  4 Hz, 2-H), 
5.18 (2H, s, PhCHg), 5.70 (1H, br d, J  10.0 Hz, NH) and 7.35 (5H, s, Ar); §c 
(50.47 MHz; CDCI3) 14.19 (3-CH3), 41.80 (C-3), 52.62 and 53.15 (CO2ÜH3), 
56.34 (C-2), 67.67 (Ar£H2), 128.53, 128.69, 129.02 and 136.66 (Ar), 157.13 
(OCONH), 171.70 and 174.67 (C.O2CH3S); m/z (El) 309 (A4+, 8 %), 250 (19, 
[A4 - C2H302J+), 206 (31, [A4 - C3H304]+) 174 (7, [A4 - PhCH2C02)+), 108 
(41, PhCH20H+) and 91 (100, PhCH2+).
2 1 0
(2S.3R)-3“Methy{aspai1ic Acid (111)
HgN 4M
H"y ^ C H s
HOgC COgH
N-Carbobenzoxy-(2S,3R)-3-methylaspartlc acid dimethyl ester (0.72 g, 2.33 
mmol) was refluxed in concentrated hydrochloric acid / glacial acetic acid (1 
: 1) (20 ml) for 2 hours. The solvent was removed in vacuo and the residue 
redissolved in water (20 ml), this was removed in vacuo to give the 
hydrochloride salt, free from excess hydrochloric acid. The residue was 
dissolved in the minimum volume of water and ammonia solution (0.11 ml,
2.3 mmol) was added. Addition of ethanol gave (2S,3R)-3-methylaspartic 
acid in the free amine form (0.19 g, 55 %), m.p. 257-259 °C (decomp.); 
(Found: C, 40.59; H, 6.44; N, 9.66. C5H9NO4 requires C, 40.81; H, 6.17; N, 
9.52.); (Found: (M  + H)+ 148.0610. C5H10NO4 requires 148.0610); [a]p 
+36.3 ° (C 1.0 in 5 M HCi) (ilt.,285 +38.7 “ (c 1.83 in 5 M HCi): iit.,288 +32.9 ° 
(c 0.8 In 5 M HCI)); 6^ (200 MHz; DgO) 1.26 (3H, d, J  7.5 Hz, 3-CH3), 3.13 
(1H, m, J  7.5 and 5.0 Hz, 3-H) and 3.95 (1H, d, J  5.0 Hz, 2-H); Sg (50.3 MHz; 
DgO) 15.72 (CH3), 42.78 (C-3), 58.99 (C-2), 175.25 and 180.13 (COgHs); 
m/z (Cl) 148 ([M + H]+, 100 %), 102 (20, [M  - C O aH H  and 58 (53, [M  - 
C204H1+).
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(2S.3S/R)-f3-£H1-3-MethvlasDarticAcid ( m )
HoN
H "^
HOgC COgH
Mesaconic acid (5 g, 38.5 mmol) was dissolved in deuterium oxide (5 ml) 
and ammonia solution added to adjust the pD to 8.6. The deuterium oxide 
was removed in vacuo to give the ammonium salt. The buffer salts 
(ammonium chloride (0.535 g, 10 mmol), magnesium chloride hexahydrate 
(0 .203 g, 1 mmol) and potassium chloride (37 mg, 0.5 mmol)) were 
dissolved in deuterium oxide and concentrated in vacuo twice before being 
redissolved in deuterium oxide (50 ml). The mesaconate diammonium salt 
was redissolved in the deuteriated buffer (50 ml, 0.2 M ammonium chloride, 
20 mM magnesium chloride hexahydrate and 10 mM potassium chloride) 
and the pD readjusted to 8.6 with sodium deutoxide. A portion of 3- 
methylaspartase enzyme solution (0.5 ml, 50 units) was diluted with 
deuterium oxide (2 ml) and lyophilysed. The residue was dissolved in 
deuterium oxide (0.5 ml) and added to the buffered substrate solution. The 
mixture was incubated at 30 °C. The reaction was monitored by NMR 
spectroscopy of 0.5 ml aliquots removed at various time intervals. Further 
aliquots of enzyme solution were added as required, until approximately one 
third of the [3-^H]-3-methylaspartic acid produced was present as the 
(2S,3R)-isomer. The enzyme was then denaturated by heating at 80 °C for 
several minutes, and filtered off. The filtrate was acidified to pD 1.0 with 
concentrated hydrochloric acid and extracted with diethyl ether (2 x 30 ml). 
The aqueous layer was concentrated in vacuo to give (2S,3S/R)-[3-^H]-3- 
methylaspartic acid (97 % deuteriated) and buffer salts (4.61 g, 81.1 %); 
(200 MHz; DgO) 1.20 (3H, s, (2S,3S)-CH3), 1.31 (3H, s, (2S,3R)-CH3), 3.81 
(1H, s, (2S,3R)-2-H) and 4.06 (1H, s, (2S,3S)-2-H).
2 1 2
,N:Q.a[b.QJaanzoxy-(2.S..3.S/R)“[3"^H]"3“Methy.{a§partic,Agid (22E)
COgHHOgC
This was synthesized in an Identical manner to that described for N- 
carbobenzoxy-(2S,3S/R)-3-methylaspartic acid (214), to give a yellow oil 
(8.75 g, 99.6 %), (Found: [M + NH4 - HgO]+ 282.1200. [CiaH^gNOg + NH4 - 
HgO]-*- requires 282.1200); Dmax(CHCl3)/cm-l 3100 (COOH1 and 1720 (CO); 
8h (200 MHz; CDGI3) 1.22 and 1.28 (6 H, 2s, 3-CH3S), 4.60 and 4.65 (2H, 
2d, J 5.0 Hz, 2-Hs), 5.08 and 5.11 (4H, 2s, ArCHgS) 6.91 and 6.98 (2H, 2d, 
J  5.0 Hz, NHs) and 7.30 (10H, s, Ars); 8c (50.3 MHz; CDCI3) 13.71 and 
13.96 (3-CH3S), 56.00 (0-2s), 67.98 (Ar^HgS), 128.54, 128.77 and 129.04 
(Ars), 136.32 (Ar-C-1), 157.01 and 157.70 (OCONHs), 175.02 and 175.65, 
178.71 and 179.21 (COgHs); m/z (Cl) 282 ([A4 + N H 4- H20]+, 10 %), 264 
(20, [A4 + H - HgOD, 220 (12, [A4 + H - CHgOgM, 108 (100, PhCHgOH), 91 
(83. PhCHg), 58 (6, [A4 + H - PhC4H50g]+).
213
N-Carbobenzoxv-(2S.3S/R)-r3-^H1-3-MethvlasDai1ic Acid Dimethyl Ester 
(212)
COoMeMeOgC
This was synthesized in an identical manner to that described for N- 
carbobenzoxy‘ (2S,3S/R)-3-methylaspartic acid dimethyl ester (215), to give 
a yellowish oil (7.42 g, 78 %), (Found: [M  + H]+ 311.1353. C igH igDNOg  
requires 311.1353); (CHCl3)/cm'l 3420 (NH) and 1730 (CO); Sh (200 
MHz; CDCI3) 1.22 (3H, s, (2S,3S)-CH3), 1.27 (3H, s. (2S,3R)-CH3), and 3.76 
(2 x 6H, 2s, CO2CH3S), 4.58 (1H, d, J 10 Hz, (2S,3R)-2-H), 4.70 (1H, d, J 10 
Hz, (2S,3S)-2-H), 5.12 and 5.17 (2 x 2H, 2s, ArCJlz). 5.53 (1H, brd, J 10 Hz, 
(2S,3S)-NH), 5.71 (1H, br d, J 10 Hz, (2S,3R)-NH) and 7.35 (10H, s, Ar); 8c 
(50.3 MHz; CDCI3) 13.06 ((2S,3S)-3-CHg), 14.12 ((2S,3R)-3-CH3), 52.66 
and 53.14 ((2S,3S/R)-C02ÜH3S), 56.27 ((2S,3S/R)-C-2), 65.15 ((2S,3S)- 
A r^H g), 67 .66  ((2S,3R)-A r£.H2), 128.58, 128.70, 129.02 and 136.59  
((2S ,3S /R )-A r), 156.29 ((2S ,3S )-O C O N H ), 157.13 ((2S ,3R )-O C O N H ), 
171.43 and 171.71 ((2S,3S/R)-£02CH3S); m/z (El) 311 {[M + H]+, 8 %), 267 
(9, [M  + H - CO gH, 251 (5, [M  - COgCHgM, 207 (15, [M  - CgHgO^j^) 174 
(9, [M - PhCHgCOgn, 108 (11, PhCHgOH) and 91 (100, PhCHg); m/z (Cl) 
311 ([M + H]+, 100 %), 267 (59, [A4 + H - COgM, 251 (7, [M - COgCHgM, 
207 (27, [A4 - CgHgO^r), 108 (20, PhCHgOH) and 91 (77, PhCHg).
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N-Carboben20XV-(2 S.3 R)-f3 -^HV3 -Methvlaspartic Acid Dimethyl Ester {220.)
r COpMeMeOgC
This was prepared in an identical manner to N-carbobenzoxy-(2S,3R)-3- 
methylaspartic acid dimethyl ester (217) to give N-carbobenzoxy-(2S,3R)~[3- 
^H]-3-methylasparlic acid dimethyl ester (0.40 g, 40 %), (Found: [M  + H]+ 
311.1353. C igH igDNOg requires 311.1353);x>„,ax (C H C y/cm -l 3420 (NH) 
and 1730 (CO); Ôh (200 MHz; CDCIg) 1.27 (3H, s, 3-CHg), 3.70 and 3.76 (2 x 
3H, 2s, COgCHgS), 4.58 (1H, d, J  10 Hz, 2-H), 5.17 (2H, s, ArCHg), 5.71 (1H, 
brd, J  10 Hz, NH) and 7.35 (5H, s, Ar); 5g (50.3 MHz; CDCIg) 14.12 (3-CHg), 
52.66 and 53.14 (COgGHgS), 56.27 (C-2), 67.66 (ArdHg), 128.58, 128.70, 
129.02 and 136.59 (Ar), 157.13 (OCONH), 171.43 and 171.71 (GOaCHgS); 
m/z (El) 311 {[M + H]+, 8 %). 267 (9, [M  + H - COg]+), 251 (5, [M  - 
COgCHgM, 207 (15, [A4 - CangOJ-^) 174 (9, [M - PhCHgCOgM, 108 (11, 
PhCHgOH) and 91 (100, PhCHg); m/z (Cl) 311 ([A4 + H]+, 100 %), 267 (59, 
[A4 + H - COg]+), 251 (7, [A4 - COgCHgM, 207 (27, [A4 - C3Hg04]+), 108 (20, 
PhCHgOH) and 91 (77, PhCHg).
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(2S.3R)-[3-^H]-3-Methylaspartic Acid U £ l)
H,N 2H
HOaCf COgH
This was prepared in an identical manner to (2S,3R)-3-methyiaspartic acid 
(171) to give (2S,3R)-[3-8 H]-3-methyiaspartic acid in the free amine form 
(0.47 g, 34 %), m.p. 258-259 “C (decomp.) (Found C, 40.10; H, 6.46; N, 9.77. 
CgHgNO^D requires C, 40.54; H, 6.80; N, 9.46) (Found; [M  + H]+ 149.0673. 
CgHgDNO^ requires 149.0670); M e  +30.5 °; 5^(200 MHz; DgO) 1.25 (3H. s, 
3-CH3) and 3.92 (1H, s, 2-H); ôg (50.3 MHz; DgO) 15.63 (CH3), 58.91 (C-2), 
175.27 and 180.15 (COgHs); m/z (Cl) 149 ([A4 + H]+, 100 %), 131 (6, [A4 - 
OH]+), 103 (9, [A4 - C02H]+) and 59 (21, [A4 - C2H04J+).
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I
Determination of Kinetic Param.ete,r§
Values were obtained for and fo"" (2S,3R)-3-methylaspartic acid and 
(2S,3R)-[3-^H]-3-methylaspartic acid at 1 mM and 50 mM potassium ion 
concentrations with the enzyme 3-methylaspartase.
An aliquot (20 jil) of 3-methylaspartase solution was added to assay buffer 
(total volume 3 ml, pH 9.0) containing (2S,3S)-3-methylaspartic acid (4 mM), 
Tris (0.5 M), magnesium chloride hexahydrate (20 mM) and potassium 
chloride (1 mM) in a 3 ml quartz cuvette (10 mm pathlength) at 30 ±  0.1 °C. 
The increase in absorbance at 240 nm due to the production of mesaconic 
acid (e 3850 M"'* cm"^; pH 9.0) was monitored. One unit of enzyme is 
defined as the amount of enzyme that converts 1 jimole of (2S,3S)-3- 
methylaspartic acid to Ijimole of mesaconic acid in 1 minute^.
Solutions containing Tris (0.5 M, pH 9.0), magnesium chloride hexahydrate 
(20 mM), potassium chloride (1 mM) and (2S,3R)-3-methylaspartic acid (2.5,
8.0, 12.5, 20.0, 25.0, 35.0, 50.0 mM) were pre-equilibrated to 30 ±  0.1 °C. A 
0.3 ml aliquot was removed and placed in a quartz cell (path length 1 mm). 
3-Methylaspartase (ca. 0.35 units) was added to initiate the reaction which 
was followed spectrophotometrically at 240 nm, recording OD at 10 minute 
intervals. Each rate determination was performed in duplicate. Reactions 
were also followed using 1 ml aliquots in quartz cuvettes of 10 mm path 
length and ca. 2.3 units of enzyme. These reactions were followed 
continuously.
Similar reactions were monitored at 50 mM potassium ion concentration for 
(2S,3R)-3-methylaspartic acid concentrations between 1 and 10 mM and for 
(2S,3R )-[3-^H]-3-m ethylaspartic acid at 1 and 50 mM potassium ion 
concentrations. The rate data was analysed by a non-linear regression 
program^^® and by Lineweaver-Burk plots.
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Table 5.1 - Rate Data for the Deamination of (2S.3R)-3-MethvlasDartic Acid
at 1 mM Potassium Chloride Concentration
Substrate concentration (mM) Rate (moi dm*8 min'^)
5 0 1 . 7 2 2  X 1 0 -5
5 0 1 . 6 9 2  X 1 0 -5
3 5 1 . 2 9 6  X 1 0 -5
3 5 1 . 3 4 4  X  1 0 -5
2 5 1 . 3 1 9  X 1 0 -5
2 0 9 . 5 3 6  X 1 0 - 5
2 0 9 . 5 3 6  X  1 0 -5
1 2 . 5 7 . 1 8 5  X 1 0 -5
1 2 . 5 7 .4 5 1  X 1 0 -5
8 6 .9 0 1  X 1 0 -5
8 7 . 0 6 7  X 1 0 - 5
2 . 5 1 . 5 9 7  X 1 0 -5
2 . 5 1 . 5 9 7  X 1 0 -5
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Table 5.2 - Rate Data for the Deamination of (2S.3RV3-MethvlasDartic Acid
at 50 mM Potassium Chloride Concentration
Substrate concentration (mM) Rate (moi dm'^ min'^)
1 0 2 . 5 7 3  X  1 0 -5
1 0 2 . 6 7 7  X 1 0 -5
8 2 . 0 7 9  X  1 0 -5
8 2 .8 8 1  X  1 0 -5
6 2 . 4 8 4  X  1 0 -5
6 2 . 2 2 8  X  1 0 - 5
4 1 . 7 3 4  X  1 0 -5
4 1 . 7 6 6  X 1 0 -5
2 1 . 1 6 7  X  1 0 -5
2 1 . 1 3 7  X  1 0 -5
1 5 . 8 3 2  X 1 0 - 6
1 5 . 5 3 6  X  1 0 - 6
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Table 5.3 - Rate Data for the Deamination of (2S.3RVr3-^H1-3-MethvlaBpartic
Acid at 1 mM Potassium Chloride Concentration
Substrate Concentration (mM) Rate (mol dm“^  min"^)
1 0 8 . 3 5 9  X  1 0 - 7
1 0 8 . 2 3 0  X  1 0 - 7
8 6 . 7 2 6  X 1 0 - 7
8 7 . 3 8 9  X 1 0 - 7
6 4 . 8 7 3  X  1 0 - 7
6 7 .0 7 1  X 1 0 - 7
4 4 .9 8 1  X 1 0 - 7
4 4 . 2 9 2  X 1 0 - 7
2 1 . 9 0 3  X 1 0 -7
2 1 . 6 4 2  X 1 0 - 7
1 1 . 0 2 6  X 1 0 - 7
1 1 . 1 6 2  X  1 0 - 7
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Table 5.4- Rate Data forlhe_DeamlnatiQn of (2S.3R)-[3r^H)-3j^ethvlasDartic
Acid at 50 mM Potassium Chloride Concentration
Substrate Concentration (mM) Rate (mol dm'^ mim^)
1 0 4 . 6 1 3  X 0 - 6
1 0 4 . 6 7 5  X 0 - 6
8 4 . 2 3 6  X 0 - 6
8 4 . 1 8 8  X 0 -6
6 3 . 8 7 9  X 0 -6
6 4 . 1 1 0 X 0 -6
4 3 .6 4 1  X 0 - 6
4 3 . 3 7 9  X 0 - 6
2 2 . 2 3 4  X 0 - 6
2 2 .2 6 1  X 0 -6
1 1 . 4 3 2  X 0 - 6
1 1 . 3 3 6  X 0 -6
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Following the Deamination of (2S.3R)-3~MethvlasDartic Acid and .ï28.3Hh[a:
^H]-3-Methvlaspartic Acid bv iR  NMR SpectmsooDV
(2S,3R)-3-Methylaspartic acid (5 mg, 34 mmol) was dissolved in imidazole 
buffer (1 ml, 50 mM, pH 9.0) containing magnesium chloride hexahydrate 
(20 mM) and potassium chloride (1 mM) and concentrated in vacuo. The 
residue was dissolved in deuterium oxide (1 ml), the pD readjusted to 8.6 
and the solution reconcentrated in vacuo. The residue was once again 
dissolved in deuterium oxide (1 ml). A 1H NMR spectrum was recorded at 
T = 0 and 3-methylaspartase solution (ca. 5 units) added. Spectra were 
recorded at one hourly time intervals for 15 hours. One reaction was also 
performed in Tris buffer to confirm that there was no buffer effect.
Similar experiments were performed with (2S,3R)-[3-^H]-3-methylaspartic 
acid (5 mg, 34 mmol).
A competition experiment containing deuteriated material (5 mg, 34 mmol) 
and non-deuteriated material (5 mg, 34 mmol) in imidazole buffer, as above, 
was also performed.
Equilibrium Measurements
(2S,3 R)-3-Methylaspartic acid (0.25 mM solution in 0.5 M Tris buffer at pH
9.0, containing 20 mM magnesium chloride and 1 mM potassium chloride, 3 
ml) was incubated with 3-m ethylaspartase (4 units), at 30 °C, until 
equilibrium was reached. Similar incubations were also carried out at 50 
mM potassium chloride concentration. The experiment was repeated with 
(2S,3R)-[3-^H]-3-methylaspartic acid. The equilibrium position for all four 
incubations was identical, within experimental error, at 0.95.
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Double Isotope Fractionation Experiments
(2S,3R)-3-Methylaspartic acid (50 mg) was incubated in buffer solution (0.5 
M Tris at pH 9.0 containing 20 mM magnesium chloride and 1 mM 
potassium chloride, 2 ml) with 3-methylaspartase (22 units). The reaction 
was followed by removing aliquots (20 pi) at various time intervals. These 
were added to buffer solution (0.5 M Tris at pH 9.0 containing 20 mM 
magnesium chloride and 1 mM potassium chloride, 3 ml) and the optical 
density at 240 nm measured. When 20 % conversion to mesaconic acid had 
occurred the reaction was quenched by the addition of concentrated 
hydrochloric acid (120 pi). The incubations were performed in a closed 
system to prevent escape of ammonia. Once the ammonium chloride 
produced in the quenching reaction had been absorbed into the solution, 
the samples were transferred to vials and freeze dried. The samples were 
then sent to Prof. A Jackson at the University of Southampton who distilled 
the ammonia produced by the deamination of (2S,3R)-3-methylaspartic acid 
into dilute sulphuric acid. The ammonia was then oxidised to dinitrogen 
using hypobromite. The ratio was determ ined by mass
spectrometry.
The /  ■'^ N ratio at the beginning of the reaction was determined by 
Kjeldahl digestion of a sample of the substrate. To (2S,3R)-3-methylaspartic 
acid (10-15 mg) was added potassium sulphate (0.3 g), concentrated 
sulphuric acid (1.2 ml), mercury sulphate (0.3 ml) (made by dissolving red 
mercuric oxide (2.5 g) in concentrated sulphuric acid (3 ml) diluted to 25 ml) 
and anti-bumping granules. The reaction mixture was boiled for 2 hours, 
during which time it went clear. The solution was then cooled to room 
temperature and water (5 ml) added, after re-cooling, zinc dust (0.12 g) was 
added. The mixture was left for 30 minutes. The zinc was then filtered off 
and the resulting solution concentrated by freeze drying. These samples 
were sent to Prof. Jackson, who again extracted the ammonia, oxidised it to 
dinitrogen and measured the nitrogen isotope ratio.
The experiments were repeated with (2S,3R)-[3-^H]-3-methylaspartic acid.
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Table 5.5 Isotope Data from Kjeldahl Digestions and,Incubations of 
(2S.3R)“aiMethyla§pajll.c.Acîd
Sample Atoms % XS f '•^(V/K)
(relative to standard 0.3663)
Kjedahl digestion 1 -0.0045
Kjedahl digestion 2 -0.0025
Kjedahl digestion 3 +0.0010
Kjedahl digestion 4 +0.0009
Kjedahl digestion 5 +0.0004
Kjedahl digestion 6 +0.0003
Incubation 1 -0.0050 0.250 1.0048
Incubation 2 -0.0022 0.207 0.9960
Incubation 3 -0.0015 0.214 1.0076
Incubation 4 -0.0011 0.207 1.0063
Incubation 5 -0.0001 0.192 1.0014
Incubation 6 +0.0002 0.208 1.0005
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Table 5.6 Isotope Data from Kleldahl Digestions and Incubations of 
(2S.3R)-[3-^Hl-3-MethvlaspartlaAcld
Sample Atoms % XS
(relative to standard 0.3663)
1 5 (V/K)
Kjedahl digestion 1 +0.0016
Kjedahl digestion 2 +0.0001
Kjedahl digestion 3 -0.0015
Kjedahl digestion 4 -0.0018
Kjedahl digestion 5 -0.0017
Kjedahl digestion 6 -0.0033
Incubation 1 -0.0020 0.195 1.0087
Incubation 2 -0.0019 0.193 1.0084
Incubation 3 -0.0028 0.198 1.0035
Incubation 4 -0.0025 0.192 1.0026
Incubation 5 -0.0026 0.175 1.0003
Incubation 6 -0.0013 0.165 0.9964
The ^^(V/K) effects for the deamination of (2S,3R)-3-methylaspartic acid and 
(2S,3R)-[3-^H]-3-methylaspartic acid were calculated using the following 
equation, where R is the isotope ratio in the ammonia after the fraction of the 
reaction, f, has occurred (approx. 20 %) and Rq is the isotope ratio in the 
substrate.
15(V/K) = log (1 - f ) / log [1 - (fR /Rq )]
The following nitrogen isotope effects are the averaged values. For the 
deamination of (2S,3R)-3-methylaspartic acid, ^^(V/K) = 1.0028 ±  0.0040, 
and for the deamination of (2S,3R)-[3-^H]-3-methylaspartic acid ^^(V/K) =
1.0033 ±  0.0043
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Prolonged Incubation of Fumaric Acid with 3-Methvlaspartase
Fumaric acid (1 g, 3.2 mmol) was dissolved in deuterium oxide (5 ml) and 
ammonia solution added to adjust the pD to 8.6 . The deuterium oxide was 
removed in vacuo to give the ammonium salt. The buffer salts (ammonium 
chloride (0.21 g, 4 mmol), magnesium chloride hexahydrate (81 mg, 0.4 
mmol) and potassium chloride (15 mg, 0.2 mmol)) were dissolved in 
deuterium oxide and concentrated in vacuo twice before being redissolved 
in deuterium oxide (20 ml). The diammonium fumarate was redissolved in 
the deuteriated buffer (20 ml, 0.2 M ammonium chloride, 20 mM magnesium 
chloride hexahydrate and 10 mM potassium chloride) and the pD readjusted 
to 8.6 with sodium deutoxide. A portion of 3-methylaspartase solution (0.1 
ml, 10 units) was diluted with deuterium oxide (1 ml) and lyophilysed. The 
residue was dissolved in deuterium oxide (0.1 ml) and added to the buffered 
substrate solution. The mixture was incubated at 30 °C for many days.  ^H 
NMR spectra were recorded for 0.5 ml aliquots of the incubation mixture at 
various time intervals.
Prolonaed Incubation of Elhvlfumaric Acid with 3-Methvlaspartase
Ethylfumaric acid (100 mg, 0.7 mmol) was dissolved in water (5 ml) and 
concentrated ammonia solution added to adjust the pH to 9.0. The water 
was removed in vacuo to give the ammonium salt. This was redissolved in 
buffer (5 ml) containing ammonium chloride (50 mg, 0.93 mmol), magnesium 
chloride (20 mg, 0.1 mmol) and potassium chloride (3.75 mg, 0.05 mmol) 
and the pH readjusted to 9.0 with concentrated ammonia solution. 3- 
Methylaspartase (0.1 ml, 10 units) was added and the mixture incubated at 
30 °C for many days. ^H NMR spectra were recorded on 0.5 ml aliquots of 
the incubation mixture, which had been concentrated in vacuo and 
redissolved in deuterium oxide, at various time intervals.
226
REFERENCES
1. H. A. Barker, Enzymologia, 1937, 2 ,175 .
2. H. A. Barker, in ‘The Bacteria,’ ed. I. C. Gunsalus and R. Y. Stanier,
Academic Press, New York, 1961, vol. 2 , Ch. 3.
3. H. Ohmori, H. Ishitani, K. Sato, 8 . Shimizu and S. Fukui, Biochem.
Biophys. Res. Comm., 1971, 4 3 ,1 5 6 .
4. H. Ohmori, H. Ishitani, K. Sato, S. Shimizu and S. Fukui, Agr. Biol.
Chem., 1 9 74 ,38 ,359 .
5. M. Roehr, Naturwissenschaften, 1961, 4 8 ,4 7 8 .
6. M. E. Maragoudakis, Y. Sekizawa, A. Baich, T. E. King and V. H.
Cheldin, Chim. Chronika, 1963, 2 8 ,3 3 .
7. S. Greenfield and G. W. Claus, J. BactehoL, 1 9 72 ,11 2 ,1 2 9 5 .
8 . H. A. Barker, V. Rooze, F. Suzuki and A. A. lodice, J. Biol. Chem.,
1964, 2 3 9 ,3 2 6 0 .
9. H. A. Barker, R. D. Smyth, R. M. Wilson and H. Weissbach, J. Bioi.
Chem., 1 9 59 ,2 3 4 ,3 2 0 .
10. C. C. Wang and H. A. Barker, J. Biol. Chem., 1969, 2 4 4 , 2516.
11. W. Buckel and A. Bobi, Eur. J. Biochem., 1976, 6 4 , 255.
12. J. T. Wachsman and H. A. Barker, J. Biol. Chem., 1955, 2 1 7 , 695.
13. J. T. Wachsman, J. Bioi. Chem., 1956, 2 2 3 ,1 9 .
14. A. Munch-Petersen and H. A. Barker, J. Biol. Chem., 1958, 2 3 0 , 649.
15. H. A. Barker, in ‘Reflections on Biochemistry,’ ed. A. Kornberg, B. L. 
Horecker, L. Cornudella and J. Oro, Academic Press, New York, 1976, 
p. 75.
16. H. A. Barker, R. D. Smyth and R. M. Wilson, Fed. Proc., 1 9 5 8 ,1 7 ,1 8 5 .
17. H. A. Barker, R. D. Smyth and H. J. Bright, Biochem. Prep., 1961, 8 ,
89.
18. H. R. Whiteley, J. Bacteriol., 1957, 7 4 , 324.
19. D. F. Horler, D. W. S. Westlake and W. B. McConnell, Can. J. 
Microbiol., 1966 ,12 , 1247.
20. W. M. Johnson and D. W. S. Westlake, Can. J. Biochem., 1969, 4 7 ,
1103.
21. W. Buckel and S. L. Miller, Eur. J. Biochem., 1 9 8 7 ,1 6 4 , 565.
22. W. Buckel and H. A. Barker, J. Bacteriol., 1974 ,11 7 ,1 2 4 8 .
23. J. G. Hauge, T. E. King and V. H. Cheldin, J. Biol. Chem., 1955, 2 1 4 ,
11 .
227
24. Y. Sekizawa, M. E. Maragoudakis, S. S. Kerwar, M. Flikke, A. Baich, T. 
E. King and V. E. Cheldelin, Biochem. Biophys. Res Commun., 1962, 
9 ,3 6 1 .
25. M. E. Maragoudakis, Y. Sekizawa, T. E. King and V. H. Cheldin, 
Biochemistry, 1966 ,5 , 2646.
26. K. Kato, M. Hayashi and T. Kamikubo, Biochim. Biophys. Acta, 1968, 
1 6 5 ,2 3 3 .
27. R. Mazumder and S. Ochoa, Methods EnzymoL, 1 9 6 9 ,1 3 ,1 9 8 .
28. H.-F. Kung, S. Cederbaum, L. Tsai and T. C. Stadtman, Proc. Nat. 
Acad. Sci. U.S.A., 1970, 6 5 , 978.
29. H. A. Barker, Methods EnzymoL, 1985 ,1 1 3 ,121.
30. G. Brendel, J. Retey, D. M. Ashworth, K. Reynolds, F. Willenbrock and 
J. A. Robinson, Angew. Chem. Int. Ed. Engl., 1988, 2 7 , 1089.
31. H. A. Lee Jr. and R. H. Abeles, J. Biol. Chem., 1963, 238, 2367.
32. K. L. Smiley and M. Sobolov, Arch. Biochem. Biophys., 1962, 97, 538.
33. C. Bradbeer, J. Biol. Chem., 1965, 240, 4675.
34. T. C. Stadtman and P. Her\z, Arch. Biochem. Biophys., 1 9 6 8 ,1 2 5 ,
226.
35. E. E. Dekker and H. A. Barker, J. Biol. Chem., 1968, 243, 3232.
36. T. C. Stadtman and L. Tsai, Biochem. Biophys. Res. Commun., 1967,
2 8 ,2 9 0 .
37. J. K. Dyer and R. N. Costilow, J. Bacteriol., 1 9 70 ,10 1 , 77.
38. Y. Tsuda and H. C. Friedman, J. Biol. Chem., 1970, 245, 5914.
39. J. M. Poston, J. Biol. Chem., 1976, 251 , 1859.
40. E. Vitiols, C. Brownson, W. Gardiner and R. L. Blakiey, J. Biol. Chem.,
1967, 2 4 2 ,3 0 3 5 .
41. D. Dolphin, in '8 2^% D. Dolphin, Wiley-lnterscience, 1982, p. v.
42. W. P. Murphy and G. R. Minot, J. Am. Med. Assoc., 1926, 87, 470.
43. E. L. Rickes, N. G. Brink, F. R Koniuszy, T. R. Wood and K. Folkes, 
Science, 1 9 48 ,10 7 , 396.
44. E. L. Smith and L. F. J. Parker, Biochem. J., 1948, 43, viii
45. D. C. Hodgkin, J. Pickworth, J. H. Robertson, K. N. Trueblood, R. J.
Prosen, J. G. White, R. Bonnet, J. R. Cannon, A. W. Johnson, I. 
Sutherland, A. Todd, E. L. Smith, Nature, 1955, 1 7 6 , 325.
46. H. A. Barker, H. Weissbach and R. D, S myth, Proc. Nat. Acad. Sci.
228
U.S.A, 1958, 4 4 , 1093.
47. H, A. Barker, R. D. Smyth, H. Weissbach, A. Munch-Petersen, J. I. 
Toohey, J. N. Ladd, B. E. Volcani and R. M. Wilson, J. Biol. Chem., 
1960, 2 3 5 ,1 8 1 ,
48. P. G. Lenhert and D. C. Hodgkin, Nature, 1961 ,192, 937.
49. B. M. Babior, Ago. Chem. Res., 1975,8, 376.
50. J. M. Pratt, Chem. Soc. Rev., 1985, 161.
51. R. H. Abeles and D. Dolphin, Ago. Chem. Res., 1976, 9 ,1 1 4 .
52. H. P. 0 . Hogenkamp, S/oc/7em/sfry, 1966,5, 417.
53. J. Retey, Anpew. Chem. Int. Ed. Engl., 1990, 29, 355.
54. J. Halpern, Science, 1985, 2 2 7 , 869.
55. J. E. Valinsky, R. H. Abeles and J. A. Fee, J. Am. Chem. Soc., 1974,
96, 4709.
56. S. A. Cockle, H. A. O. Hill, R. J. P. Williams, S. P. Davies and M. A. 
Foster, J. Am. Chem. Soc., 1972, 94, 275.
57. B, M. Babior and D. C. Gould, Biochem. Biophys. Res. Commun., 
1970, 3 4 ,4 4 1 .
58. B. M. Babior, T. H. Moss and D. C. Gould, J. Biol. Chem., 1972, 247, 
4389.
59. G. R. Buettnerand R. E. Coffman, Biochim. Biophys. Acta, 1977, 480, 
495.
60. Y. Zhao, P. Such and J. Retey, Anpew. Chem. Int. Ed. Engl., 1992, 
3 1 ,2 1 5 .
61. U. Leutbecher, S. P. J. Albracht and W. Buckel, FEBS Lett, 1992, 
3 0 7 ,1 4 4 .
62. B. M. Babior, T. H. Moss, W. H. Orme-Johnson and H. Beinert, J. Biol. 
Chem., ^974, 249,4537.
63. J. E. Valinsky, R. H. Abeles and A. S. Mildvan, J. Biol. Chem., 1974, 
2 4 9 ,2 7 5 1 .
64. P. A. Frey and R. H. Abeles, J. Biol. Chem., 1966, 241 , 2732.
65. B. M. Babior, J. Biol. Chem., 1969, 244, 449.
66. O. W. Wagner, H. A. Lee Jr., P. A Frey and R. H. Abeles, J. Biol. 
Chem., 1966, 241, 1751.
67. B. M. Babior, T. J. Carty and R. H. Abeles, J. Biol. Chem., 1974, 248,
1689.
229
68. M. Flavin, P. J. Ortiz and S. Ochoa, Nature, 1955 ,175, 823.
69. M. Flavin and S. Ochoa, J. Biol. Chem., 1957, 229, 965.
70. J. Retey, in 'B12’, ed. D. Dolphin, Wiley-lnterscience, 1982, vol. 2 , ch. 
13, p. 359.
71. S. H. G. Allen, R. W. Kellermeyer, R. Stjernholm and H. G. Wood, J. 
Bacteriol., 1964, 8 7 , 171.
72. H. G. Wood, H. Lochmuller, C. Riepertinger and F. Lynen, Biochem.
Z , 1 9 6 3 ,3 3 7 ,2 4 7 .
73. J. J. B. Cannata, A. Focesi Jr., R. Mazumder, R. C. Warneer and S. 
Ochoa, J. Biol. Chem., 1965, 240, 3249.
74. B. Zagalak, J. Retey and H. Sund, Eur. J. Biochem., 1974 ,44, 529.
75. R. W. Kellermeyer, S, H. G. Allen, R. Stjernholm and H. G. Wood, J. 
Biol. Chem., 1964, 239, 2562.
76. R. Mazumder and S. Ochoa, Methods EnzymoL, 1 9 6 9 ,1 3 ,1 9 8 .
77. H. Eggerer, P. Overath, F. Lynen and E. R, Stadtman, J. Am. Chem.
Soc., 1960 ,82 , 2643.
78. R. W. Swick, Proc. Nat. Acad. Sci. U. S. A.,1962, 42, 288.
79. R. W. Kellermeyer and H. G. Wood, Biochemistry, 1962 ,1 , 1124.
80. E. F. Phares, M. V. Long and S. F. Carson, Biochem. Biophys. Res.
Commun., 1962, 8 ,142 .
81. M. Sprecher, M. Y. Clark and D. B. Sprmson, Biochem. Biophys. Res. 
Commun., 1964 ,15 , 581.
82. J. Retey, E. H. Smith and B. Zagalak, Eur. J. Biochem., 1978 ,83, 437.
83. J. Retey and B. Zagalak, Angew. Chem. Int. Ed. Engl., 1 9 73 ,12 , 671.
84. H. A. Barker, Ann. Rev. Biochem., 1972, 41 , 55.
85. R. L. Switzer, in 'B12', ed. D. Dolphin, Wiley-lnterscience, 1982, vol. 2 , 
ch. 11, p. 291.
86. H. A. Barker, F. Suzuki, A. A. lodice and V. Rooze, Ann. N. Y. Acad. 
Sc/., 1964, 112, 644.
87. R. L. Switzer and H. A. Barker, J. Biol. Chem., 1967, 242, 2658.
88. F. Suzuki and H. A. Barker, J. Biol. Chem., 1966, 241 , 878.
89. U. Leutbecher, R. Bocher, D. Linder and W. Buckel, Eur. J. Biochem.,
1992, 2 0 5 ,7 5 9 .
90. E. N. G. Marsh and D. E. Holloway, FEBS Lett, 1992, 310, 167.
91. D. E. Holloway and E. N. G. Marsh, FEBS Lett., 1993, 317, 44.
230
92. M. Brecht, J. Kellermann and A. Pluckthun, FEBS Lett, 1993, 3 1 9 , 84.
93. A. G. Lezius and H. A. Barker, Biochemistry, 1965, 4 , 510.
94. J. I. Toohey, D. Perlman and H. A. Barker, J. Bioi. Chem., 1969, 2 3 6 ,  
2119.
95. Y. Uchida, M. Hayashi and T. Kamikubo, Vitamines, 1975, 4 9 ,1 9 .
96. M. Sprecher, R. L. Switzer and D. B. Sprinson, J. Biol. Chem., 1966, 
2 4 1 ,8 6 4 .
97. R. G. Eagar, B. G. Baltimore, M. M. Herbst, H. A. Barker and J. H. 
Richards, Biochemistry, 1972,11 , 253.
98. R. L. Switzer, B. G. Baltimore and H. A. Barker, J. Biol. Chem., 1969, 
2 4 4 , 5263.
99. G. Hartrampf and W. Buckel, FEBS Lett.,^ 9 8 4 ,1 7 1 ,7 3 .
100. H. F. Kung and T. C. Stadtman, J. Biol. Chem., 1971, 2 4 6 , 3378.
101. L. Tsai and E. R. Stadtman,Methods EnzymoL, 19 71 ,18 , 233.
102. G. Michel, G. Hartrampf and W. Buckel, Eur. J. Biochem., 1 9 8 9 ,1 8 4 , 
103.
103. G. Michel and W. Buckel, FEBS Lett., 1 9 91 ,28 1 ,1 0 8 .
104. G. Hartrampf and W. Buckel, Eur. J. Biochem., 1 9 8 6 ,1 5 6 , 301.
105. R. H. Abeles, A. M. Brownstein and C. H. Randles, Biochem. Biophys.
Acta, 1 9 60 ,41 ,531 .
106. T. Toraya, T. Shirakashi, T. Kosuga and S. Fukui, Biochem. Biophys. 
Res. Commun., 1976, 6 9 , 475.
107. T. Toraya, E. Krodel, A. S. Mildvan and R. H. Abeles, B/oc/7em/sf/y, 
1 9 7 9 ,1 8 ,4 1 7 .
108. T. Toraya, K. Ushio, S. Fukui and H. P. G. Hogenkamp, J. Biol. Chem., 
1977, 2 5 2 ,9 6 3 .
109. A. A. Poznznskaja, K. Tanizawa, K. Soda, T. Toraya and S. Fukui, 
Arch. Biochem. Biophys., 1979 ,194 , 379.
110. M. K. Essenberg, P. A. Frey and R. H. Abeles, J. Am. Chem. Soc., 
1971, 9 3 , 1242.
111. T. Toraya, M. Uesaka, M. Kondo and S. Fukui, Biochem. Biophys.
Res. Commun., 1973, 5 2 ,3 5 0 .
112. T. Toraya, M. Uesaka and S. Fukui, Biochemistry, 1 9 74 ,13 , 3895.
113. T. Toraya and S. Fukui, Biochem. Biophys. Res. Commun., 1969 ,36 , 
469.
231
114. T. Toraya, M. Kondo, Y. Isemura and S. Fukui, Arc/?. Biochem. 
Biophys., 1 9 79 ,19 4 ,3 7 9 .
115. T. Toraya, Y. Sugimoto, Y. Tamao, S. Shimizu and S. Fukui, 
Biochemistry, 1971 ,10 , 3475.
116. R. G. Eagar Jr., W. W. Bachovchin and J. H. Richards, Biochemistry, 
1975, 14 ,5 5 23 .
117. W. W. Bachovchin, R. G. Eagar Jr., K. W. Moore and J. H. Richards, 
Biochemistry, 1977 ,16 ,1082 .
118. B. Zagalak, P. A. Frey, G. L. Karabatsos and R. H. Abeles, J. Biol. 
Chem., 1966, 2 4 1 ,3 0 2 8 .
119. P. A. Frey, G. L. Karabatsis and R. H. Abeles, Biochem. Biophys. Res. 
Commun., 1965 ,18 , 551.
120. A. M. Brownstein and R. H. Abeles, J. Biol. Chem., 1961, 2 3 6 , 1199.
121. J. Retey, A. Umani-Rochi, J. SeibI and D. Argoni, Experimentia, 1966, 
2 2 ,5 0 2 .
122. J. E. Valinsky and R. H. Abeles, Arch. Biochem. Biophys., 1 9 7 5 ,1 6 6 , 
608.
123. Y. Tamao, Y. Morikawa, S. Shimizu and S. Fukui, Biochem. Biophys. 
Acfa, 1 9 68 ,1 5 1 ,2 6 0 .
124. T. Toraya, K. Ohashi, H. Ueno and S. Fukui, Bioinorg. Chem., 1975, 4
245.
125. T. Toraya and R. H. Abeles, Arch. Biochem. Biophys., 1980, 2 0 3 ,1 7 4 .
126. G. N. Schrauzer and J. W. Sibert, J. Am. Chem. Soc., 1970, 8 2 ,1 0 2 2 .
127. P. A. Frey, M. K. Essenberg, R. H. Abeles and S. S. Kerwar, J. Am.
Chem. Soc., 1970 ,92 , 4488.
128. C. Bradbeer, J. Biol. Chem., 1965, 2 4 0 , 4669.
129. B. H. Kaplan and E. R. Stadtman, J. Biol. Chem, 1968, 2 4 3 , 1787.
130. B. H. Kaplan and E. R. Stadtman, J. Biol. Chem, 1968, 2 4 3 , 1794.
131. O. C. Wallis, A. W. Johnson and M. F. Lappert, FEBS Lett., 1979, 97 ,
196.
132. B. M. Babior and T. K. Li, Biochemistry, 1969, 8,154.
133. J. Retey, C. J. Suckling, D. Arigoni and B. M. Babior, J. Biol. Chem., 
1974, 2 4 9 , 6359.
134. T. J. Carty, B. M. Babior and R. H. Abeles, J. Biol. Chem., 1974, 2 4 9 ,  
1683.
232
135. P. Diziol, H. Haas, J. Retey, S. W. Graves and B. M. Babior, Eur. J. 
Biochem., 1 9 80 ,10 6 , 221.
136. S. W. Graves, J. S. Krouwer and B. M. Babior, J. Biol. Chem., 1980, 
2 5 5 ,7 4 4 4 .
137. D. A. Weisblat and B. M. Babior, J. Biol. Chem., 1971, 2 4 6 , 6064.
138. S. W. Graves, J. A. Fox and B. M. Babior, Biochemistry, 1 9 80 ,19 , 
3630.
139. M. R. Hollaway, H. A White, K. N. Joblin, A. W. Johnson, M. F. Lappert 
and O. C. Wallis, Eur. J. Biochem., 1978, 8 2 ,1 4 3 .
140. B. M. Babior, Biochim. Biophys. Acta, 19 68 ,16 7 , 456.
141. B. M. Babior, J. Biol. Chem., 1970, 2 4 5 , 6125.
142. P. Y. Law, D. G. Brown, E. L. Lein, B. M. Babior and J. M. Wood, 
Biochemistry, 1971 ,10 , 3428.
143. B. Babior, in 'B^2% ed. D. Dolphin, Wiley-lnterscience, 1982, vol. 2, ch.
10, p. 282.
144. T. P. Chirpich, V. Zappia, R. N. Costilow and H. A. Barker, J. Bid.
1970, 2 4 5 , 1778.
145. V. Zappia and H. A. Barker, Biochem. Biophys. Acta, 1970, 2 0 7 , 505.
146. J. J. Baker and T. C. Stadtman in 'B^g', ed. D. Dolphin, Wiley- 
lnterscience, 1982, vol. 2, ch. 8, p. 206.
147. R. M. Petrovich, F. J. Ruzicka, G. H. Reed and P. A. Frey, J. Biol. 
Chem., 1 9 91 ,26 6 ,7 6 5 6 .
148. C. G. D. Morley and T. C. Stadtman, Biochemistry, 1970, 9, 4890.
149. J. J. Baker, C. van der Drift and T. C. Stadtman, Biochemistry, 1973, 
1 2 , 1054.
150. J. J. Baker, Fed. Proc., 1973 ,32 , 2126.
151. T. C. Stadtman, Adv. EnzymoL, 1973, 38 , 413.
152. W. J. McGahren, B. A, Hardy, G. O. Morton, F. M. Lovell, N. A.
Pekinson, R. T. Hargreaves, D. B. Borders and G. A. Ellestad, J. Org. 
Chem., 1981 ,46 ,792 .
153. M. L. Moss and P. A. Frey, J. Biol. Chem., 1990, 2 6 5 , 18112.
154. P. A. Frey, Chem. Rev., 1990, 90 ,1 3 43 .
155. M. D. Ballinger, P. A. Frey and G. H. Reed, Biochemistry, 1992 ,31 , 
10782.
156. D. J, Aberhart, S. J. Gould, H.-J. Lin, T. K. Thirubengadam and B. H.
233
Weiller, J. Am. Chem. Soc., 1983 ,105 , 5461.
157. T. C. Stadtman and P. Renz,Fed. Proc., 1967,26, 343.
158. J. M. Poston, Science, 1977 ,195, 301.
159. J. M. Poston and B. A. Hemmings, J. Bacteriol., 1 9 7 9 ,1 4 0 , 1013.
160. K. U. Ingold, in ‘Organic Free Radicals', ed. W. A. Prior, Am. Chem. 
Soc. Symposium Series 69, 1978, ch. 11, p. 198.
161. A. G. Davies, B. T. Golding, R. S. Hay-Motherwell, S. Mwesigye- 
Kibende, D. N. R. Rao and M. C. R. Symons, J. Chem. Soc. Chem. 
Comm., 1988, 378.
162. P. Dowd, M. Shapiro and J. Kang, Tetrahedron, 1984, 40, 3069.
163. P. Dowd and M. Shapiro, Tetrahedron, 1984, 40, 3063.
164. S. Wollowitz and J. Halpern, J. Am. Chem. Soc., 19 88 ,11 0 , 3112.
165. J. N. Lowe and L. L. Ingraham, J. Am. Chem.Soc., 1971, 93, 3801.
166. H. Flohr, W. Pannhorst and J. Retey, Anpew. Chem. Int. Ed. Engl.,
1976, 1 5 ,5 6 1 .
167. P. Dowd, S.-C. Choi, F. Duah and C. Kaufman, Tetrahedron, 1988, 4 4 , 
2137.
168. Y. Murakami, Y. Hisaeda and T. Ohno, Chem. Lett, 1987,1357.
169. Y. Murakami, Y. Hisaeda and T. Ohno, J. Chem. Soc. Chem.
Commun., 1988, 856.
170. Y. Murakami, Trends Biotech., 1992 ,10 ,170 .
171. ‘Enzyme Nomenclature’, International Union of Biochemistry, 
Academic Press, 1984, p 428.
172. J. M. Merrick and S. Roseman, J. Biol. Chem., 1960, 3 2 5 , 1274.
173. N. Tudball and J. G. O ’Neill, Microbios., 1 9 75 ,13 ,217 .
174. A. J. L. Cooper and A. Meister, Biochem. Biophys. Res. Commun., 
1973, 5 5 ,7 8 0 .
175. T. J. Carty, B. M. Babior and R. H. Abeles, J. Biol. Chem., 1971,246,  
6313.
176. R. N. Costilo and L. Laycock, J. Biol. Chem., 1971, 246, 6655.
177. J. C. Rabinowitz and W.E. Pricer, J. Am. Chem. Soc., 1956, 78, 5702.
178. E. R. Vagelos, J. M. Earl and E. R. Stadtman, J. Biol. Chem., 1959, 
2 3 4 ,4 9 0 .
179. E. Y. Levin and D. L. Coleman, J. Biol. Chem., 1967, 242, 4248,
180. N. J. MacLeod and J. B. Pridham, J. Biol. Chem., 1963, 246, 45.
234
181. A. I. Virtenen and J. Tarnanen, 8/oc/7em. Z ,  1932, 2 5 0 , 193.
182. H. Tabor, A. H Meyer, O. Hayaishi and J. White, J. Biol. Chem., 1952, 
1 9 6 ,1 2 1 .
183. J. Koukol and E. E. Conn, J. Biol. Chem., 1961, 236, 2692.
184. R. P. Cook and B. Woolf, Biochemical J., 1928,22, 474.
185. Y. Kurata, Exp. Cell Res.,1962, 28 , 424.
186. F. Salvatore, V. Zappia and C. Costa, Comp. Biochem. Physiol., 1965, 
1 6 ,3 0 3 .
187. S. Sazuki, J. Yamagushi and M. Tokushige, Biochem. Biophys. Acta, 
1973, 3 2 1 ,3 6 9 .
188. J. S. Takagi, N. Ida, M. Tokushige, M. Sakamoto and Y. Shimura,
Nucl. Acids Res., 1985 ,13 , 2063.
189. T. F. Emery,Biochemistry, 1963, 2, 1041.
190. W. E. Karsten, R. B. Gates and R. E. Viola, Biochemistry, 1986, 2 5 , 
1299.
191. V. R. Williams and D. J. Lartigue, Methods EnzymoL, 1 9 69 ,13 , 354.
192. R. H. Depue and A. G. Moat, J. Bacteriol., 1961, 8 2 , 383.
193. K. Mizuta and M. Tokushige, Biochem. Biophys. Acta, 1 9 7 5 ,4 0 3 , 221.
194. N. Ida and M. Tokushige, J. Biochem., 1984, 96, 1315.
195. N. Ida and M. Tokushige, J. Biochem., 1985, 9 8 , 793.
196. 1.1. Nuiry, J. D. Hermes, P. D. Weiss, C-Y Chan and P. J. Cook, 
Biochemistry, 1984, 2 3 , 5168.
197. D. J. T. Porter and H. J. Bright, J. Biol. Chem., 1980, 255, 4772.
198. S. J. Field and D. W. Young, J. Chem. Soc. Perkin Trans. I, 1983, 351.
199. N. W. Cornell and C. A. Villee, Comp. Biochem. Physiol., 1968, 2 7 , 
603.
200. T. G. Lessie and F. C. Neidhart, J. Bacteriol., 1967, 9 3 , 1800.
201. K. R. Hanson and E. A. Havir, The Enzymes’, ed. P. D. Boyer, 
Academic Press, NY, 1972,7, p. 75-163.
202. M. M. Rechler, J. Biol. Chem., 1969, 2 4 4 ,5 5 1 .
203. A. Peterkofsky, J. Biol. Chem., 1 962 ,237 , 787.
204. T. A. Smith, F. H. Cordelle and R. H. Abeles, Arc/?. Biochem. Biophys., 
1967, 1 2 0 ,7 2 4 .
205. R. B. Wickner, J. Bioi. Chem., 1 969 ,244 , 6550.
206. I. Givot, T. Smith and R. Abeles, J. Biol. Chem., 1969, 2 4 4 , 6341.
235
—207. T. Furata, H. Takahashi and Y. Kasuya, J. Am. Chem. Soc., 1 9 90 ,11 2 , 
3633.
208. T. Furata, H. Takahashi, H. Shibasaki and Y. Kasuya, J. Biol. Chem., 
1992, 2 6 7 , 12600.
209. M. R. Young, G. H. N. Towers and A. C. Neish, Can. J. Botany, 
1 9 6 6 ,4 4 ,3 4 1 .
210. R. J. Bandoni, K. Moore, P. V. Stubba Rao and G. H. N. Towers, 
Phytochemistry, 1968, 7 , 205.
211. K. HahIbrock and D. Scheel, Annu. Rev. Plant Physiol. Plant Mol.
Biol., 1 9 89 ,40 ,347 .
212. E. A. Havir and K. R. Hanson, Biochemistry, 1973 ,12 , 1583.
213. E. A. Havir and K. R. Hanson, Biochemistry, 1 9 75 ,14 ,1620 .
214. E. A. Havir and K. R. Hanson, Biochemistry, 1968, 7 , 1904.
215. E. A. Havir and K. R. Hanson, Methods EnzymoL, 1970, 575.
216. K. R. Hanson, E. A. Havir and C. Ressler, Biochemistry, 1 9 79 ,18 ,
1431.
217. N. Amrhein and K. H. Godeke, Plant Sci. Lett., 1977, 8 ,3 1 3 .
218. B. Laber, H. H. Kiltz and N. Amrhein, Z  Naturforsch.C: Biosci., 1986, 
4 1 ,9 .
219. J. Zon and N. Amrhein, Liebigs Ann. Chem., 1992, 625.
220. K. R. Hanson and E. A. Havir, Fed. Proc. Fed. Am. Soc. Exp. BioL,
1969, 2 8 ,6 0 2 .
221. K. R. Hanson and E. A. Havir, Arch. Biochem. Biophys., 1 9 7 0 ,1 4 1 , 1.
222. J. Zon and B. Laber, Phytochemistry, 1988, 2 7 ,7 1 1 .
223. W. W. Cleland, Bioorganic Chemistry, 1987 ,13 ,217 .
224. O. Adachi, K. Matsushita, E. Shinagawa and M. Ameyama, Agric.
Biol. Chem., 1990, 5 4 , 2839.
225. M. W. Hsiang and H. J. Bright, J. Biol. Chem., 1967, 2 4 2 , 3079.
226. M. W. Hsiang and H. J. Bright, Methods EnzymoL, 1 9 69 ,13 , 347.
227. M. W. Hsiang and H. J. Bright, Fed. Proc., 1967 ,26 , 605.
228. W. T. Wu, Ph. D. Thesis, Louisiana State University, 1968.
229. M. A. Cohen, Ph, D. Thesis, Southampton University, 1989.
230. W. T. Wu and V. R. Williams, J. Biol. Chem., 1968, 2 4 3 , 5644.
231. S. K. Goda, N. P. Minton, N. P. Botting and D. Gani, Biochemistry,
1992, 3 1 , 10747.
236
232. V. R. Williams and W. Lîbano, Biochim. Biophys. Acta, 1 9 66 ,1 1 8 ,1 4 4 .
233. H. J. Bright, Biochemistry, 1967, 6, 1191.
234. H. J. Bright and L. L. Ingraham, Biochim. Biophys. Acta, 1960, 4 4 ,
586.
235. H. J. Bright and R. Silverman, Biochim. Biophys Acta, 1964, 8 1 ,1 7 5 .
236. H. J. Bright, J. Biol. Chem., 1965, 2 4 0 , 1198.
237. G. A. Fields and H. J. Bright, Biochemistry, 1970, 9 , 3801.
238. H. Bright, J. Biol. Chem., 1964, 2 3 9 , 2307.
239. G. Walsh, in ‘Enzymatic Reaction Mechanisms’, W. H. Freeman, San 
Francisco, 1979, Ch. 18.
240. M. F. Winkler and V. R. Williams, Biochim. Biophys. Acta, 1 9 6 7 ,1 4 0 ,
287.
241. M. Akhtar, N. P. Botting, M. A. Cohen and D. Gani, Tetrahedron, 1987, 
4 3 ,5 8 9 9 .
242. M. Akhtar, M. A. Cohen and D. Gani, J. Chem. Soc. Chem. Commun., 
1986, 1290.
243. N. P. Botting, M. Akhtar, M. A. Cohen and D. Gani, Biochemistry, 1988, 
2 7 ,2 9 5 3 .
244. N. P. Botting, M. A. Cohen, M. Akhtar and D. Gani, Biochemistry, 1988, 
2 7 ,2 9 5 6 .
245. N. P. Botting and D. Gani, Biochemistry, 1992 ,31 , 1509.
246. N. P. Botting, A. A. Jackson and D. Gani, J. Chem. Soc. Chem. 
Commun., 1989,1583.
247. N. P. Botting and D. Gani, unpublished results.
248. N. P. Botting, M. Akhtar, C, H. Archer, M. A. Cohen, N. R. Thomas, S. 
Goda, N. P. Minton and D. Gani, in ‘Molecular Recognition: Chemical 
and Biochemical Problems 11’, ed. S. M. Roberts, RSC, 1992.
249. H. A. Barker, R. D. Smyth, E. J. Wawszkiewicz, M. N. Lee and R. M. 
Wilson, Arch. Biochem. Biophys., 1958, 7 8 , 468.
250. H. A. Barker, in ‘Enzymes’, ed. P. D. Boyer, 3rd ed. vol. 6, p. 509.
251. C. C. Wang and H. A. Barker, J. Biol. Chem., 1969, 2 4 4 , 2527.
252. A. I. Vogel, in ‘A Textbook of Quantitative Inorganic Analysis, Including 
Elementary Instrumental Analysis’, Longmans, 1961, 3rd Edition., p. 
784.
253. U. K. Laemmeli, Nature, 1970, 2 2 7 , 680.
237
254. B. Hartzoulakis, personal communication.
255. P. Walden, Chem. Ber., 1891,24, 2035.
256. C. Rappe, Acta Chem. Scand., 1963 ,17 , 2766.
257. O. E. Edwards and M. Lesage, Can. J. Chem., 1963 ,4 1 ,1592.
258. H. C. Brown and G. Zweifel, J. Am. Chem. Soc., 1960, 82, 3222.
259. A. I. Meyers and D. L. Temple, J. Am. Chem. Soc., 1970, 92, 6644.
260. K. Barlos, P. Mamos, D. Papaioannou, S. Patrianakou, J. Chem.
Soc., Chem. Commun., 1987, 1583.
261. K. Barlos, D. Papaioannou and D. Theodoropoulos, J. Org. Chem., 
1982, 47, 1324.
262. I. Muramatsu, M. Murakami, T. Yoneda and A. Hagitani, Bull. Chem. 
Soc. Jpn., 1965, 38, 244.
263. Dictionary of Organic Compounds, ed. J. R. A. Pollock and R. 
Stevens, Chapman and Hall, New York, 1982, 5th Edition, vol. 4, p. 
3749.
264. F. A. Loewus, F. H. Westheimer and B. Vennesland, J. Am. Chem. 
Soc., 1 9 53 ,75 ,5018 .
265. D. Arigoni and E. L. Eliel, in Topics in Stereochemistry’, ed. N. L. 
Allinger and E. L. Eliel, Interscience, New York, 1969, vol 4, p. 155.
266. H. Weber, PhD Dissertation No. 3591, ETH, Zurich, Switzerland, 
1965.
267. H. Weber, J. SeibI and D. Arigoni, Helv. Chim. Acta, 1966, 49, 741.
268. A. Steitwieser and M. R. Granger, J. Org. Chem., 1967, 3 2 , 1528.
269. H. R. Levy, F. A. Loewus and B. Vennesland, J. Am. Chem. Soc., 
1959, 7 9 ,2 9 4 9 .
270. H. Gunther, M. A. Alizade, M. Kellner. F. Biller and H. Simon, Z  
Naturforsch., 1973, 28, 241.
271. W. A. Cowdrey, E. D. Hughes and C. K. Ingold, J. Am. Chem. Soc., 
1937, 59, 1208.
272. H. C. Brown and S. Krishnamurthy, J. Am. Chem. Soc., 1973, 95, 
1669.
273. W. L. F. Armarego, B. A. Milloy and W. Pendergast, J. Chem. Soc. 
Perkin Trans 1, 1976, 2229.
274. S. Brandange and L. Morch, Acta Chem. Scand,. Ser. B, 1979, 33, 
776.
238
275. D. J. Prescott and J. L. Rabinowitz, J. Biol. Chem., 1968, 2 4 3 , 1551,
276. L. F. Fieser and M. Fieser, in ‘Reagents for Organic Synthesis’, John 
Wiley and Sons, New York, 1967, vol. 1.
277. Dictionary of Organic Compounds, ed. J. R. A. Pollock and R.
Stevens, Chapman and Hall, New York, 1982, vol. 5.
278. Vogel’s Textbook of Practical Organic Chemistry, ed. B. S. Furniss, A. 
J. Hannaford. P. W. G. Smith and A. R. Tatchell, Longman Scientific 
and Technical, 1989, 5th Edition, p. 692.
279. J. B. Lee, J. Am. Chem. Soc., 1966, 8 8 , 3440.
280. Vogel’s Textbook of Practical Organic Chemistry, ed. B. S. Furniss, A. 
J. Hannaford. P. W. G. Smith and A. R. Tatchell, Longman Scientific 
and Technical, 1989, 5th Edition, p. 1073.
281. W. Kirmse and L. Horner, Ann., 1959 ,6 2 5 ,34.
282. Dictionary of Organic Compounds, ed. J. R, A. Pollock and R.
Stevens, Chapman and Hall, New York, 1982, vol. 3.
283. Vogel’s Textbook of Practical Organic Chemistry, ed. B. S. Furniss, A. 
J. Hannaford. P. W. G. Smith and A. R. Tatchell, Longman Scientific 
and Technical, 1989, 5th Edition, p. 887.
284. N. P. Botting, unpublished observations.
285. D. Seebach and D. Wasmuth, Angew. Chem. Int. Ed. Engl., 1981, 20, 
971.
286. U. Schollkopf, Topics in Curr. Chem., 1 9 8 3 ,1 0 9 ,6 5 .
287. U. Schollkopf, J. Nozulak and M. Grauert, Synthesis, 1985, 55.
288. S. Hanessian, K. Sumi and B. Vanasse, Syn. Lett., 1992, 33.
289. E. M. Richards, J. C. Tebby. R. S. Ward and D. H. Williams, J. Chem. 
Soc. (C), 1969, 1542.
290. V. du Vigneaud and C. E. Meyer, J. Biol. Chem., 1 9 3 2 ,9 8 , 295.
291. S. M. Birnbaum, L. Levintow, R. B. Kingsley and J. P. Greenstein, J. 
Biol. Chem., 1952 ,194, 455.
292. M. Wilchek and A. Patchornik, J. Org. Chem., 1963, 28, 1874.
293. G. W. Anderson, J. E. Zimmerman and F. M. Callahan, J. Org. Chem., 
1 9 6 7 ,89 ,5 0 1 3 .
294. U. Schollkopf, U. Groth and C. Deng, Angew. Chem. Int. Ed. Engl., 
1 9 8 1 ,2 0 ,7 9 8 .
295. N. R. Thomas, Ph. D. Thesis, University of Southampton, 1990.
239
296. A. Paquet, Can. J. Chem., 1982, 6 0 , 976.
297. A. Fers ht, in ‘Enzyme Structure and Mechanism,’ W. H. Freeman, New 
York, 1985, 2nd Edition.
298. W.-B. Chiao and W. H. Saunders, J. Am. Chem. Soc., 1977, 9 9 , 6699.
299. Y.-T. Tao and W. H. Saunders, J. Am. Chem. Soc., 1 9 8 3 ,1 0 5 , 3183.
300. M. H. O ’Leary, in ‘Isotope Effects on Enzyme-Catalysed Reactions,’ 
eds. W. W. Cleland, M. H. O ’Leary and D. B. Northrop, University Park 
Press, Baltimore, 1977, pp. 233-251.
301. R. H. Burris, Methods EnzymoL, 1957, 4 , 355.
302. P. Fresenius, ‘Organic Chemical Nomenclature’, John Wiley and 
Sons, New York, 1988.
303. W. C. Still, M. Kahn and A. J. Mitra, J. Org. Chem., 1978, 4 3 , 2923.
304. M. M. Bradford, Anal. Biochem., 1976 ,72 , 248.
305. D. D. Perrin, W. L. F. Armarego and D. R. Perrin, ‘Purification of 
Laboratory Chemicals’, Permagon Press, Oxford, 1980, 2nd Edition.
306. E. Fischer, Chem. Ber., 1907, 4 0 , 489.
307. J. E. Rose, Ph. D. Thesis, University of St. Andrews, 1992.
308. R. J. Leatherbarrow, Enzfitter, A non-linear regression data analysis 
program (from the Chemistry Department, Imperial College of 
Science, Technology and Medicine, London, SW7 2AY, U. K.) 
published and distributed by Biosoft, Cambridge, CB2 U P , U. K.,
1987.
240
Appendix 1
Recombinant 3-methylaspartase was used, when it became available, as 
the preparations had a higher specific activity. The recombinant enzyme 
was prepared, by Dr Mahmoud Akhtar, utilizing the method below.
Grow Up and Purification of Recombinant 3-Methvlaspartase
L-Broth (3 I) was autoclaved and allowed to cool. L-Broth (1 I) contains 
sodium chloride (10 g), Bacto-yeast extract (5 g) and Bacto-tryptone (10 g) 
and has a pH of 7.5.
Ampercillin was added to a concentration of 50 mg/l and the broth 
innoculated with cells containing plasmid, pSG4. The mixture was shaken 
at 37 °C for 16 hours. The cells were then harvested.
Cell paste (10 g) was suspended in 50 mM potassium phosphate buffer (20 
ml, pH 7.6) containing mercaptoethanol (1 mM) and the protease inhibitor 
phenylmethanesulphonyl fluoride (PMSF) (200 pi of a 34 mg ml""* solution in 
/so- propanol). The solution was sonicated (140 W, 20 kHz) in eight 30 
second bursts at 0-5 °C. Acetone (25 ml), precooled to -20 °C, was added 
with stirring over 5 minutes and stirring continued at 4 °C for a further 10 
minutes. The cell debris and precipitated protein were removed by 
centrifugation at 0 °C (37 000 g, 30 min.) to give a crude extract. A further 
portion of precooled acetone (30 ml) was added and, after being stirred for 
10 minutes, the precipitated protein was collected by centrifugation at 0 °C 
(37 000 g, 20 m in.). The protein pellet was resuspended in 50 mM 
potassium phosphate buffer (2.5 ml, pH 7.6) with swirling at 4 °C and the 
insoluble material was removed by centrifugation at 10 °C (37 000 g, 10 
min.).
The protein solution (2.85 ml) was applied to a column of Sephadex G-150 
(1.3 X  170 cm), pre-equilibrated with 50 mM potassium phosphate buffer (pH 
7.6) containing 10 mM mercaptoethanol at 4 °C. The protein was eluted with
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the same buffer at a rate of 6 ml h"\ collecting 6 ml fractions. The active 
fractions (25 - 39) were pooled and the protein solution was concentrated to 
3 ml by ultrafiltration (Amicon cell fitted with a YM10 filter), at 4 °C. Distilled 
water (15 ml) was added to the ultrafiltration cell to dilute the salt and the 
protein solution was again concentrated to 3 ml.
A 1 ml aliquot of the protein solution was applied to an LKB-Pharmacia TSK 
DEAE-5PW  column (2.15 x 15 cm) equilibrated with 10 mM potassium 
phosphate buffer (pH 7.6). The column was washed with the same buffer at 
a flow rate of 4 ml min’ ’*, collecting 4 ml fractions and a salt gradient of 0 - 
500 mM KCI in the same buffer was applied. The active enzyme eluted in a 
volume of 24 ml at approximately 80 mM KCI. The pooled active fractions 
were concentrated to 1 ml by ultrafiltration as before and the potassium ion 
concentration was reduced to 10 mM by adding distilled water and 
reconcentrating the protein to about 1 ml, as above. The resulting solution 
was reapplied to the TSK DEAE-5PW FPLC column, pre-equlibrated as 
before and the active enzyme was collected in three 4 ml fractions after 
application of the salt gradient. The protein was obtained in 22 % yield.
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